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ARTICLE
Regulation of Chemical Risks: Lessons for
Reform of the Toxic Substances Control Act
from Canada and the European Union*
Adam D.K. Abelkop**
John D. Graham***

Industrial chemicals are ubiquitous. There are approximately
100,000 chemical substances in commerce around the world.1
About 30,000 substances are produced at a quantity greater than
one metric tonne per year.2 In the United States (U.S.), of the
84,000 chemicals listed on the federal government’s inventory,
approximately 8,000 (non-polymeric) chemicals are produced in
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volumes greater than eleven tonnes per year.3 A relatively small
fraction of chemicals account for the vast majority of production
volume, but consumers are nonetheless exposed to thousands of
chemicals through products that they use every day. They are
used in electronics, clothing, furniture, and carpets. They make
up products such as cosmetics, detergents, paints, adhesives, and
surfactants.
Chemicals provide many benefits to consumers, but they also
present risks. Identifying which uses pose significant risks can be
a difficult process, as is deciding what should be done when
significant risks are identified. Of the chemicals in commerce that
have been tested, the majority have been shown to not be
hazardous, but industry and government lack even basic data on
the intrinsic properties, uses, and exposure pathways for a large
number of substances.4 For decades, nations around the world
have been updating their regulatory programs to address this
worrisome gap in information because it hampers the
effectiveness of regulatory risk management and impairs public
confidence in the safety of the chemical industry.5
Regulation of industrial chemicals is in a period of global
maturation.6 In 2002, the United Nations World Summit on
Sustainable Development (WSSD) established the goal that “by
2020, . . . chemicals are used and produced in ways that lead to
3. U.S. GOV’T ACCOUNTABILITY OFFICE, GAO-13-249, TOXIC SUBSTANCES: EPA
HAS INCREASED EFFORTS TO ASSESS AND CONTROL CHEMICALS BUT COULD
STRENGTHEN ITS APPROACH 10 n.12 (2013) [hereinafter GAO TOXIC SUBSTANCES].
4. See id. at 12–17; JOHN S. APPLEGATE & KATHERINE BAER, STRATEGIES FOR
CLOSING
THE
CHEMICAL
DATA
GAP
1
(2006),
available
at
http://www.progressivereform.org/articles/Closing_Data_Gaps_602.pdf;
CHEM.
MFRS. ASS’N, PUBLIC AVAILABILITY OF SIDS-RELATED TESTING DATA FOR U.S. HIGH
PRODUCTION VOLUME CHEMICALS (1998); ENVTL. DEF. FUND, TOXIC IGNORANCE:
THE CONTINUING ABSENCE OF BASIC HEALTH TESTING FOR TOP-SELLING
CHEMICALS IN THE UNITED STATES (1997), available at http://www.edf.
org/sites/default/files/243_toxicignorance_0.pdf; NAT’L RESEARCH COUNCIL,
TOXICITY TESTING: STRATEGIES TO DETERMINE NEEDS AND PRIORITIES 19 (1984);
John S. Applegate, Bridging the Data Gap: Balancing the Supply and Demand
for Chemical Information, 86 TEX. L. REV. 1365, 1380–83 (2008).
5. See Michael Gilek et al., Introduction to REGULATING CHEMICAL RISKS:
EUROPEAN AND GLOBAL CHALLENGES 1, 3 (Johan Eriksson et al. eds., 2010).
6. Gunnar Bengtsson, Global Trends in Chemicals Management, in
REGULATING CHEMICAL RISKS: EUROPEAN AND GLOBAL CHALLENGES 192, 199–202
(Johan Eriksson et al. eds., 2010); HENRIK SELIN, GLOBAL GOVERNANCE OF
HAZARDOUS CHEMICALS: CHALLENGES OF MULTILEVEL MANAGEMENT 1–7 (2010).
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the minimization of significant adverse effects on human health
and the environment.”7 The WSSD goal constitutes one of several
international responses to the need for coordinated assessment
and management of the potential adverse effects from chemical
exposures. In 1999, the government of Canada revised the
Canadian Environmental Protection Act (CEPA) to accelerate the
processes of chemical assessment and management. CEPA8
mandated that the government categorize its inventory of
existing substances to identify priorities for assessment, and the
government completed the categorization on schedule in 2006.9
That year, the Canadian government launched its Chemicals
Management Plan (CMP) to meet the WSSD goal.10
Also in 2006, the European Union (EU) enacted the
Registration, Evaluation, Authorization, and Restriction of
Chemicals (REACH) regulation to address gaps in data, to go
beyond prior EU Directives in the control of industrial chemicals,
to protect human health and the environment, and to enhance
the sustainability and competitiveness of the European chemical
industry.11
Japan enacted revisions to its chemicals law in 2003 and
2009, along with South Korea in 2008 and 2013, and China in
7. The World Summit on Sustainable Development, Johannesburg, S. Afr.,
Aug. 26–Sept. 4, 2002, Report of the World Summit on Sustainable Development,
U.N. Doc. A/CONF.199/20. See also United Nations Conference on Environment
and Development, Rio de Janeiro, Braz., June 3–14, 1992, Preliminary Report of
the United Nations Conference on Environment and Development, U.N. Doc.
A/CONF.151/26 (Vol. II), Annex II (Aug. 13, 1992).
8. See Canadian Environmental Protection Act, S.C. 1999, c. 33, available at
http://www.ec.gc.ca/lcpe-cepa/default.asp?lang=En&n=24374285-1. The two laws
are referred to as “CEPA 1988” and “CEPA 1999.” For our purposes, we use the
acronym “CEPA” to refer to the 1999 legislation and specify “CEPA 1988” when
referring to the earlier law.
9. CEPA § 73(1). Categorization of Existing Substances, ENV’T CAN.,
http://www.ec.gc.ca/lcpe-cepa/default.asp?lang=En&n=5F213FA8-1&wsdoc=169
5F8D0-5CC4-EDA1-AF63-6F23A94064DD (last modified July 9, 2013).
10. Press Release, Prime Minister of Canada, Canada’s New Government
Improves Protection against Hazardous Chemicals (Dec. 8, 2006), available at
http://www.pm.gc.ca/eng/media.asp?category=1&id=1450.
11. Lucas Bergkamp & Mike Penman, Introduction to THE EUROPEAN UNION
REACH REGULATION FOR CHEMICALS: LAW AND PRACTICE 3–4 (Lucas Bergkamp
ed., 2013); Veerle Heyvaert, Regulating Chemical Risk: REACH in a Global
Governance Perspective, in REGULATING CHEMICAL RISKS: EUROPEAN AND GLOBAL
CHALLENGES 219–21 (Johan Eriksson et al. eds., 2010).
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2010 and 2013, to name only a few.12 Additionally, U.S. states,
prominently California, have enacted new programs aimed at
assessing and reducing the potential for adverse effects from
chemical exposures.13
Meanwhile, the U.S. Congress has been slow to modernize
the Toxic Substances Control Act of 1976 (TSCA), despite a broad
consensus that the current design of TSCA is outmoded.14
Recently, there have been some signs of progress in the TSCA
reform effort. In May 2013, the late Senator Frank Lautenberg
(Democrat–New Jersey) and Senator David Vitter (Republican–
Louisiana) released a bill entitled the Chemical Safety
Improvement Act—the most significant of several recent TSCA
reform bills because of its bipartisan sponsorship.15 The House of
Representatives has recently held hearings on TSCA reform, and
a draft reform bill has been circulated for comment.16 Although it
is far from clear that Congress will pass TSCA reform in the near
future, there is more legislative momentum for reform than there

12. Jean-François Tremblay, China Steps Up Toxin Controls, 91 CHEMICAL &
ENGINGEERING NEWS 10 (Mar. 4, 2013); Korea Toxic Chemicals Control Act
(TCCA), CHEM. INSPECTION & REGULATION SERV., http://www.cirsreach.com/KoreaTCCA/Korea_Toxic_Chemicals_Control_Act_TCCA.html
(last
visited Nov. 5, 2014); Speech by MEP Minister Zhou Shengxian at 2013 National
Work Meeting on Environmental Protection, MINISTRY OF ENVTL. PROT. – CHINA
(Feb. 4, 2013), http://english.mep.gov.cn/Ministers/Speeches/201303/t20130320
_249648.htm; The Amended Japanese Chemical Substances Control Law,
REACH24H CONSULTING GRP. (Mar. 17, 2011), http://www.reach24h.com/enus/cscl.html.
13. See, e.g., CAL. DEP’T OF TOXIC SUBSTANCES CONTROL, SAFER CONSUMER
PRODUCTS, PROPOSED REGULATIONS, R-2011-02: ATTACHMENTS (2013), available
at
http://www.dtsc.ca.gov/LawsRegsPolicies/Regs/upload/2-SCP-REVISEDProposed-Regulations_APA-MARKUP-April-2013.pdf.
14. See, e.g., Revisiting the Toxic Substances Control Act of 1976: Hearing
Before the Subcomm. on Commerce, Trade, & Consumer Prot. of the H. Comm.
on Energy & Commerce, 111th Cong. 1 (2009) [hereinafter House, Revisiting
TSCA],
available
at
http://www.gpo.gov/fdsys/pkg/CHRG-111hhrg67095/
pdf/CHRG-111hhrg67095.pdf; MITCHELL P. SMITH, ENVIRONMENTAL AND HEALTH
REGULATION IN THE UNITED STATES AND THE EUROPEAN UNION 26-27 (2012).
15. Chemical Safety Improvement Act, S. 1009, 113th Cong. (2013), available
at http://cen.acs.org/content/dam/cen/91/web/S-1009-113th-Congress.pdf.
16. STAFF OF H.R. ENERGY & COMMERCE COMM., 113TH CONG., DISCUSSION
DRAFT ON CHEMICALS IN COMMERCE ACT (Comm. Print 2014), available at
http://docs.house.gov/meetings/IF/IF18/20140429/102160/BILLS-113pihTheChemicalsinCommerceAct.pdf.
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has been since 1976 as evidenced by the serious bipartisan
negotiations under way in both chambers of the U.S. Congress.17
As the market for industrial chemicals is global, and because
chemical releases can cross borders, future legislation and
regulations will likely have international effects on industry
management practices, trade patterns, and the global
distribution of risks to human health and the environment. Thus,
the TSCA reform effort is not an isolated national effort but can
be viewed in the context of the global trend toward modernization
of chemicals management. United States policymakers have the
opportunity to learn from the experiences of other nations to craft
legislation that will work in harmony with ongoing regulatory
efforts.
The cross-national diffusion of environmental policy
innovation has been well documented.18 While one country rarely
adopts verbatim the environmental reforms of another, key
concepts and procedures are often borrowed and tailored.
In that spirit, the purpose of this Article is to compare the
regulatory systems in Canada and the EU, and use comparative
17. See Press Release, Senate Comm. on Env’t & Pub. Works, Vitter
Announces Growing Support for Bipartisan TSCA Reform Bill (Apr. 15, 2014),
available at http://www.epw.senate.gov/public/index.cfm?FuseAction=PressRoom.PressReleases&ContentRecord_id=f88d6771-eafb-65e1-85bc-86dca0416958.
18. See generally ANNE-MARIE SLAUGHTER, A NEW WORLD ORDER (2004);
David Lazer, Global and Domestic Governance: Modes of Interdependence in
Regulatory Policymaking, 12 EUR. L.J. 455, 455 (2006). On environmental law,
see Francesca Bignami & Steve Charnovitz, Transatlantic Civil Society
Dialogues, in TRANSATLANTIC GOVERNANCE IN THE GLOBAL ECONOMY 270 (Mark
A. Pollack & Gregory C. Shaffer eds., 2001); Gabrielle Bouleau & Matt Kondolf,
Rivers of Diversity: Water Regulation in California and the EU, in
TRANSATLANTIC REGULATORY COOPERATION: THE SHIFTING ROLES OF THE EU, U.S.,
AND CALIFORNIA 84 (David Vogel & Johan F.M. Swinnen eds., 2011); Mauro
Pettricione, Reconciling Transatlantic Regulatory Imperatives with Bilateral
Trade, in TRANSATLANTIC REGULATORY COOPERATION: LEGAL PROBLEMS AND
POLITICAL PROSPECTS (George A. Bermann et al. eds., 2001); Per-Olof Busch &
Helge Jörgens, The International Sources of Policy Convergence: Explaining the
Spread of Environmental Policy Innovations, 12 J. EUR. PUB. POL’Y 860 (2005);
Veerle Heyvaert, Globalizing Regulation: Reaching Beyond the Borders of
Chemical Safety, 36 J.L. & SOC’Y 110 (2009); Noah M. Sachs, Jumping the Pond:
Transnational Law and the Future of Chemical Regulation, 62 VAND. L. REV.
1817 (2009); Joanne Scott, From Brussels with Love: The Transatlantic Travels
of European Law and the Chemistry of Regulatory Attraction, 57 AM. J. COMP. L.
897 (2009); Tseming Yang & Robert V. Percival, The Emergence of Global
Environmental Law, 36 ECOLOGY L.Q. 615 (2009).
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insights to draw some lessons that may be of interest to U.S.
policy makers engaged in TSCA reform. CEPA and REACH are
seen by stakeholders as state of the art in chemicals assessment
and management, and thus the U.S. may draw useful insights
from them. Indeed, the European Union and Canada have each
been urging other countries to join in a globalization of the
REACH or Canadian programs, respectively.19 Regardless of
what TSCA reformers choose to learn from the Canadian and
European experiences, a secondary objective of the Article is to
provide comparative information that may be of interest to
reformers in Canada, Europe, or other countries and regions
where chemical risk management is under consideration for
reform. Thus, the Article’s long-term value extends beyond the
current U.S. debate over TSCA reform.
The Article is organized in three Parts. In Part I, we describe
the scope of our analysis, our research methods, and our
analytical approach. In Parts II and III, we compare CEPA and
REACH across two significant dimensions: (1) prioritization of
existing chemicals for assessment and regulation; and (2)
placement of the burdens to produce data and demonstrate safety
of specific chemical uses. We conclude by summarizing the
possible lessons for TSCA reform and highlighting some future
research needs.
I.

COMPARATIVE ANALYSIS OF RISK
REGULATION IN CEPA AND REACH

Regulation of chemicals generally seeks to prevent or reduce
adverse effects to human health and the environment. In a
variety of ways, regulation facilitates the generation of safetyrelated information and ensures that such information is made
available to regulators and, where permissible, to the public.
Safety information is also disseminated via material safety data
sheets and labels throughout supply chains where chemicals are
processed, transported, and used.20 Such information facilitates
19. Alex Scott, Global Approach to Chemical Regulations: A Worthy, But
Difficult Goal, CHEMICAL & ENGINEERING NEWS, June 11, 2012, at 26.
20. See generally Material Safety Data Sheets (MSDSs) - General, CANADIAN
CTR. FOR OCCUPATIONAL HEALTH & SAFETY, http://www.ccohs.ca/oshanswers
/legisl/msdss.html (last visited Nov. 1 2014).
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informed safety decisions and stimulates green market forces by
encouraging safety in the design and selection of chemicals for
use in products. Safety information also may spawn risk
management measures that can range from guidance on safe
handling practices and spill prevention measures to limitations or
prohibitions on certain substances or particular uses of those
substances.21
Regulatory programs often pursue safety objectives through a
process that includes some mechanism for identification of
chemicals of concern, assessment of the environmental releases,
exposures, and risks posed by those chemicals in specific uses, as
well as the management of those releases, exposures, and risks.22
If substitution of a different chemical is considered in the
management phase, the risks of the target chemical may be
compared to the risks of possible substitutes, including an
evaluation of the utility of various chemical alternatives in
accomplishing the function needed by industry and consumers.23
Thus, the management phase of chemical regulation entails a
variety of analyses that go beyond an inquiry into the intrinsic
properties of a chemical.
A. Risk Assessment and Safety
Risk is present when there is a hazard and sufficient
exposure to that hazard. Risk assessment, the primary tool used
to make safety determinations, includes four primary
components.24 We offer some depth in the review of the four
21. Bengt Bucht, Capacity Building for Chemicals Control: Legislation,
Institutions, Public-Private Relationships, in REGULATING CHEMICAL RISKS:
EUROPEAN AND GLOBAL CHALLENGES 283, 285 (Johan Eriksson et al. eds., 2010).
22. Andreas Klinke & Ortwin Renn, Risk Governance: Contemporary and
Future Challenges, in REGULATING CHEMICAL RISKS: EUROPEAN AND GLOBAL
CHALLENGES 9, 13–22 (Johan Eriksson et al. eds., 2010).
23. See Ragnar Löfstedt, The Substitution Principle in Chemical Regulation:
A Constructive Critique, 17 J. RISK RES. 543 (2014).
24. See, e.g., NAT’L RESEARCH COUNCIL, RISK ASSESSMENT IN THE FEDERAL
GOVERNMENT: MANAGING THE PROCESS 3 (1983) [hereinafter NRC 1983]. JOHN S.
APPLEGATE ET AL., THE REGULATION OF TOXIC SUBSTANCES AND HAZARDOUS
WASTES: CASES AND MATERIALS 3–4 (Robert C. Clark et al. eds., 2d ed. 2011); see
also C.J. van Leeuwen, General Introduction, in RISK ASSESSMENT OF
CHEMICALS: AN INTRODUCTION 2–6 (C.J. van Leeuwen & T.G. Vermeire eds., 2d
ed. 2007); Celia Campbell-Mohn & John S. Applegate, Learning from NEPA:
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components because it is critical for the reader to appreciate (a)
how complex a comprehensive risk assessment can be and why
rudimentary assessments are useful, (b) the significant degree of
uncertainty that can accompany the findings of even well-done
risk assessments, and (c) the role of risk assessment in assessing
the effectiveness of alternative risk management measures. Since
there are good textbooks on the basics of chemical risk
assessment,25 we simply summarize the four basic components to
set the stage for the comparison of CEPA and REACH with
regard to risk assessment and management practices.
First, hazard identification evaluates inherent chemical
properties to determine the capacity of a substance to cause
adverse effects in humans or the environment.26 Since regulatory
resources are limited, governments tend to target chemicals that
exhibit particularly troubling properties. Of special concern for
human health are chemicals that have toxic effects at relatively
low doses, or are known to be carcinogens, mutagens, or
reproductive (CMR) toxins. More recently, emphasis has been
given to chemicals that are known or suspected to disrupt the
endocrine system of the body—endocrine-disrupting chemicals
(EDCs).27 Greater priority for environmental wellbeing is also
given to chemicals that may persist (P) in the environment rather
than break down, that may bioaccumulate (B) in organisms, and
that may be toxic (T). Chemicals that have all three properties
are called PBTs.28 Chemicals that are very persistent and very

Guidelines for Responsible Risk Regulation, 23 HARV. ENVTL. L. REV. 93, 95–98
(1999).
25. See, e.g., RICHARD WILSON & EDMUND A.C. CROUCH, RISK-BENEFIT
ANALYSIS 113–21 (2001); HUMAN AND ECOLOGICAL RISK ASSESSMENT: THEORY AND
PRACTICE (Dennis J. Paustenbach ed., 2d ed. 2009).
26. NRC 1983, supra note 24, at 19–23.
27. See generally Laura N. Vandenberg et al., Hormones and EndocrineDisrupting Chemicals: Low-Dose Effects and Nonmonotonic Dose Responses, 33
ENDOCRINE REV. 378 (2012), available at http://www.ncbi.nlm.nih.gov/
pmc/articles/PMC3365860/.
28. See generally ADAM D.K. ABELKOP, TODD V. ROYER & JOHN D. GRAHAM,
PERSISTENT, BIOACCUMULATIVE, AND TOXIC (PBT) CHEMICALS: TECHNICAL
ASPECTS, POLICIES, AND PRACTICES (forthcoming 2015); JOHN WARGO, GREEN
INTELLIGENCE: CREATING ENVIRONMENTS THAT PROTECT HUMAN HEALTH 284–87
(2009).
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bioaccumulative are sometimes referred to as vPvBs and may
also be regulated as a special class.29
The Fifteenth Century German scientist Paracelsus (credited
for founding the discipline of toxicology) explained that “the dose
makes the poison.”30 Alcohol can kill people if ingested in
excessive amounts, but alcohol can also improve health if
consumed in moderation.31 All substances can cause toxic effects,
but some cause toxic effects at much lower exposure levels than
others. There is some evidence suggesting that some EDCs and
reproductive toxins may cause effects at low doses that were
previously considered safe.32 Thus, the hazard identification
process, by itself, does not provide meaningful information about
risk because knowledge of risk also requires knowledge of the
amount of exposure in the real-world environment.33
The second step of risk assessment is dose-response
assessment, where the level of exposure to a substance (e.g., the
dose) is related to the frequency and/or severity of adverse effects
(the response).34 Sometimes the level of exposure is simply
compared to the level of exposure that is considered safe, with the
ratio of the exposure level to the safe dose serving as an indicator
of risk. The dose-response relationship is influenced by how the
chemical is taken up, distributed, and metabolized by the body
and the biological mechanisms that relate dose to adverse effects.
As the dosage to an organism increases, and other factors are
held constant, the probability and/or severity of adverse effects is
expected to increase. If large numbers of people are exposed to
substances that exhibit toxic effects at relatively low doses, the

29. REACH, art. 14(3)(d); ABELKOP, ROYER & GRAHAM , supra note 28.
30. APPLEGATE ET AL., supra note 24, at 4.
31. See, e.g., Alcohol Use: If You Drink, Keep it Moderate, MAYO CLINIC (Feb.
11, 2014), http://www.mayoclinic.org/healthy-living/nutrition-and-healthy-eating
/in-depth/alcohol/art-20044551.
32. See TED SCHETTLER ET AL., GENERATIONS AT RISK: REPRODUCTIVE HEALTH
AND THE ENVIRONMENT 63 (MIT Press Paperback ed. 2000). See generally
Vandenberg et al., supra note 27.
33. On the importance of exposure in risk assessment, see ALISON C. CULLEN
& H. CHRISTOPHER FREY, PROBABILISTIC TECHNIQUES IN EXPOSURE ASSESSMENT: A
HANDBOOK FOR DEALING WITH VARIABILITY AND UNCERTAINTY IN MODELS AND
INPUTS (1999).
34. NRC 1983, supra note 24, at 19, 21, 23–27.
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number of adverse health outcomes in the population can be
substantial.35
The concept of dose-response assessment applies to nonhuman species as well as people, but the unit of analysis may be
different. When dose-response analysis is performed to protect
humans, the protection is modeled at the level of the individual
human being (or even an organ or tissue). When applied
ecologically, dose-response analysis is designed to inform
protection at the population level, except in rare cases such as an
endangered or threatened species.36
When there is an exposure level that is sufficiently small to
effectively eliminate any possible adverse effects on an organism,
that dose is called a threshold.37 Since some individuals are more
sensitive to chemical risks than others, the strict threshold for an
entire population of human beings is the threshold for the most
susceptible person in the population.38 In practice, sensitivity to
chemical exposure is usually analyzed for groups of people rather
than on an individual-by-individual basis. The “safe”39 dose of a
35. The low-dose effects of bisphenol-A, the primary component of many
plastics, are a matter of intense scientific and public debate. See SARAH A.
VOGEL, IS IT SAFE? BPA AND THE STRUGGLE TO DEFINE THE SAFETY OF CHEMICALS
(2013); WARGO, supra note 28, at 272–76.
36. See David L. Eaton & Steven G. Gilbert, Principles of Toxicology, in
CASARETT & DOULL’S TOXICOLOGY: THE BASIC SCIENCE OF POISONS 17, 19 (Curtis
D. Klaassen & John B. Watkins eds., 7th ed. 2008).
37. Id. at 23, 23–24 (A threshold occurs when there is “some dose below
which the probability of the individual responding is zero.”); NRC 1983, supra
note 24, at 25 (“[B]elow a particular dose (the "threshold" dose of a given
carcinogen) there is no adverse effect.”).
38. On the distinction between the individual and population dose-response
function, see NAT’L RESEARCH COUNCIL, SCIENCE AND DECISIONS: ADVANCING RISK
ASSESSMENT 141–43 (2009) [hereinafter NRC 2009].
39. The term safe is in quotation marks because laboratory tests with limited
numbers of animals cannot demonstrate safety in the strict sense that such a
term may be understood by some citizens. In practice, toxicologists find a dose
where there is no observable adverse effect, though there may by some effects
that are not statistically significant or not adverse. A more modern procedure is
to use the dose-response data in the animal test to calculate a lower confidence
limit on the dose predicted to produce a defined incidence rate of adverse
effect—usually about ten percent or so—or a change in a continuous
physiological parameter of a pre-set magnitude. The important point is that a
negative test result at a particular dose does not necessarily mean that the dose
is completely safe. For a classic introduction to the issues in using animal data
in risk assessment and safety determinations, see David P. Rall, The Use of
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chemical in humans is typically assumed to be a fraction of the
presumed threshold in laboratory animals because margins of
safety—also known as uncertainty factors or assessment
factors—are applied to account for possible uncertainties,
including the imperfections in data quality, the extrapolation of
data from the test species to humans, the extrapolation of effects
from high experimental doses to low doses, and intra-species
variability (e.g., some humans are more sensitive than others).40
Historically, thresholds have been assumed to exist for noncancer effects but not for cancer; however, recent reviews suggest
that this distinction is too simple since some non-cancer effects
may not exhibit thresholds while some cancer effects may exhibit
thresholds.41
Third, exposure assessment aims to determine the extent to
which human and non-human species will come into contact with
a substance, whether via respiration, ingestion, or dermal
contact.42 To quantify the exposure for a population of interest,
the exposure assessor usually works with information on the
production quantity of a chemical, the amount of the chemical
dedicated to various uses, the quantity released into the
environment (air, water, soil) during specific uses, the transport
and fate of the chemical in the environment, and the ultimate
population distribution of exposure.43 The behaviors of people on
a day-to-day basis (e.g., dietary habits and indoor versus outdoor
activity) can significantly influence the level of human exposure
to a substance.44 Exposures may be measured directly (e.g., with
air and water quality measurements or with personal exposure
monitors) or estimated through the use of mathematical models.
Laboratory Animal Carcinogenicity Data in Occupational Risk Assessment, in
CHEMICAL RISK ASSESSMENT AND OCCUPATIONAL HEALTH: CURRENT APPLICATIONS,
LIMITATIONS, AND FUTURE PROSPECTS 105, 105–11 (C. Mark Smith et al. eds.,
1994). For a basic statistical treatment of the issues, see CHARLES D. HOLLAND &
ROBERT L. SIELKEN, QUANTITATIVE CANCER MODELING AND RISK ASSESSMENT
(1993).
40. For a classic introduction to the determination of “safe” doses, see JOSEPH
V. RODRICKS, CALCULATED RISKS: THE TOXICITY AND HUMAN HEALTH RISKS OF
CHEMICALS IN OUR ENVIRONMENT (2d ed. 2006).
41. NRC 2009, supra note 38, at 177.
42. CULLEN & FREY, supra note 33, at 2.
43. See id.
44. Id.

11

3_ABELKOP&GRAHAM FINAL

2015

8/24/2015 12:05 PM

REGULATION OF CHEMICAL RISKS

119

A key statistic of growing importance to risk assessment is the
“intake fraction,” the proportion of a released chemical that
ultimately is taken in by people via ingestion, respiration, or
dermal absorption.45
Fourth, risk characterization generates a (usually)
quantitative estimation of the magnitude of risk to human health
and the environment from specific uses of a chemical.46 A simple
version of characterization may be the ratio of an exposure from a
specific use to a safe level. A more complex characterization is a
quantitative indication of risk such as a probability of an adverse
effect or a projected incidence rate of adverse effect in an exposed
Characterization requires the examination of
population.47
hazard and exposure data together, accounting for uncertainties
and assumptions in test data, monitoring data, and data
generated from computer modeling programs.48
The same chemical may be characterized as high risk or low
risk depending on how it is used by industry, how much of the
chemical is released near population centers or downwind or
downstream of population centers, or how much of the chemical
may reach consumers via the use of specific products (e.g.,
dishwashing, detergents, paints, and flame retardants). Thus, for
an industrial chemical with numerous uses, the risk
characterization—and especially the exposure assessment—can
be quite complex.49 The adoption of risk management measures
also influences the risk characterization by reducing the
exposures to the target chemical. Thus, the risk characterization
may portray not only the current level of risk, but also the
projected levels of risk under alternative risk management
measures.
Recently, the scientific committees of the European
Commission’s Directorate-General for Health and Consumers
produced an important document on the need for refinement of
45. See Deborah H. Bennett et al., Defining Intake Fraction, 36 ENVTL. SCI. &
TECH. 3A, 5A (2002), available at http://ehs.sph.berkeley.edu/krsmith/
publications/02_bennett_1.pdf.
46. Id. at 4A.
47. Campbell-Mohn & Applegate, supra note 24, at 96–97.
48. See id.
49. On the complexities in exposure assessment, see CULLEN & CHRISTOPHER
FREY, supra note 33.
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risk assessment procedures.50 For ecological risk assessment, the
document recommends moving toward approaches capable of
better understanding and quantifying actual damages to the
structure and functioning of ecosystems. For human risk
assessment, the recommendation is to move from a substantially
hazard-driven
approach
toward
more
exposure-driven
assessments.51
Exposure assessments on a chemical-by-chemical basis have
an important limitation: they do not account for simultaneous
exposure to more than one chemical. There may be adverse
effects from cumulative exposure to multiple chemicals or even
synergistic effects (e.g., where exposure to one chemical causes
biological changes that render an organism vulnerable to
exposures to another chemical). Thus, exposures to more than one
chemical complicate the risk assessment process.52
Any form of risk assessment may leave some questions
unanswered due to the current limitations in scientific
knowledge. For example, when humans are exposed to very small
doses of chemical carcinogens, the doses may be too small to
detect a possible elevation of cancer risk through either animal
testing or epidemiological observation.53 More generally,
uncertainties arise with regards to both the proper interpretation
of hazard data on specific substances (e.g., scientific synthesis or
interpretation of multiple studies concerning the toxicology
and/or epidemiology of adverse effects from chemical exposures).
The biological mechanisms that give rise to adverse effects may
provide important clues to the shape of the dose-response curve
at low doses and to the reliability and relevance of animal test
data for human risk determination.54 It is not always easy to

50. See EUROPEAN COMM’N, ADDRESSING THE NEW CHALLENGES FOR RISK
ASSESSMENT (2012), available at http://ec.europa.eu/health/scientific_committees
/emerging/docs/scenihr_o_037.pdf.
51. Id.
52. See, e.g., M.E. Meek et al., Risk assessment of Combined Exposure to
Multiple Chemicals: A WHO/IPCS Framework, 60 REG. TOXICOLOGY &
PHARMACOLOGY S1, S1 (2011); Pamela R. D. Williams et al., Cumulative Risk
Assessment (CRA): Transforming the way we Assess Health Risks, 46 ENVTL. SCI.
& TECH. 10868, 10868 (2012).
53. See Rall, supra note 39, at 107–08.
54. See id. at 108.
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determine whether only one biological mechanism is at work or
whether multiple mechanisms are contributing to adverse effects.
Since risk assessments are often conducted in the face of
incomplete data and imperfection in basic scientific
understanding, assumptions—based on professional judgment
and policy values—are made throughout the process.55 There are
a surprisingly large number of methodological choices
(approximately fifty)56 in chemical risk assessment that can
drastically affect the outcomes of the assessment,57 and those
choices are associated with greater uncertainty for some
chemicals than for others. Some of these choices are determined
by a regulatory agency’s science-policy guidance (e.g., a general
presumption has been established that chemicals shown to cause
cancer in laboratory animals are an indication of potential human
cancer risk) while others are left for professional judgment on an
assessment-by-assessment basis (e.g., when should an
assessment focus on the inhalation route of exposure and omit
detailed consideration of the potential for dermal contact or
ingestion of the substance).58
Risk assessments contain inherent uncertainty, but risk
assessors can still perform better in priority setting than lay
citizens with no scientific training. Indeed, insights from risk
assessments—like much of the knowledge in clinical medicine—
arise from professionals who have learned about real-world
experiences with multiple chemicals in the past. Moreover, risk

55. Howard Latin, Good Science, Bad Regulation, and Toxic Risk Assessment,
5 YALE J. ON REG. 89, 91–92 (1988).
56. For a tabular presentation of over fifty analytic choices in chemical risk
assessment, see U.S. GOV’T ACCOUNTABILITY OFFICE, GAO-01-810, CHEMICAL
RISK ASSESSMENT: SELECTED FEDERAL AGENCIES’ PROCEDURES, ASSUMPTIONS, AND
POLICIES, 120–50 (2001).
57. See NAT’L RESEARCH COUNCIL, SCIENCE AND JUDGMENT IN RISK
ASSESSMENT 106 (1994) [hereinafter NRC 1994]; Campbell-Mohn & Applegate,
supra note 24, at 100–1; Oliver A. Houck, Tales from a Troubled Marriage:
Science and Law in Environmental Policy, 17 TUL. ENVTL. L.J. 163, 167–68
(2003); Latin, supra note 55, at 92–94; Howard Latin, Ideal Versus Real
Regulatory Efficiency: Implementation of Uniform Standards and ‘Fine-Tuning’
Regulatory Reforms, 37 STAN. L. REV. 1267, 1267–71 (1985); Mark Eliot Shere,
The Myth of Meaningful Environmental Risk Assessment, 19 HARV. ENVTL. L.
REV. 409, 413–14 (1995).
58. See NRC 1994, supra note 57, at 7.
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assessments become even more informative as critical data gaps
on chemicals in commerce are filled and uncertainties reduced.
Finally, the need for risk assessment does not end when it
becomes clear that the risks of an existing chemical in specific
uses are significant. Some form of risk assessment is also
essential to inform the innovative process of green chemistry.
Regulators and industry cannot be certain that replacing one
chemical with another contributes to lower levels of health and
environmental risk without carefully examining the relative risks
of the target and substitute chemicals.59 Professional judgments
about risk tradeoffs also play an important role in the process of
chemical substitution.
Since the science underpinning risk assessment is maturing
and new data are constantly being collected on individual
chemicals, real-world risk assessment should be a dynamic
process. The results in one risk assessment report may need to be
updated in response to new information. Sometimes the new
information suggests greater risk than previously projected;60 in
other cases, the new information is reassuring because it suggests
less risk than previously predicted.61 Thus, risk assessment is a
process that unfolds with changes in the available information
base, in the amounts of chemicals used in different applications,
and in scientific advancements.62
Although such adaptive
59. See George M. Gray & John D. Graham, Regulating Pesticides, in RISK
VERSUS RISK: TRADEOFFS IN PROTECTING HEALTH AND THE ENVIRONMENT 173–92
(John D. Graham & Jonathan B. Wiener eds., 1995); see generally Löfstedt,
supra note 23.
60. The thresholds for some substances (e.g., lead) have been repeatedly
lowered as new scientific information showed adverse effects at lower and lower
doses. JOE THORNTON, PANDORA’S POISON: CHLORINE, HEALTH, AND A NEW
ENVIRONMENTAL STRATEGY 79 (2001). This phenomenon has been provocatively
called “shrinking thresholds.” Id. at 79–80. See generally Janna G. Koppe &
Jane Keys, PCBs and the Precautionary Principle, in THE PRECAUTIONARY
PRINCIPLE IN THE 20TH CENTURY: LATE LESSONS FROM EARLY WARNINGS 64, 71–74
(Paul Harremoes et al. eds., 2002).
61. For case studies where new information shows less risk than previously
predicted, see PHANTOM RISK: SCIENTIFIC INFERENCE AND THE LAW 6 (Kenneth R.
Foster et al. eds., 1993); Aaron Wildavsky & Robert Owen Rye, Detecting Errors
in Environmental and Safety Studies, in BUT IS IT TRUE? A CITIZEN’S GUIDE TO
ENVIRONMENTAL HEALTH AND SAFETY ISSUES 410, 412–14 (1997).
62. Under TSCA’s new chemicals program, EPA has been creative in
allowing new chemicals with low releases and low exposures to be marketed
with less data than normal, but also with plans for continued monitoring to
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approaches to risk assessment and management have appeal,
they are not easy to incorporate into the adversarial legal
environment that has characterized implementation of TSCA.
B. Balancing Risk and Benefits in Various Uses
The risk assessment process is designed to inform industrial
managers as well as regulators about safety and the possible need
for—and effectiveness of—risk management measures. The
applicability of management measures will vary depending on
how industry is using a chemical.
There are a wide variety of measures that may reduce risk:
application of new technologies to industrial processes to prevent
or reduce emissions, leaks, and spills; performance standards
that limit volume, concentration, or releases over time;
information or educational interventions that alert consumers,
workers, or other market actors to potential risks and greener
alternatives; stricter handling and waste-disposal practices;
restrictions on specific chemical uses; and complete prohibitions
on the manufacture and importation of substances. When
regulators are considering a ban, it is not uncommon for
manufacturers and users to undertake voluntary measures to
either reduce risk with the existing chemical or to implement
chemical substitution.63
Since the benefits and risks of a chemical vary enormously by
use, it is rare that useful chemicals are prohibited in all
applications. Even a chemical such as dichloro-diphenyltrichloroethane (DDT), which has been known for decades to
cause toxicity to wildlife when released into the environment, is
still used in the developing world to control vectors for malaria.64

ensure safety over time. Ortwin Renn & E. Donald Elliott, Chemicals, in THE
REALITY OF PRECAUTION: COMPARING RISK REGULATION IN THE UNITED STATES AND
EUROPE 223, 231–32 (Jonathan B. Wiener et al. eds., 2011).
63. The wisdom of relying on substitute chemicals is spawning an entire new
field of analysis sometimes called “alternatives assessment.” Cheryl Hogue,
Assessing Alternatives to Toxic Chemicals, CHEMICAL & ENGINEERING NEWS, Dec.
16, 2013, at 19-20. Alternatives assessment is a close cousin of risk-tradeoff
analysis. See generally Gray & Graham, supra note 59, at 178–89.
64. On the harmful effects of DDT (from its breakdown product DDE), see
Jeffrey L. Lincer, DDE-Induced Eggshell- Thinning in the American Kestrel: A
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But this is the only residual use of DDT permitted under the
Stockholm Convention on Persistent Organic Pollutants, and the
present uses of DDT on a global basis are substantially less than
global use of DDT prior to the ban.65 The argument is that the
benefits of DDT use for malaria control justify the environmental
risk.66 Risk-reduction measures may be preferred to bans in
situations where there are no effective, safe, or affordable
substitutes and where the benefits of the chemical to industry,
consumers, and the public are significant.67
The regulatory approaches in Canada and the EU share
much in common but also differ in significant ways. We thus turn
to a comparison of the two regulatory systems, keeping in mind
this background on how risk assessment is used to inform risk
management.
C. CEPA and REACH as a Basis for Comparison
The Canadian and European approaches to chemicals
governance lend themselves well to a comparative analysis. The
CMP and REACH were both launched in late 2006, and U.S.
policy makers can learn from an empirical investigation of how
each program has proceeded. Significant work in assessment and
management has been completed under both laws. Yet,
implementation is not complete, as both have set 2020 as a
tentative implementation milestone.68 Open questions remain as

Comparison of the Field Situation and Laboratory Results, 12 J. APPLIED
ECOLOGY 781 (1975).
65. Shobha
Sadasivaiah,
Yeşim
Tozan
&
Joel
G.
Breman,
Dichlorodiphenyltrichloroethane (DDT) for Indoor Residual Spraying in Africa:
How Can It Be Used for Malaria Control?, 77 AM. J. TROPICAL MED. & HYGIENE
249, 251 (2007).
66. See Tina Rosenberg, What the World Needs Now is DDT, N.Y. TIMES, Apr.
11, 2004, http://www.nytimes.com/2004/04/11/magazine/what-the-world-needsnow-is-ddt.html; WARGO, supra note 28, at 187–88.
67. See generally ORG. FOR ECON. COOPERATION & DEV., THE ECONOMIC
APPRAISAL OF ENVIRONMENTAL PROJECTS AND POLICIES: A PRACTICAL GUIDE 145–
47, 150–51 (1995); MEG POSTLE, COST-BENEFIT ANALYSIS AND CHEMICAL RISK
MANAGEMENT (1997).
68. EUROPEAN COMM’N, ROADMAP ON SUBSTANCES OF VERY HIGH CONCERN 2
(2013) [hereinafter SVHC ROADMAP], available at http://register.consilium.
europa.eu/doc/srv?l=EN&f=ST%205867%202013%20INIT; VIRGINIA POTER &
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to how the CMP will proceed into its final years and how EU
Authorities will implement REACH. Therefore, while our primary
focus is on drawing lessons to inform the ongoing debate over
TSCA reform, our report also sheds light on what Canadian and
European lawmakers can learn from each other’s programs.69
Canada and EU Member States are amongst the U.S.’s
largest trading partners, and chemicals management can raise
notable trade issues.70 The U.S. is already working to harmonize
regulations with Canada and the EU through the Regulatory
Cooperation Council and the Transatlantic Trade and Investment
Partnership, respectively.71 The U.S. also has the opportunity
with TSCA reform to design a regulatory program that acts in
harmony with both CEPA and REACH. European and Canadian
approaches to chemicals governance also make for a fruitful
comparison because the Nordic countries and Canada have
traditionally been among the most active nations in international
chemicals governance due to their concern about adverse effects
of pollutants on Arctic populations and ecology.72
Finally, in congressional hearings on TSCA reform,
legislators have shown a keen interest in regulatory activities in

VINCENZA GALATONE, CHEMICALS MANAGEMENT PLAN: MOVING FORWARD IN 2013,
ICG CEPA UPDATE CONFERENCE 3 (June 6, 2013).
69. See Jonathan B. Wiener & Alberto Alemanno, Improving International
Regulatory Cooperation: TTIP as a Step Toward a Global Policy Laboratory, 78
LAW & CONTEMPORARY PROBLEMS (forthcoming 2015) (examining regulatory
variation as a learning exercise).
70. Lawrence A. Kogan, REACH and International Trade Law, in THE
EUROPEAN UNION REACH REGULATION FOR CHEMICALS: LAW AND PRACTICE 31517 (Lucas Bergkamp ed., 2013). See, e.g., Lawrence A. Kogan, REACH Revisited:
A Framework for Evaluating whether a Non-Tariff Measure has Matured into an
Actionable Non-Tariff Barrier to Trade, 28 AM. U. INT’L L. REV. 489, 514-24
(2013); SELIN, supra note 6, at 97–99.
71. See generally Hearing on the Regulatory Aspects of Trans-Atlantic Trade
and Investment Partnership (TTIP), U.S.-EU Free Trade Agreement, Before the
Committee on Trade, European Parliament, (2013) (testimony of John D.
Graham, Ph.D., Dean, School of Public and Environmental Affairs, Indiana
University, USA), available at http://www.europarl.europa.eu/document/
activities/cont/201310/20131015ATT72818/20131015ATT72818EN.pdf; UNITED
STATES-CANADA REGULATORY COOPERATION COUNCIL, JOINT ACTION PLAN (2011),
available at http://www.whitehouse.gov/sites/default/files/us-canada_rcc_joint
_action_plan3.pdf.
72. SELIN, supra note 6, at 170–71.
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both Europe and Canada.73 Testimony, however, has tended to
focus on REACH, with only scant references to CEPA and the
CMP. This report therefore fills a gap in the recent dialogue on
TSCA reform by bringing Canadian experiences to the forefront of
the discussion.
There is already a comparative literature on TSCA and
REACH. Professor John Applegate, for example, employs a
Hegelian dialectic method, presenting TSCA as the thesis and
REACH as its antithesis (the “anti-TSCA”).74 There are also a
few reports that include CEPA in their comparative analyses.75

73. See, e.g., Assessing the Effectiveness of U.S. Chemical Safety Laws:
Hearing Before the Sub. on Superfund, Toxics, & Envtl. Health of the S. Comm.
on Env’t & Pub. Works, 112th Cong. 81 ( 2011), available at
http://www.gpo.gov/fdsys/pkg/CHRG-112shrg85224/pdf/CHRG112shrg85224.pdf; Prioritizing Chemicals for Safety Determination: Hearing
Before the Subcomm. on Commerce, Trade, & Consumer Prot. of the H. Comm.
on Energy & Commerce, 111th Cong. 6 (2009) [hereinafter House, Prioritizing
Chemicals], available at http://www.gpo.gov/fdsys/pkg/CHRG-111hhrg74851/pdf/
CHRG-111hhrg74851.pdf; House, Revisiting TSCA, supra note 14, at 130.
74. John S. Applegate, Synthesizing TSCA and REACH: Practical Principles
for Chemical Regulation Reform, 35 ECOLOGY L.Q. 721, 724 (2008) [hereinafter
Applegate, Synthesizing]. See also Mikael Karlsson, The Precautionary Principle
in EU and US Chemicals Policy: A Comparison of Industrial Chemicals
Legislation, in REGULATING CHEMICAL RISKS: EUROPEAN AND GLOBAL
CHALLENGES (Johan Eriksson et al. eds. 2010); Ragnar E. Löfstedt & David
Vogel, The Changing Character of Regulation: A Comparison of Europe and the
United States, 21 RISK ANALYSIS 399 (2001) (comparing TSCA to REACH’s
predecessor); James T.O. Reilly, What REACH Can Teach Us about TSCA:
Retrospectives on America’s Failed Toxics Statute, 1 EUR. J. OF RISK REG. 40
(2010); Renn & Elliott, supra note 62, at 223–56; U.S. GOV’T. ACCOUNTABILITY
OFFICE, GAO-07-825, CHEMICAL REGULATION: COMPARISON OF U.S. AND RECENTLY
ENACTED EUROPEAN UNION APPROACHES TO PROTECT AGAINST THE RISKS OF TOXIC
CHEMICALS 4–5 (2007), available at http://www.gao.gov/new.items/d07825.pdf.
75. See RICHARD DENISON, NOT THAT INNOCENT: A COMPARATIVE ANALYSIS OF
CANADIAN, EUROPEAN UNION, AND UNITED STATES POLICIES ON INDUSTRIAL
CHEMICALS
I-5
(2007),
available
at
http://www.edf.org/sites/default/
files/6149_NotThatInnocent_Fullreport.pdf [hereinafter DENISON, NOT THAT
INNOCENT]; U.S. GOV’T ACCOUNTABILITY OFFICE, GAO-06-217R, CHEMICAL
REGULATION: APPROACHES IN THE UNITED STATES, CANADA, AND THE EUROPEAN
UNION 6 (2005), available at http://www.gao.gov/new.items/d06217r.pdf; ANNE
WORDSWORTH, CHEMICALS POLICY IN CANADA, THE EUROPEAN UNION AND THE
UNITED STATES 7 (2007), available at http://s.cela.ca/files/555_EU.pdf; Richard
Denison, Ten Essential Elements in TSCA Reform, 39 ENVTL. L. REP. 10020,
10022 (2009) [hereinafter Denison, Ten Essential]; Daryl Ditz, Dialogue, Lessons
from Canada and Europe, Toxic Substances Chemical Act Reform: Chemical
Prioritization (pt. 2), 42 ENVTL. L. REP. 10316-17 (2013).
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Dr. Richard Denison of the Environmental Defense Fund released
a noteworthy report in 2007 reviewing the design of REACH,
TSCA, and CEPA.76 He provides useful comparative insights on
how the design of each program addresses prioritization, data
production, risk management for new and existing substances,
and information sharing and disclosure.77 Our Article builds on
the work of Applegate, Denison, and others by drawing findings
from empirical observations after seven years of CMP and
REACH implementation.
D. Research Method
We gathered information from primary legislative and
regulatory texts, regulatory guidance materials, secondary
scientific and policy literatures, and notes from several rounds of
interviews with dozens of specialists in government, industry,
public interest organizations, and the academic community. We
conducted interviews by phone, in person, and through e-mail
exchanges. To encourage candor, we assured interviewees that we
would not assign specific viewpoints to specific individuals. We
list all of the interviewees and their organizational affiliations in
Appendix A.
To learn about REACH, we, along with Professor Lois Wise
(Indiana University) and Ágnes Botos (REACH consultant in
Budapest, Hungary), interviewed twenty-nine individuals,
including officials in the European Commission in Brussels
(Directorate-General for the Environment and DirectorateGeneral for Enterprise and Industry), the European Chemicals
Agency (ECHA) in Helsinki, and public interest organizations in
the U.S. and Europe. These interviews took place between
December 2010 and June 2011. In addition to the more
structured interviews, we attended the 2011 ECHA Stakeholder
Day in Helsinki, Finland and the 2011 Helsinki Chemicals Forum
in May of 2011.78 This initial round of research led to the

76. DENISON, NOT THAT INNOCENT, supra note 75, at I-5.
77. See generally id.
78. ECHA Sixth Stakeholders Day, EUROPEAN CHEMICALS AGENCY,
http://echa.europa.eu/web/guest/view-article/-/journal_content/32e60e70-22ed4092-8b10-9c21f709306b (last visited Nov. 6, 2014). See Helsinki Chemicals
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publication of an article in 2012 entitled, Regulating Industrial
Chemicals: Lessons for U.S. Lawmakers from the European
Union’s REACH Program.79
We, along with Professor Todd Royer, Mallory Mueller (both
from Indiana University), and an interdisciplinary panel of
experts from Europe and the U.S., gathered more recent data
through a second round of thirty-eight interviews conducted
between November 2012 and June 2013. This project culminated
in the publication of a book in 2015 entitled Persistent,
Bioaccumulative, and Toxic (PBT) Chemicals: Technical Aspects,
Policies, and Practices.80 Although the interviews focused on the
science and policy of PBTs, we were also able to gather data from
these interviews on the current state of assessment and
management practices under REACH and other regulatory
programs to inform our analysis.
To learn about CEPA and the CMP, we interviewed fifteen
individuals in Environment Canada, Health Canada, Canadian
industry, academics, and a Canadian public interest organization.
One of the authors also attended the 2013 CEPA Update
Conference, organized by the Industry Coordinating Group for
CEPA, in Mississauga, Ontario in June 2013.81 The conference
featured detailed presentations from representatives of
government and industry on the administration of CEPA and the
CMP.82
Altogether, we interviewed eighty-two individuals from 2010
to 2014 who offered insight on chemicals regulation. Thus, our
report draws significantly on stakeholder perspectives.

Forum 2011: Presentations, FINNEXPO, http://finnexpo.multiedition.fi/gallery/
main.php?g2_itemId=618 (last updated May 20, 2011).
79. Adam D.K. Abelkop et al., Regulating Industrial Chemicals: Lessons for
U.S. Lawmakers from the European Union’s REACH Program, 42 ENVTL. L.
REP. 11042 (2012).
80. ABELKOP, ROYER & GRAHAM, supra note 28.
81. INDUS. COORDINATING GRP. FOR CEPA, 2013 CEPA UPDATE CONFERENCE,
AGENDA
(2013),
available
at
http://www.intertek.com/icg-cepa-updateconference-flyer/.
82. Id.
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E. Scope and Dimensions of Comparison
While the regulation of new substances is an important and
somewhat contentious aspect of regulatory design (about 600 new
industrial chemicals are introduced into U.S. commerce each
year),83 our analysis is limited to existing substances because
regulatory programs, prominently those under CEPA and TSCA
as well as EU regulations that pre-date REACH, all treated new
substances with greater scrutiny than existing substances.
Historically, existing substances lacking a significant prior
history of major health or environmental risks were simply
grandfathered into acceptance under a presumption of safety,
without a full set of basic data on uses, exposure pathways, and
hazardous properties.84 REACH and the CMP are designed to
address this disparity in assessment. The focus of TSCA reform is
also on existing industrial chemicals.85 Moreover, regulation of
existing chemicals is even more politically controversial than new
chemicals because there are identifiable companies, workers, and
consumers who derive their livelihood from existing substances.
For these reasons, we focus on the legacy of existing industrial
chemicals.
We concentrate on industrial chemicals because agricultural
chemicals, biocides, and pharmaceuticals tend to raise different
policy and scientific issues. They are also regulated under
different statutory regimes.
Our analysis explores two aspects of regulatory design:
prioritization of existing substances for risk assessment and
regulation and the allocation of burdens to produce safety data
and demonstrate safe use of chemicals. We have chosen these two
dimensions for examination because (a) they are central to any
chemical regulatory system, (b) they capture some of the most
innovative features of the Canadian and European systems, and

83. GAO TOXIC SUBSTANCES, supra note 3, at 1.
84. APPLEGATE ET AL., supra note 24, at 281; DENISON, NOT THAT INNOCENT,
supra note 75, at I-1.
85. See JERRY H. YEN, CONG. RESEARCH SERV., R43136, PROPOSED REFORM OF
THE TOXIC SUBSTANCES CONTROL ACT (TSCA) IN THE 113TH CONGRESS: S. 1009
COMPARED WITH S. 696 AND CURRENT LAW 1 (2013), available at
http://fas.org/sgp/crs/misc/R43136.pdf.
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(c) Canada and Europe differ significantly on these two
dimensions.
There are many other features of the two regulatory
programs that could be compared: the legal definitions of safety,
the treatment of confidential business information, the
procedures for regulating new chemicals,86 the guidelines for
measuring the benefits and risks of specific uses including the
risks of possible substitutes, and the role of public participation
and judicial review in the regulatory processes. We encourage
application of a comparative approach to these issues as well.
II.

PRIORITIZATION AND SCREENING IN
RISK ASSESSMENT

Above we provided some basic information on the general
steps involved in risk assessment. In this Part, we compare CEPA
and REACH in their approaches to prioritization and risk
assessment. We begin by providing additional detail on
prioritization and the use of screening techniques in risk
assessment. We then deliver empirical descriptions of these
processes under CEPA and REACH, followed by lessons for U.S.
policy makers.
Risk assessment requires information on hazards and
exposures; however, there are wide variations in the amount,
type, and level of detail of data that assessors may include in
their evaluations. A comprehensive risk assessment includes data
on numerous matters such as degradation/persistence,
bioaccumulation, toxicity (human health and ecological), doseresponse functions for various toxicological endpoints (e.g.,
reproductive effects and carcinogenicity), production and
importation volume, commercial uses, concentrations present in
various environmental media, releases from different uses, waste
disposal methods, and potential pathways for exposure after
release into the environment occurs.87 Sources of data vary. They
may be generated from laboratory tests (e.g., toxicity tests on
86. REACH uses the same processes to govern new and existing chemicals.
87. John S. Applegate, The Government Role in Scientific Research: Who
Should Bridge the Data Gap in Chemical Regulation?, in RESCUING SCIENCE
FROM POLITICS 259–60 (Wendy Wagner & Rena Steinzor eds., 2006) [hereinafter
Applegate, RESCUING]; see generally NRC 1983, supra note 24, at 19–20.
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animals) or field observations (e.g., biomonitoring in human blood
or remote sensing of chemicals in the environment).88 Data may
also be estimated based on complicated computer modeling
programs that employ statistical techniques.89
The information necessary to support a comprehensive risk
assessment can be difficult, time consuming, and expensive to
obtain.90 Even a single component of the risk assessment,
namely the hazard characterization of a chemical, has taken
decades to complete in some cases, and the resulting
management decisions have been highly contentious. For
example, the Environmental Protection Agency’s (EPA) risk
assessment process for formaldehyde under TSCA began in the
early 1980s.91 Several draft risk assessments were released for
peer review and public comment, including a most recent draft
released in 2010.92
Likewise, the EPA assessment of
trichloroethylene (a common groundwater contaminant) began in
the 1980s, and while multiple drafts of the risk assessment have
been produced, the final draft was issued in 2014.93 Indeed, both
CEPA 1999 and REACH were enacted, in part, because
assessment and management decisions under their predecessors

88. See id. at 20, 22–23.
89. See id. at 24–26.
90. See, e.g., Applegate, RESCUING, supra note 87, at 262–63; APPLEGATE ET
AL., supra note 24, at 8–9; DENISON, NOT THAT INNOCENT, supra note 75, at A-15–
A-22; Klinke & Renn, supra note 22, at 10–13; NRC 1983, supra note 24;
Campbell-Mohn & Applegate, supra note 24, at 99–102; Shere, supra note 57, at
440–42.
91. JOHN D. GRAHAM ET AL., IN SEARCH OF SAFETY: CHEMICALS AND CANCER
RISK 28–34 (1988).
92. See generally, NAT’L RESEARCH COUNCIL, REVIEW OF THE ENVIRONMENTAL
PROTECTION AGENCY’S DRAFT IRIS ASSESSMENT OF FORMALDEHYDE R9 (2011),
available at http://www.nap.edu/openbook.php?record_id=13142; Integrated Risk
Information System: IRIS Toxicological Review of Formaldehyde (Inhalation)
(External Review Draft 2010), EPA, http://cfpub.epa.gov/ncea/iris_drafts/
recordisplay.cfm?deid=223614 (last visited Nov. 4, 2014); Jeremy P. Jacobs, NAS
Reviewers Slam EPA’s Formaldehyde Assessment, N.Y. TIMES (Apr. 8, 2011),
http://www.nytimes.com/gwire/2011/04/08/08greenwire-nas-reviewers-slamepas-formaldehyde-assessmen-83879.html.
93. See EPA, NO. 740-R1-4002, TSCA WORKPLAN CHEMICAL RISK ASSESSMENT
FOR TRICHLOROETHYLENE: DEGREASER, SPOT CLEANING, AND ARTS & CRAFTS USES
(2014), available at http://www.epa.gov/oppt/existingchemicals/pubs/TCE_OPPT
WorkplanChemRA_FINAL_062414.pdf.
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took too long.94 TSCA reformers are also looking for a way to
accelerate risk assessment and management and reduce the
ossification that has plagued EPA decision-making under TSCA
in the past.
In an ideal world, complete data sets would be available for
all chemicals that people and the environment may be exposed to.
Yet, industry and regulatory agencies are faced with the legacy of
tens of thousands of substances that appear on various
inventories of existing chemicals in commerce. Given limited
personnel and financial resources, there are two general
approaches to streamline the risk assessment process to enable
more expedient management decisions: the use of a screening, or
a tiered approach to risk assessment, and systems for prioritizing
which chemicals should be assessed first.
An alternative to comprehensive risk assessment is a
screening level assessment. Screening techniques can be
accomplished much faster than comprehensive risk assessments
since screening assessments require relatively limited data to
implement.95 Screening assessments often rely on modeling and
estimation techniques.96 If new data are generated for screening,
tests may use “higher and fewer doses of the compound being
studied, fewer test subjects, a shorter time period of observation,
and less extensive evaluation of the toxic outcomes.”97
94. See Bjorn Hansen, Background and Structure of REACH, in THE
EUROPEAN REACH REGULATION FOR CHEMICALS 17–18 (Lucas Bergkamp ed.,
2013); M.E. Meek & V.C. Armstrong, The Assessment and Management of
Industrial Chemicals in Canada, in RISK ASSESSMENT OF CHEMICALS: AN
INTRODUCTION 591, 597 (C.J. van Leeuwen & T.G. Vermeire eds., 2007).
95. NAT’L
RESEARCH
COUNCIL,
APPLICATIONS
OF
TOXICOGENOMIC
TECHNOLOGIES TO PREDICTIVE TOXICOLOGY AND RISK ASSESSMENT 73 (2007)
[hereinafter NRC 2007] (“A screening test can be defined as one designed to
detect a state or property more quickly and cheaply than more elaborate tests
for that state or property. In predictive toxicology, the property being detected
by screening tests is generally hazard. Screening tests may not give complete
information on toxicity, such as the time course, chronic effects, or dose-response
characteristics. Therefore, . . . screening data provide an input to the hazard
identification step in risk assessment but do not allow full determination of
risk.”)
96. Id. at 74 (“[T]he current practice of [EPA] under [TSCA], in the absence of
more extensive preexisting data, is to screen new chemicals based solely on
physicochemical data using quantitative structure-activity relationship
models.”).
97. Id.

25

3_ABELKOP&GRAHAM FINAL

2015

8/24/2015 12:05 PM

REGULATION OF CHEMICAL RISKS

133

Comprehensive risk assessments, on the other hand, ideally rely
on the generation of new data, higher quality tests (e.g., greater
number of test subjects over a longer period of time), and a wider
variety of data, as well as consideration of a richer suite of
endpoints.
A regulatory system might favor screening level assessment
over comprehensive risk assessment to avoid “paralysis by
analysis.” Value of information (VOI) analysis is a useful frame
for intelligent priority setting and information gathering. “VOI is
entirely decision-centric. In a VOI analysis, an information source
is valued solely on the basis of the probability and magnitude of
its potential impacts on a specific decision at a specific time with
a specific state of prior knowledge.”98 In other words, regulators
only need to gather just enough information that allows them to
make a risk determination. If additional information would not
likely lead to a different determination of risk, then obtaining
that information might not be cost-effective.
Whether a chemical’s governance regime emphasizes a
comprehensive or screening approach to risk assessment, priority
setting for assessment and management is essential to maximize
the public health and environmental benefits of regulation.
Effective prioritization requires regulators to apply science-based
criteria to identify chemicals of concern and further prioritize
among those chemicals—including numerous uses—for purposes
of assessment and management.99
A priority-setting system for risk assessment could start with
a focus on chemicals with hazardous properties,100 or it could
98. NRC 2009, supra note 38, at 82. See generally ADAM FINKEL,
CONFRONTING UNCERTAINTY IN RISK MANAGEMENT: A GUIDE FOR DECISIONMAKERS (1990), available at http://digitalcollections.library.cmu.edu/awweb/
awarchive?type=file&item=438442; NAT’L RESEARCH COUNCIL, ENVIRONMENTAL
DECISIONS IN THE FACE OF UNCERTAINTY 165–71 (2013) (discussing VOI for risk
assessment) [hereinafter NRC 2013]; NRC 2009, supra note 38, at 82–84.
99. See generally Ditz, supra note 75.
100. Comments from Ortwin Renn, Professor, University of Stuttgart (Apr. 27,
2014) (on file with author). In Europe, the hazard aspect is sometimes
subdivided into four components: chemicals that threaten human health (e.g.,
toxic, carcinogenic, genotoxic, reproductive toxin, endocrine disruptor);
chemicals that threaten environmental quality (e.g., ecotoxicity, endangered
species, ecosystem integrity, purity of air, soil, and water, restriction of land
use); chemicals with hazardous traits that could lead to damages over time (e.g.,
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start with a focus on chemicals that are commonly released into
the environment (e.g., due to high-volume production and
dispersive uses). If a priority-setting system starts with a focus on
chemical properties, it must later consider uses and exposures or
it may not address significant risks. If the system starts with an
exposure focus, it must later consider hazard or it may also miss
significant risks. Conceptually, priority setting for risk
assessment could consider both hazard and exposure from the
start, but such a risk-based priority-setting process is more
complex, data intensive, time-consuming, and expensive for
government and industry. Regardless of whether priority setting
for risk assessment starts with consideration of hazard, exposure,
or both, the result of priority setting is a manageable number of
chemicals and/or uses that are subject to risk assessments.
To be efficient, priority setting must use some rudimentary
form of screening based on priority criteria. However, without
hard data the priority-setting approach will leave a lingering
uncertainty about whether the screening techniques have missed
a bad actor. Thus, there is a tension between the desire for timely
risk management decisions and the need to fill the data gaps that
are a source of concern. A classic chicken-egg dilemma plagues
the design of any priority-setting scheme.101
There is a
temptation to wait for adequate data, since data are needed in
order for the government to set evidence-based priorities. If risk
assessments are delayed until adequate data are available, the
resulting risk assessments and regulatory decisions might be
made in a more informed and perhaps somewhat less contentious
way.102 On the other hand, since it would take many years to
develop adequate data on thousands of existing chemicals, there
is a cogent argument for undertaking preliminary risk
assessments promptly, to identify chemicals and uses of likely
concern, before adequate data are available on all chemicals.103
persistency, potential to bioaccumulate, potential to break down into more
harmful substances, capability of being transported over long distances); and
chemicals that can lead to harm if combined with other chemicals or if used in
special contexts in which exposure and damage are likely to occur. Id.
101. Ditz, supra note 75, at 10317 (indicating that risk-based prioritization is
problematic if data on risk are not available).
102. See id.
103. See id. at 10316.

27

3_ABELKOP&GRAHAM FINAL

2015

8/24/2015 12:05 PM

REGULATION OF CHEMICAL RISKS

135

The precautionary principle, which was introduced in the
1992 Rio Declaration on Environment and Development, supports
such an approach and was incorporated into CEPA through its
preamble: “Where there are threats of serious or irreversible
damage, lack of full scientific certainty shall not be used as a
reason for postponing cost-effective measures to prevent
environmental degradation.”104 CEPA section 76.1 directs EC
and HC to consider the weight of evidence and to apply the
precautionary principle in conducting and interpreting risk
REACH is also based on precautionary
assessments.105
reasoning.106 Screening level assessments can be precautionary
by applying worst-case scenarios for exposure and conservative
assumptions about toxicity (e.g., based on the known toxicity of
structurally similar chemicals). We now assess how prioritization
and tiered levels of assessment are incorporated into CEPA and
REACH.
A. CEPA 1999 and the CMP
The government of Canada regulates industrial chemicals
primarily under the authority of the Canadian Environmental
Protection Act, which was first enacted in 1988 and revised in
1999.107 CEPA 1999 formed the basis for present regulatory
activities by requiring Environment Canada (EC) and Health
Canada (HC) to categorize existing chemicals by the end of 2006
in order to identify priority substances for risk assessment.108 In
2006, the government of Canada launched the Chemicals
Management Plan to submit the identified substances warranting
104. Canadian Environmental Protection Act, S.C.1999, c. 33, Preamble
(Can.), available at http://www.ec.gc.ca/lcpe-cepa/default.asp?lang=En&n=
24374285-1 [hereinafter CEPA].
105. The Act Part 5: Controlling Toxic Substances, ENV’T CAN.,
http://www.ec.gc.ca/lcpe-cepa/default.asp?lang=En&n=24374285-1&offset=6
(last visited Nov. 4, 2014).
106. Commission
Regulation
1907/2006,
Registration,
Evaluation,
Authorisation and Restriction of Chemicals, art. 1(3), 2006 O.J. (L 396) 1 (EC)
[hereinafter REACH].
107. The Canadian literature refers to the laws as CEPA 1988 and CEPA
1999. Here, we use “CEPA” to refer to the 1999 legislation and specify when we
are referring to the earlier law.
108. CEPA § 73(1).
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further evaluation to various degrees of screening assessments
(less than full risk assessments) to determine whether
management is called for. Existing chemicals are listed on the
Domestic Substances List (DSL)—a total of about 23,000
substances that were manufactured in or imported into Canada
in quantities equal to or greater than 100 kg/yr between January
1, 1984 and December 31, 1986.109 The categorization identified
each substance as a priority or non-priority, based on ecological
and health criteria. The CMP further designated priority
The
substances as high, medium, or low priorities.110
relationship between categorization and the CMP is depicted in
Figure 1.

109. See Domestic Substances List, ENV’T CAN., https://ec.gc.ca/lcpecepa/default.asp?lang=En&n=5F213FA8-1 (last modified Sept. 17, 2013).
110. See id.
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Figure 1. Overview of Prioritization and Risk Assessment
under CEPA

Categorization
(1999–2006)
~ 23,000 substances on the Domestic Substances List
categorized as high or low priority;
~ 4,300 substances identified as high priority

Chemicals Management Plan
(2006–2020)
Further prioritization and screening assessment
of the ~ 4,300 identified priority substances

No further action

Toxic Substances List
Provides authority for
risk management,
~ 30 policy tools
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1. Categorization
CEPA section 73(1) established four criteria to categorize
chemicals on the DSL: greatest potential for exposure (GPE) to
individuals in Canada, persistence (P), bioaccumulation (B), and
inherent toxicity (iT) to human beings and non-human
organisms.111 The CMP also uses these criteria for further
prioritization—PBiT as ecological criteria, and GPE and iT as
human health criteria.112
Under CEPA, there is a difference between inherently toxic
and toxic. The “inherent toxicity” determination is equivalent to a
toxicity determination in other contexts; it is solely a hazardbased determination of whether a substance causes toxic effects
at tested doses.113 Canada uses the iT designation, though,
because “toxic”—without the preceding “i” for “inherent”—has a
specific legal meaning under CEPA that does not correspond with
The
the general scientific understanding of toxicity.114
determination that a substance is “toxic”—often referred to as
“CEPA-toxic”—is a purely legal finding and is distinct from
whether the substance is “inherently toxic.” A substance is
CEPA-toxic “if it is entering or may enter the environment in a
quantity or concentration under conditions that” may result in
harm to human health or the environment.115 Thus, while
inherent toxicity is a hazard-based determination, the formal
“toxic” (CEPA-toxic) determination is risk-based, as it

111. CEPA § 73(1)(b). Separate bodies of regulations define persistence and
bioaccumulation
thresholds
more
precisely.
See
Persistence
and
Bioaccumulation Regulations, SOR/2000-107 (Can.), available at http://lawslois.justice.gc.ca/PDF/SOR-2000-107.pdf.
112. See generally Christine Norman, Healthy Env’ts & Human Safety
Branch, Health Can., Prioritization and Assessment—Experience Under
Canada’s Chemicals Management Plan at the SVOCs in the Indoor
Environment Workshop 5, 6, 8 (Jan. 2011), available at http://epa.gov/ncct/
expocast/files/SVOC/12_NORMAN%20SVOC.pdf; Overview of the Existing
Substances Program, ENV’T CAN. (Mar. 21, 2011), http://www.ec.gc.ca/lcpecepa/default.asp?lang=En&n=EE479482-1&wsdoc=4AB637F0-A096-3237-14BAE034127B3A9A.
113. Id.
114. Meek & Armstrong, supra note 94, at 594.
115. CEPA § 64.
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incorporates potential for exposure.116 Inherent toxicity is a
categorization and prioritization criterion, while CEPA-toxicity is
a legal designation that authorizes the initiation of the risk
management process.
Categorization of the DSL under CEPA constitutes an initial
prioritization effort.117 Regulators applied the criteria through
chemical-specific hazard profiles—rudimentary analyses based on
existing data, modeling, expert judgments, and plausible
assumptions. The agencies constructed these profiles by
gathering and evaluating data themselves and through
submissions by interested parties. The data collection and
decision-making steps for EC and HC in the categorization
process are depicted in Figure 2.
EC and HC completed the categorization of the DSL on
schedule in September 2006, identifying ~ 3,900 substances that
met either or both of the human health and ecology criteria for
categorization.118 In addition, HC determined that another 300–
400 substances, which met neither the human health nor ecology
criteria, nonetheless warranted further attention from a human
health perspective, bringing the total number of prioritized
substances to ~ 4,300.119 That EC and HC completed DSL
categorization on schedule is a remarkable achievement, given
the scale and complexity of the task. The establishment of strict
legislative time frames for prioritization and other assessment
tasks is viewed as central to the success story.

116. G.C. GRANVILLE CONSULTING CORP., REPORT TO THE ICG ON SCREENING
ASSESSMENTS UNDER THE CMP 3 (2012).
117. Categorization of Existing Substances, ENV’T CAN., http://www.ec.gc.ca/
lcpe-cepa/default.asp?lang=En&n=5F213FA8-1&wsdoc=169
5F8D0-5CC4EDA1-AF63-6F23A94064DD (last modified July 9, 2013).
118. See generally Search Engine for the Results of DSL Categorization, ENV’T
CAN. (July 9, 2013), http://www.ec.gc.ca/lcpe-cepa/default.asp?lang=En&n=5F2
13FA8-1&wsdoc=D031CB30-B31B-D54C-0E46-37E32D526A1F
[hereinafter
ENV’T CAN., Search Engine Results]. See also Summary of Government of
Canada Categorization for Substances on the DSL, ENV’T CAN. Sept. 2006 (on file
with authors).
119. See SUZANNE EASTON, GLBTS SUBSTANCE WORKING GRP., CANADA’S
CHEMICALS MANAGEMENT PLAN (CMP) (DRAFT) 6 (2008), available at
http://www.epa.gov/bns/integration/200804/Easton040808.pdf.
For
precise
results of the DSL categorization, see ENV’T CAN., Search Engine Results, supra
note 118.
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Figure 2. DSL Categorization Process for Environment
and Health Canada
DSL Substances

Collection of Existing Data

Scientific Evaluation of Data

Likely or unlikely P or B and iT to
human or non-human organisms; greatest
potential exposure

Data Submission by Interested Parties

Evaluation of Additional Data

Publication of Final
Categorization Decisions

Not considered P or B and iT to
non-human organisms; not
considered GPE or iT to humans

Considered P or B and iT to
non-human organisms;
considered GPE or iT to
humans

No further action at this time as a
result of this exercise

Prioritized for screening
assessment under the CMP
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Following the initial categorization, EC and HC examined
industry data gathered from 2001 to 2006 to determine whether
certain priority substances were still in commerce within Canada
at or above the 100 kg/year DSL threshold.120 Through this
process, EC removed 145 PBiTs that did not meet the criteria
from priority consideration. 121 However, these substances are
not completely free of regulation because they are subject to
requirements under the CEPA Significant New Activity (SNAc)
approach, which governs the re-introduction and new uses of
existing substances.122
For the remaining priority substances (more than 4,000),
further assessment was warranted. The CEPA section 73
“categorization-level” hazard profiles triggered a Screening Level
Risk Assessment (SLRA) under section 74.123 Under CEPA, a
SLRA assesses the weight of evidence and applies the
precautionary principle to determine whether a substance is
CEPA-toxic or capable of becoming so.124 Recall that the riskbased determination that a substance is CEPA-toxic authorizes
the initiation of the risk management process.

120. See ENVTL. DEF., CANADA’S CHEMICALS MANAGEMENT PLAN: PROGRESS
ANALYSIS 2006–2011, at 12 (2011), available at http://environmentaldefence.ca/
reports/canadas-chemicals-management-plan.
121. See ENV’T CAN., SCREENING ASSESSMENT REPORT 14 (2008), available at
http://www.ec.gc.ca/lcpe-cepa/documents/substances/pbti-pbit/final_145_PBiTeng.pdf; Gov’t of Can., Assessment Report on 145 PBiT Substances and Order
Amending
the
Domestic
Substances
List,
CHEMICAL
SUBSTANCES,
http://www.chemicalsubstanceschimiques.gc.ca/plan/approach-approche/pbit145eng.php (last modified May 16, 2014).
122. See CEPA § 80; Gov’t of Can., Significant New Activity (SNAc) Approach,
CHEMICAL SUBSTANCES, http://www.chemicalsubstanceschimiques.gc.ca/plan/
approach-approche/snac-nac-eng.php [hereinafter SNAc Approach] (last
modified Sept. 10, 2012).
123. See CEPA §§ 73, 74.
124. CEPA § 76.1 (mandating application of the precautionary principle); see
HEALTH CAN., SCREENING ASSESSMENT OF EXISTING SUBSTANCES UNDER THE
CANADIAN ENVIRONMENTAL PROTECTION ACT, 1999, at 1 (2004), available at
http://www.hc-sc.gc.ca/ewh-semt/alt_formats/hecs-sesc/pdf/contaminants/existsu
b/exist_substances-substances_existantes-eng.pdf; Meek & Armstrong, supra
note 94, at 611 (for descriptions of the SLRA process); Norman, supra note 112,
at 9.
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The CMP constitutes the government of Canada’s strategy to
further prioritize and assess the priority substances by 2020.125
This represents a gargantuan task considering a single
comprehensive risk assessment can take decades to complete. The
CMP, therefore, embodies a compromise between making
informed decisions and making expedient decisions. As such, the
CMP strategy, discussed in greater detail below, is a response to
Canada’s experience with conducting comprehensive risk
assessments as part of its Priority Substances List mechanism.
2. Priority Substances List
The Priority Substances List (PSL) is a complex process that
is no longer used in Canada; however, it is necessary to describe
the PSL in order to explain why the government of Canada
adopted the more streamlined CMP approach. Whereas the CMP
is not formally mentioned in any legislation, CEPA 1988 and
CEPA 1999 established and maintained the PSL framework for
prioritization and risk assessment of industrial chemicals.126
Under the PSL, EC and HC subjected listed substances to a
more comprehensive risk assessment rather than a SLRA. Both
forms of risk assessment are designed to inform the
determination as to whether or not a substance is CEPA-toxic,
but the SLRA approach tends to be much more focused, less
resource-intensive, and more rapidly completed.127 The level of
assessment in a SLRA is flexible and depends on the nature of
the information available, as well as the potential risks, and can
range from a lower tier to an in-depth assessment. SLRAs can
rely heavily on modeling and estimation techniques and
conservative (high) estimates of exposure. Full risk assessments,
though, may require the generation of new data to determine, for

125. VIRGINIA POTER, Industry Coordinating Group CEPA Update Conference:
Chemicals Management Plan – Progress Made and Lessons Learned (Oct. 8,
2014) (on file with authors); GOV’T OF CAN., CHEMICALS MANAGEMENT PLAN:
PROGRESS REPORT 1 (2013), available at http://www.ec.gc.ca/ese-ees/5C49C89DD6C2-48C2-A256-72870B4044AA/Progress%20Report%20%28December%202
013%29_EN.pdf.
126. CEPA § 46(1)(a).
127. Id.
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example, modes of action and more likely exposure scenarios.128
Though these more comprehensive assessments conducted for
PSL substances provided regulators with much more information
than screening assessments, they were much more time and
resource intensive, and therefore constrained the number of
substances that authorities could evaluate expeditiously.
The first PSL, published in 1989, listed forty-four
chemicals.129 The PSL includes a five-year timeline to complete
risk assessments.130 Risk assessments were completed in early
1994, and twenty-five substances were identified as CEPAtoxic.131 The government published the second PSL in 1995, this
time listing twenty-five substances for risk assessment.132
Authorities found eighteen of them to satisfy the criteria for
CEPA-toxicity.133
Through the CEPA PSL framework, Canada has addressed a
number of substances of notoriety, including dioxins, furans,
hexachlorobenzene (HCB), hexachlorobutadiene (HCBD), and
chlorinated paraffins, to name a few.134
Nonetheless, the
government, industry, and non-governmental organizations
(NGOs) all considered the PSL process to be too slow and,
ultimately, impractical.135
The excessive length of the
assessment process was a major driver for the creation of the
1999 update of CEPA, with its requirement for an allowable
seven-year period to categorize substances on the DSL. Notably,
the PSLs were established under the original CEPA 1988
legislation. To date, the PSL mechanism has not been used under
CEPA 1999, and it seems unlikely that it will be used in the
128. ABELKOP, ROYER & GRAHAM, supra note 28.
129. First Priority Substances List (PSL1), ENV’T CAN., http://www.ec.gc.ca/eseees/default.asp?lang=En&n=95D719C5-1 (last modified June 21, 2013).
130. CEPA § 78.
131. ENV’T CAN., A GUIDE TO UNDERSTANDING THE CANADIAN ENVIRONMENTAL
PROTECTION ACT, 1999, at 9 (2004), available at http://www.ec.gc.ca/lcpecepa/E00B5BD8-13BC-4FBF-9B74-1013AD5FFC05/Guide04_e.pdf.
132. Id.
133. See id.; Second Priority Substances List (PSL2), ENV’T CAN.,
http://www.ec.gc.ca/ese-ees/default.asp?lang=En&n=C04CA116-1 (last modified
June 21, 2013).
134. PSL2, supra note 133; PSL1, supra note 129.
135. Meek & Armstrong, supra note 94, at 596–97 (compare our previous
comments about the length of time taken for EPA assessments).
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foreseeable future. The PSL provides an informative contrast to
Canada’s successor—the CMP.
3. Chemicals Management Plan
The government of Canada introduced the Chemicals
Management Plan (CMP) in 2006, following the completion of the
DSL categorization.136 The CMP is a strategy that is designed by
EC and HC in cooperation with industry and NGO stakeholders.
Its primary purpose is to protect human health and the
environment while acting as Canada’s plan to achieve the sound
management of chemicals in accordance with the WSSD 2020
goal.137 A secondary purpose is to increase public confidence in
industry and government chemical management.138
Though the CMP is not formally mentioned in legislation,
CEPA provides the primary legal authority for actions under the
CMP.139 The CMP is designed to facilitate coordination between
CEPA and other laws, including those that govern food and
drugs, cosmetics, and pesticides.140 To that end, EC and HC also
draw legal authority for CMP actions from a variety of laws in
addition to CEPA. Though many decisions have been politically
contentious,141 thus far, government, industry, and some NGO
stakeholders seem to be pleased with the design and progression
of the CMP.142 As such, the CMP has all but displaced the PSL
as a prioritization mechanism for the assessment of chemicals in
Canada.

136. Press Release, Prime Minister of Canada, supra note 10.
137. See U.N., DEP’T OF ECON. & SOCIAL AFFAIRS, DIVISION FOR SUSTAINABLE
DEVELOPMENT, CANADA NATIONAL REPORTING TO CSD-18/19, THEMATIC PROFILE
ON CHEMICALS 1 (2011), available at http://www.un.org/esa/dsd/dsd_aofw_ni/
ni_pdfs/NationalReports/canada/Chemicals.pdf.
138. Canadian Government Takes Action on Harmful Chemicals, NEWSLETTER
(ECHA,
Helsinki,
Fin.),
Oct.
16,
2014,
at
23,
available
at
http://newsletter.echa.europa.eu/documents/6362380/21743968/newsletter_2014
_issue_5_october_en.pdf.
139. See id.
140. U.N., DEP’T OF ECON. & SOCIAL AFFAIRS, supra note 137, at 1–2.
141. See generally Dayna Nadine Scott, Beyond BPA: We need to Get Tough on
Toxics, GLOBE & MAIL, Jan. 4, 2012, http://www.theglobeandmail.com/globedebate/beyond-bpa-we-need-to-get-tough-on-toxics/article4085163/.
142. See ENVTL. DEF., supra note 120, at 15.
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Authorities are scheduled to work through the CMP in
phases from 2006 to 2020.143
The phases are somewhat
overlapping but also address some distinct sectors.
Phase I of the CMP included three primary initiatives. The
first initiative of CMP Phase I was the industry “Challenge.”144
It targeted nearly 200 of the substances identified in the
categorization as highest priority.145 EC and HC first divided the
challenge substances into twelve “batches” to be addressed
sequentially.146 CEPA section 71 provides the government with
the authority to compel businesses to provide information about
the substances that they manufacture, import, and use.147 EC
and HC published a list of each batch in the Canada Gazette
approximately every three months beginning in February 2007,
using authority under section 71 to challenge industry to provide
data on the chemicals in the batch within six months of the
publication.148 Much of the submitted information consisted of
release and exposure data, since industry had only six months to
provide it—generally not enough time to plan and carry out new
laboratory tests.149 In some cases, however, additional data were
supplied. After receiving the data, EC and HC conducted SLRAs,
which they released for public comment.150
143. POTER, supra note 125.
144. Gov’t of Can., The Government of Canada “Challenge” for Chemical
Substances That Are a High Priority for Action, CHEMICAL SUBSTANCES,
http://www.chemicalsubstanceschimiques.gc.ca/challenge-defi/index-eng.php
(last modified July 28, 2011).
145. See, e.g., Proposed Risk Management Approach for Benzenamine, Nphenyl-, Reaction Products with Styrene and 2,4,4-Trimethylpentene (BNST),
ENV’T CAN. (Aug. 2009), http://www.ec.gc.ca/ese-ees/default.asp?lang=En&n=
136D3FBF-1.
146. See Gov’t of Can., supra note 144.
147. CEPA § 71.
148. See, e.g., Canadian Environmental Protection Act, 1999, C. Gaz. 141(5)
162–77, available at http://publications.gc.ca/gazette/archives/p1/2007/2007-0203/pdf/g1-14105.pdf; Canadian Environmental Protection Act, 1999, C. Gaz.
141(19) 1178–1201, available at http://publications.gc.ca/gazette/archives/
p1/2007/2007-05-12/pdf/g1-14119.pdf.
149. Dayna Nadine Scott, Testing Toxicity: Proof and Precaution in Canada’s
Chemicals Management Plan, 18 REV. EUR. COMMUNITY & INT’L ENVTL. L. 59, 66
(2009). However, the categorization process did provide industry with an
indication of the substances that would be subject to risk assessment, giving
businesses time to gather data. Id.
150. See id. at 164.
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The ministries used the SLRA for each substance to
determine whether or not it satisfied the criteria for CEPAtoxicity. When the assessment led the ministries to conclude that
the substance is CEPA-toxic, they developed a risk management
proposal, which they finalized after considering public
comments.151 In addition to being a vehicle to determine whether
risk management is necessary, the Challenge also encouraged
companies to voluntarily reduce emissions of high-priority
substances and substitute, if possible, safer alternatives.
The second initiative of CMP Phase I was a Rapid Screening
Assessment of potential PiTs and BiTs that were manufactured
or imported in quantities less than 1,000 kg/yr (under the 1986
DSL)—a total of 1,066 substances.152 EC evaluated whether
these substances were already being assessed through other
programs, searched for red flags by determining if the substances
appeared on priority or regulatory lists in other jurisdictions, and
applied conservative ecological exposure scenarios to determine if
further assessment was warranted. When the ecological exposure
estimates were not of concern, HC then applied a rapid screening
framework from a human health perspective.153 Through this
process, EC and HC determined that 472 potential substances
required further assessment, 533 required no further action
because their estimated exposures were not of concern, and sixtyone needed to be withdrawn from rapid screening either because
they were removed from DSL (were no longer in commerce) or,
the opposite—they were found to be manufactured or imported in
quantities exceeding 1,000 kg/yr.154
The third initiative of CMP Phase I, which now extends into
Phase II, is the Petroleum Sector Stream Approach.155 EC and
HC divided 164 high priority petroleum substances into five
151. See id. at 164–65.
152. ENV’T CAN. & HEALTH CAN., RAPID SCREENING OF SUBSTANCES OF LOWER
CONCERN: RESULTS OF THE SCREENING ASSESSMENT, at ii. (2013), available at
http://www.ec.gc.ca/ese-ees/2A7095CD-A88C-4E7EB089486086C4CBC4/RSI%20
Final%20-%20EN.pdf.
153. See id.
154. Id. at ii–iii.
155. See Gov’t of Can., The Petroleum Sector Stream Approach, CHEMICAL
SUBSTANCES,
http://www.chemicalsubstanceschimiques.gc.ca/petrole/indexeng.php (last modified Sept. 5, 2014).
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streams and have proceeded to gather information from industry,
conduct SLRAs, and propose risk management options where
applicable, or as necessary, through the same processes as in the
Challenge.156
Phase II was announced in 2011 and includes an additional
rapid screening effort based on exposure-related information,157
an approach to address polymers,158 and the Substance
Groupings Initiative (SGI).159 Under the SGI, EC and HC have
placed an additional 500 substances into nine groups of similar
chemicals—organic flame retardants, for example—and will
proceed in the same spirit as in the Challenge and the Petroleum
The rationale for assessing
Sector Stream Approach.160
substances in groups is that they may share similar chemical
properties or may be used in similar ways.161 This approach
emphasizes the use of the “read-across” technique, whereby the
characteristics of a chemical (without direct data) are estimated
based on the characteristics of previously examined chemicals
with similar molecular structures.162 Assessing like chemicals
together, therefore, could facilitate the identification of safer
substitutes and create efficiencies for risk assessment and
management, and this appears to be the case, with a number of
draft assessments on various groupings announced on the CMP
156. Id.
157. See ENV’T CAN., RAPID SCREENING OF SUBSTANCES FROM PHASE ONE OF THE
DOMESTIC SUBSTANCES LIST INVENTORY UPDATE: RESULTS OF THE FINAL
SCREENING ASSESSMENT 4–5 (2014), available at http://www.ec.gc.ca/eseees/7340E1B7-1809-4564-8C49-F05875D511CB/FSAR_RSII_EN.pdf. To date,
117 substances have been identified that may not require further risk
assessment because of low exposure potential. Id. at 5.
158. See Gov’t of Can., Polymer Approach, CHEMICAL SUBSTANCES,
http://www.chemicalsubstanceschimiques.gc.ca/plan/approach-approche/polymer
-eng.php (last modified Mar. 19, 2012).
159. See Vincenza Galatone, ICG CEPA Update Conference: Chemicals
Management Plan: Moving Forward in 2013 (June 6, 2013) (conference
presentation on file with authors); Gov’t of Can., The Substance Groupings
Initiative, CHEMICAL SUBSTANCES, http://www.chemicalsubstanceschimiques.
gc.ca/group/index-eng.php (last modified Aug. 15, 2014) [hereinafter Gov’t of
Can. SGI].
160. See id.
161. Id.
162. Steven J. Enoch, Chemical Category Formation and Read-Across for the
Prediction of Toxicity, in 8 RECENT ADVANCES IN QSAR STUDIES 209 (Tomasz
Puzyn et al. eds., 2010).
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website.163 However, an aggressive use of this approach might
test the limits of the read-across screening technique, which could
ultimately undermine confidence in the assessment process.164
Following the first two phases of the CMP, the Canadian
government will still have to conduct SLRAs for about 1,700
priority substances identified in categorization.165 How the
ministries will execute the next phase of the CMP is uncertain,
but it seems clear that, regardless of the outcomes of the next
prioritization activities, the government will proceed in the same
fashion as in the Challenge, Petroleum Sector Stream Approach,
and SGI, with information gathering, screening assessment, and
risk management. The CMP and DSL categorization embody VOI
principles by soliciting a limited amount of information on a
specific, manageably sized group of prioritized substances with a
strict deadline for information submission. Each phase of the
CMP is presented in Figure 3.

163. See generally Gov’t of Can. SGI, supra note 159.
164. See CHEM. SENSITIVITIES MANITOBA & CAN. ENVTL. LAW ASS’N, A RESPONSE
TO THE PROPOSED RISK MANAGEMENT APPROACH FOR CHEMICALS MANAGEMENT
PLAN INDUSTRY CHALLENGE BATCH 3 SUBSTANCES, PUBLISHED IN CANADA GAZETTE
PART I, VOL. 143, NO. 10 - MARCH 7, 2009 at 3–4, (2009) [hereinafter CSM &
CELA], available at http://www.cela.ca/sites/cela.ca/files/652%20CMP%20
batch%203.pdf (critiquing overreliance on analogue data).
165. Galatone, supra note 159, at 4.
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Figure 3. Chemicals Management Plan
Phase 1: 2006 – 2012
Industry
Challenge

Rapid Screening
1,100 substances
examined

Screening level
risk assessments
of ~ 200
substances in
twelve batches

533 require no
further action (low
exposure
estimates)

Petroleum Sector
160 high priority
petroleum sector
substances,
assessed together
using, for
example, “read
across” methods
Not yet completed

Fifty-two substances concluded “toxic” and forty-eight
proposed as “toxic”

Phase 2: 2012 – 2016
Rapid Screening
Identification of
remaining lower
concern
substances based
on updated
exposure
information
140 substances
examined
117 require no
further action (low
exposure
estimates)

Substance
Grouping
Initiative
~ 500 substances
organized into
nine groups of
similar substances
(e.g., organic
flame retardants)

Polymers
~ 600 substances
no action yet, but
proposal for
phased
information
gathering
Will carry over to
Phase 3 as
necessary

Phase 3: 2016 – 2020
~ 1700 substances remain to
undergo screening level risk
assessments
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The various initiatives under the CMP are designed to
further prioritize substances to undergo SLRAs, which in turn
are designed to determine whether or not a substance satisfies
the criteria for CEPA-toxicity.166 There are three potential
outcomes if a SLRA leads authorities to determine that a
substance is CEPA-toxic.167 First, the government may opt to
take no further action.168 In practice, this has been a rare
conclusion and appears to be avoided if possible. Second, the
ministries may add the substance to a PSL, triggering a more
detailed and comprehensive risk assessment.169 As noted above,
this approach has been all but abandoned because it is seen as an
unnecessary iteration. Third, the ministries may recommend that
a substance be added to Schedule 1 of CEPA, the Toxic
Substances List (TSL), and where applicable, the Virtual
Elimination List (VEL) as well.170
Not all outcomes of the SLRA process, however, are
discretionary. If the government finds that a substance “may
have a long-term harmful effect on the environment,” satisfies the
PBiT criteria, and its presence in the environment “results
primarily from human activity,” it must be recommended for
addition to the TSL.171 For any substance recommended for
addition to the TSL—discretionary or mandatory—the
government may also have to recommend it for addition to the
VEL if it meets certain criteria.172
The addition of a substance to the TSL provides the
ministries with the authority to propose and initiate risk
management, including a possible phase out of the substance. If a
substance is also added to the VEL, the ministries must enact a
restriction on its emissions by “prescrib[ing] the quantity or
concentration of the substance that may be released into the
environment . . . from any source. . . .”173 In practice, if a SLRA
166. CEPA § 74.
167. Id. § 77(2).
168. Id. § 77(2)(a).
169. Id. § 77(2)(b).
170. Id. § 77(2)(c).
171. Id. § 77(3); Toxic Substances List, ENV’T CAN., http://www.ec.gc.ca/lcpecepa/default.asp?lang=En&n=0DA2924D-1 (last modified Nov. 6, 2013).
172. CEPA § 77(4).
173. Id. § 65(3).
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indicates that a substance is CEPA-toxic, it is routinely added to
the TSL. As of November 2013, there are 132 substances on the
TSL and, as of February 2009, only two substances on the
VEL.174 We elaborate on some risk management techniques
below in Part III A as part of our discussion of how CEPA
allocates the burdens of producing data and proving safety. In the
following sub-section, we continue the discussion of prioritization
and assessment processes by introducing the European Union’s
REACH regulation.
B. REACH
The Registration, Evaluation, Authorization, and Restriction
of Chemicals (REACH) regulation is a compilation of four
separate bodies of regulation that govern the cradle-to-grave
manufacture, importation, and use of industrial chemicals in the
EU.175 The European Chemicals Agency (ECHA), in cooperation
with Member State governments and the European Commission,
administers REACH. Though all of the components of REACH
are related to one another, each serves a distinct function and is
somewhat independent of the others.
The prioritization processes under REACH are not analogous
with those under CEPA. While Canada’s categorization and CMP
identified a subset of chemicals that warrant further assessment,
the underlying principle of REACH is that almost all chemicals
warrant further assessment.176 Context is important here:
Europe’s political environment is different from Canada’s (and
the United States’), and REACH serves the entire EU
marketplace rather than that of a single nation. Whereas
Canada’s DSL lists about 23,000 existing substances, there are
about 100,000 substances listed on the EUs various chemicals
174. Toxic Substances List – Schedule 1, ENV’T CAN., http://www.ec.gc.ca/lcpecepa/default.asp?lang=En&n=0DA2924D-1&wsdoc=4ABEFFC8-5BEC-B57AF4BF-11069545E434 (last modified Aug. 4, 2014); Virtual Elimination List,
ENV’T CAN., http://www.ec.gc.ca/lcpe-cepa/default.asp?lang=En&n=768FCB63-1
(last modified Mar. 7, 2013).
175. REACH, Preamble 3, 4, 7. For a description of the processes under
REACH, see generally Nicolas Herbatschek et al., The REACH Programmes and
Procedures, in THE EUROPEAN UNION REACH REGULATION FOR CHEMICALS: LAW
AND PRACTICE 82, 82–170 (Lucas Bergkamp ed., 2013).
176. See id.
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inventories.177
REACH is designed to facilitate industry
assessment and subsequent voluntary management through
registration, to identify Substances of Very High Concern
(SVHCs) for authorization, and to identify uses of concern for
restriction.178 The following sub-sections discuss prioritization
for assessment and management under registration, evaluation,
authorization, and restriction.
1. Registration
Registration is based on the principle of “no data, no
market”179 —the notion that nearly all chemicals on the market
warrant complete risk assessments. Given that there are more
than 100,000 substances in commerce in the EU, and many of
them lack even basic data sets on hazard characteristics and
potential exposure pathways, the development of data constitutes
a gargantuan task.180 The REACH registration process does set
some priorities. As explained below, the schedule for registration
is sequenced by firm production level and by certain hazard
characteristics.
The general registration provision requires that “any
manufacturer or importer of a substance . . . in quantities of one
tonne or more per year shall submit a registration to the
[European Chemicals] Agency.”181 Downstream users—often
small or large companies that make use of a chemical in
consumer products or services—may also provide use and safety

177. EUR. CHEM. AGENCY (ECHA), GUIDANCE FOR IDENTIFICATION AND NAMING
SUBSTANCES UNDER REACH AND CLP 10 (2014), available at
http://echa.europa.eu/documents/10162/13643/substance_id_en.pdf [hereinafter
ECHA, IDENTIFICATION]. About 150,000 substances were pre-registered for the
2008 pre-registration deadline. Press Release, ECHA, List of Pre-Registered
Substances Published (Dec. 19, 2008), available at http://echa.europa.eu/
documents/10162/13585/pr_08_59_publication_pre-registered_substances_list_
20081219_en.pdf.
178. See Lucas Bergkamp & Dae Young Park, The Organizational and
Administrative Structures, in THE EUROPEAN UNION REACH REGULATION FOR
CHEMICALS: LAW AND PRACTICE 23, 37 (Lucas Bergkamp ed., 2013).
179. REACH, art. 5.
180. See generally ECHA, IDENTIFICATION, supra note 177, at 10.
181. REACH, art. 6(1).
OF
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information on their own or assist in the preparation of
registration dossiers through a lead registrant.182
The registration must take the form of a technical dossier,
which includes information on: the identity of the manufacturer,
importer, or producer; the identity, including chemical and
physical properties, of the substance; the manufacture and uses
of the substance; environmental fate and pathways;
(eco)toxicological information; guidance on safe use; and research
summaries.183 Ideally, registration dossiers including this data
will contain comprehensive risk assessments. Empirical
investigations of the amount and quality of information included
within registration dossiers, however, suggest that some dossiers
leave much to be desired and may be more analogous to screening
level assessments due to their heavy reliance on modeling and
estimation techniques rather than hard data.184
REACH contains a tiered phase-in period for registration
that is based partly on production volume of individual firms
(rather than the marketplace as a whole) and partly on toxicity.
The first registration deadline in December 2010 applied to
companies that manufactured or imported any substances at
volumes of 1,000 tonnes per year or more, substances that are
“very toxic” to aquatic organisms at volumes of 100 tonnes per
year or more, and CMRs at volumes of one tonne per year or
more.185 In response to this first deadline, ECHA received
roughly 25,000 registration dossiers covering about 3,400
substances.186 The second registration deadline was in June
2013 and applied to companies that manufactured or imported
substances at volumes of 100 tonnes per year or more.187 The
third and last registration deadline is June 2018, when all
182. Id. art. 37.
183. See REACH, art. 10(1)(a).
184. See generally, e.g., Greta Stieger et al., Assessing the Persistence,
Bioaccumulation Potential and Toxicity of Brominated Flame Retardants: Data
Availability and Quality for 36 Alternative Brominated Flame Retardants, 116
CHEMOSPHERE 118 (2014).
185. See REACH, art. 23(1).
186. First REACH registration was a success!, ECHA NEWSLETTER (ECHA,
Helsinki, Finland), Dec. 2010, at 5, available at http://echa.europa.eu/
documents/10162/13585/echa_newsletter_2010_6_en.pdf.
187. REACH, art. 23(2).
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substances manufactured or imported in quantities of one tonne
or more are to be registered.188 As of September 2014, the
REACH database contains information on 12,735 substances
from 49,100 registration dossiers.189
The registration dossier under REACH must contain a
minimum set of data, or the substance may not be put on the
market in Europe.190 The tiers in the registration process
influence the data requirements that are applicable. Chemicals
produced or imported in higher volumes and chemicals that
exhibit certain hazardous properties (e.g., CMR properties and
aquatic toxicity) have not only earlier registration deadlines, but
also have more demanding data requirements.191 For example,
once the ten-tonne threshold is reached for a registrant, the
registration dossier must include a Chemical Safety Report
(CSR), which details potential exposure scenarios and risk
management measures.192 Additional information on potential
exposures and risk characterization is also required for PBT,
vPvB, and other substances classified as “dangerous” under the
European Council’s Dangerous Substances Directive relating to
the classification, packaging, and labeling of dangerous
substances.193

188. Id. art. 23(3).
189. Registered Substances, ECHA, http://echa.europa.eu/information-onchemicals/registered-substances (last updated Sept. 24, 2014).
190. Id. art. 5.
191. See REACH, art. 12(1), 23.
192. See id. arts. 10(a)(x), (b), 14(1)(3).
193. See id. art. 14(4); Directive 67/548, of the European Parliament and the
Council of 27 June 1967 on the Approximation of Laws, Regulations and
Administrative Provisions Relating to the Classification, Packaging and
Labelling of Dangerous Substances 67/548/EEC, 1967 O.J. (L 196) 235. The
Dangerous Substances Directive will be replaced by the Classification, Labelling
and Packing Regulation. See Regulation (EC) 1272/2008 of the European
Parliament and of the Council of 16 December 2008 on Classification, Labelling
and Packaging of Substances and Mixtures, Amending and Repealing Directives
67/548/EEC and 1999/45/EC, and Amending Regulation (EC) No 1907/2006,
2008 O.J. (L 353) 1.
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2. Evaluation
REACH contains two distinct evaluation processes: dossier
and substance evaluation.194 Dossier evaluation entails ECHA
evaluation of a specific registration dossier. Dossier evaluation is
a compliance check that is meant to verify that the registration
dossiers submitted by industry fulfill all of the registration data
requirements.195 REACH mandates that ECHA must conduct a
compliance check on no less “than [five percent] of the total
[number of dossiers] received by the Agency for each tonnage
band . . . .”196 REACH does not obligate ECHA to examine the
other ninety-five percent of registration dossiers for substantive
compliance. From this five percent baseline, ECHA prioritizes its
selection of dossiers to examine through random selection
(twenty-five percent) as well as a mix of hazard and exposure
characteristics and technical concerns (seventy-five percent),
including potential PBT, vPvB, or CMR characteristics; wide
dispersive use; or excessive confidentiality claims.197
The compliance check process is procedurally straightforward
but can be scientifically intensive.198 When ECHA carries out an
overall compliance check, it assigns the task to a team of about
five specialists, including physical chemists, environmental
experts, and human health experts.199 Experts are responsible
for a substantive examination of the portions of the dossier in
their area of specialization. The experts determine whether the
registrant provided the required and appropriate data. They
analyze the quality of the data by evaluating the reliability and
validity of the study reports included within the dossier. The
194. See Herbatschek et al., supra note 175, at 126–33.
195. See generally ECHA, DOSSIER EVALUATION, 1-5 (2013), available at
http://echa.europa.eu/documents/10162/13607/pro_0017_03_dossier_evaluation_
en.pdf.
196. REACH, art. 41(5).
197. Id.
198. For a detailed description of the steps involved in dossier evaluation, see
ECHA, DOSSIER EVALUATION (2014), available at http://echa.europa.eu/
documents/10162/13607/procedure_dossier_evaluation_en.pdf.
199. See Evaluation process: Safeguarding the scientific quality of registration
information, ECHA, http://newsletter.echa.europa.eu/home/-/newsletter/entry/6
_11-evaluation-process;jsessionid=49BAC7F58F48304C08629EB038A4B67F.
live2 (last visited Oct. 28 2014).
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team also examines any exposure scenarios, which are required
for PBTs, vPvBs, CMRs, and all “classified” (dangerous)200
substances manufactured or imported at volumes greater than
ten tonnes per year (i.e., those classified under the EU’s version
of the Globally Harmonized System for one hazardous property or
another). Finally, the team evaluates the risk management
measures described in the dossier and may consider whether the
measures are likely to be sufficient to achieve “adequate control”
of exposures.201 The team may request more data to support the
effectiveness of risk management measures or suggest that
alternative measures be considered.
Not all compliance checks review the entire dossier. Targeted
compliance checks are also employed frequently by ECHA.202
They are typically automated (i.e., through use of screening of
dossiers with information technology tools) and focused on
portions of the dossier that are of special concern to ECHA (e.g.,
substance identification information or nano-materials).203 In
many cases, only a small fraction of a dossier is reviewed during a
compliance check, and only those experts necessary for the
targeted review are employed.204
Substance evaluation is an altogether different process,
carried out by Member States in collaboration with ECHA and
the European Commission.205 It involves evaluation of a specific
200. Directive 67/548, of the European Parliament and the Council of 27 June
1967 on the Approximation of Laws, Regulations and Administrative Provisions
Relating to the Classification, Packaging and Labelling of Dangerous
Substances 67/548/EEC, 1967 O.J. (L 196) 235.
201. See REACH, Annex I, § 5.1.1. See also REACH, Annex I § 6.4 (indicating
that risk is adequately controlled if the estimated exposure levels will not exceed
the derived no effect level or the predicted no effect concentration for the
substance, and the likelihood and severity of an event occurring due to a
physiochemical property of the substance (e.g., flammability, explosivity) is
negligible).
202. See Target met for 5% compliance checks of the 2010 registration
dossiers, ECHA, http://echa.europa.eu/view-article/-/journal_content/title/targetmet-for-5-percent-compliance-checks-of-the-2010-registration-dossiers
(last
visited Oct. 28, 2014).
203. See Herbatschek et al., supra note 175, at 130.
204. See generally id. at 126.
205. See ECHA, SUBSTANCE EVALUATION 1 (2013), available at
http://echa.europa.eu/documents/10162/13607/pro_0023_01_substance_evaluatio
n_en.pdf.
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substance rather than a specific dossier.206 Substance evaluation
is not itself a regulatory process, but the outcomes of a substance
evaluation can trigger regulations under other provisions of
REACH or other EU legislation.
The aim of the substance evaluation process is to clarify the
risks to human health and the environment associated with the
use of specific chemical substances.207 As a result, it is expected
that the substance evaluation processes will be triggered by riskbased or hazard-based concerns. A Member State is expected to
draw from registration dossiers prepared by industry, but may
also request additional information from registrants that extends
beyond the minimum data requirements that REACH specifies
If a registration dossier is missing
for registration.208
information on certain hazards (e.g., types of toxicity), the
substance evaluation process may be employed to obtain the
necessary information from industry, which can then be used for
both classification and labeling.209 Substance evaluation is
important because it can lead to enactment of new risk
management measures through the authorization or restriction
processes in REACH or instruments under other European
chemicals legislation.210 For example, substance evaluation could
lead to the setting of a new occupational exposure limit to protect
workers throughout Europe or it could lead to a proposal for
harmonized classification of the substance under the EU
Classification, Labelling and Packing (CLP) Regulation.211
ECHA, through its Member State Committee, determines
which substances will undergo substance evaluation, and lists
them on the Community Rolling Action Plan.212 The selection of
substances is based on criteria that are related to human health
206. See generally Herbatschek et al., supra note 175, at 131.
207. Id. at 1.
208. See id. at 7–8.
209. See id.
210. See id. at 7.
211. See Regulation (EC) 1272/2008 of the European Parliament and of the
Council of 16 December 2008 on Classification, Labelling and Packaging of
Substances and Mixtures, Amending and Repealing Directives 67/548/EEC and
1999/45/EC, and Amending Regulation (EC) No 1907/2006, 2008 O.J. (L 353)
20.
212. REACH, art. 44(2).
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and environmental quality, including the chemical’s hazardous
properties, the potential for exposure, and aggregated tonnage of
production (registration data).213 Political concerns may play a
role in a Member State’s decision to nominate a chemical or
Compared to the registration
substance for evaluation.214
process, the substance evaluation process under REACH has been
the subject of very limited practical implementation by EU
Authorities, although this could change due to recent
commitments in the Community Rolling Action Plan for
substance evaluation.215
3. Authorization
The authorization process is intended to protect human
health and the environment by facilitating the substitution of
SVHCs with suitable, safer alternatives.216 A SVHC is defined by
Article 57 as a CMR, a PBT, a vPvB, or a substance of equivalent
concern, such as an endocrine disruptor.217 A variety of prioritysetting issues have arisen in the assessment and management of
these substances given the number of potential SVHCs—about
1,500—and legislative ambiguity in how to prioritize substances
at various stages of the authorization process and other risk
management processes.
Under authorization, a SVHC is placed on a Candidate List,
denoting that the substance is a “candidate” to be placed on the

213. See id. art. 44(1). See also ECHA, SELECTION CRITERIA TO PRIORITISE
SUBSTANCES FOR SUBSTANCE EVALUATION 1-2 (2011), available at
https://echa.europa.eu/documents/10162/13628/background_doc_criteria_ed_32_
2011_en.pdf.
214. See Herbatschek et al., supra note 175, at 152–55 (indicating that
political preferences of Member States influence the prioritization of substances
for consideration of inclusion on the Candidate List).
215. See
generally
Community
Rolling
Action
Plan,
ECHA,
http://echa.europa.eu/web/guest/information-on-chemicals/evaluation/communit
y-rolling-action-plan (last visited Nov. 7, 2014)
216. See REACH, art. 55, 58(2).
217. See id. art. 55, 57, 58(1), (3) (laying out the parameters for what
constitutes a substance of very high concern). For a description of potential
harm to human health and the environment from endocrine disruptors, see
Patricia Hunt, Toxins All Around Us, SCI. AM. (Sept. 11, 2011),
http://www.scientificamerican.com/article.cfm?id=toxins-all-around-us.
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formal Authorization List (REACH Annex XIV).218 Substances
on the Authorization List must be phased out, though exceptions
for specific uses may be authorized based on certain
socioeconomic and risk factors, depending on the characteristics
of the substance.219
ECHA, at the request of the Commission, or a Member State
government may request that a substance be placed on the
Candidate List by submitting a dossier in accordance with Annex
XV of REACH to identify the substance as a SVHC.220 ECHA’s
Member State Committee, a committee of experts comprised of
representatives from the Member States, evaluates each
substance that has been proposed for inclusion on the Candidate
List.221 A unanimous decision of the Committee places the
substance on the Candidate List, while a split vote turns the
listing decision over to the Commission.222 ECHA may then
recommend substances on the Candidate List for inclusion on the
Authorization List to the Commission, which may place
substances on the Authorization List through comitology.223
Comitology is the process by which the Commission adopts
implementing acts to apply uniformly throughout the EU without
each individual Member State government having to adopt
implementing legislation.224
218. See REACH, art. 59(1).
219. See id. art. 55.
220. See id. art. 59(2). See ECHA, GUIDANCE FOR THE PREPARATION OF AN
ANNEX XV DOSSIER FOR THE IDENTIFICATION OF SUBSTANCES OF VERY HIGH
CONCERN
(2014)
[hereinafter
ECHA,
GUIDANCE],
available
at
http://echa.europa.eu/documents/10162/13638/svhc_en.pdf.
221. See Role of the Member State Committee in the Authorisation Process,
ECHA,
http://echa.europa.eu/role-of-the-member-state-committee-in-theauthorisation-process (last visited Nov. 7, 2014).
222. Herbatschek et al., supra note 175, at 157. To date, all Member State
Committee decisions on candidate listing have been unanimous, with
contentious negotiation occurring prior to voting. Id.
223. See ECHA, PRIORITISATION AND ANNEX XIV RECOMMENDATION 1–2, 4
(2013), available at http://echa.europa.eu/documents/10162/13607/prioritisation_
annex_xiv_recommendation_en.pdf; Herbatschek et al., supra note 175, at 135–
38.
224. See generally Regulation (EU) 182/2011 of the European Parliament and
of the Council of 16 February 2011 Laying Down the Rules and General
Principles Concerning Mechanisms for Control by Member States of the
Commission’s Exercise of Implementing Powers, 2011 O.J. (L 55/13). Under
comitology, the Commission drafts an implementing act for submission to a
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The authorization process begins with the identification of
SVHCs.225 As of 2014, 175 Annex XV dossiers have been
submitted to formally identify substances as SVHCs, 161
substances have been placed on the Candidate List, and thirtyone substances have been placed on the Authorization List.226
Based on existing classifications of substances under various EU
regulations, the CLP Regulation for example, early estimates
indicated that there might be as many as 1,500 substances
eligible for classification as a SVHC.227 In 2013, the Commission
estimated that, at most, 440 substances will need to be assessed
for SVHC classification by 2020. 228 Each SVHC may undergo a
rudimentary or screening-level assessment prior to a
management decision on how to proceed.229
To determine which Candidate List substances should be
evaluated first to determine if they should be included on the
Authorization List, REACH specifies prioritization criteria in
Article 58 as PBT and vPvB characteristics, wide dispersive uses,
significant market level production and importation volume, and
ECHA’s capacity to deal with the authorization applications.230
ECHA has developed a scoring system based on those criteria to
committee of representatives of the Member States referred to as the REACH
Comitology Committee (distinct from the ECHA Member State Committee). See
generally id. The Comitology Committee then decides whether an implementing
act should be adopted through a majority vote. See id.
225. Herbatschek et al., supra note 175, at 152.
226. Authorisation List, ECHA, http://echa.europa.eu/addressing-chemicals-ofconcern/authorisation/recommendation-for-inclusion-in-the-authorisationlist/authorisation-list (last visited Nov. 7, 2014); Candidate List of Substances of
Very High Concern for Authorisation, ECHA, http://echa.europa.eu/candidatelist-table (last updated Dec. 17, 2014); Submitted SVHC Proposals, ECHA,
http://echa.europa.eu/registry-of-submitted-svhc-intentions (last visited Mar. 16,
2015).
227. Herbatschek et al., supra note 175, at 152. See C&L Inventory, ECHA,
http://echa.europa.eu/regulations/clp/cl-inventory (last visited Jan. 18, 2015)
(providing various lists of chemical inventories, including those with hazardous
properties).
228. SVHC ROADMAP, supra note 68, at 12.
229. Id. at 15.
230. See REACH, art. 58. See also ECHA, PRIORITISATION OF SUBSTANCES OF
VERY HIGH CONCERN (SVHCS) FOR INCLUSION IN THE AUTHORISATION LIST (ANNEX
XIV) 4 (2014) [hereinafter PRIORITISATION FOR AUTHORISATION], available at
http://echa.europa.eu/documents/10162/13640/gen_approach_svhc_prior_in_reco
mmendations_en.pdf.
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prioritize substances on the Candidate List.231 However, prior to
2013, no comprehensive, formal procedure had been specified for
setting priorities among potential SVHCs to determine which of
the ~1,500 should first be evaluated to determine if they actually
are SVHCs that require risk management.232 The lack of clarity
in REACH about how to set priorities among numerous potential
SVHCs has been a source of confusion for government and
stakeholders.233
To further complicate the process, the full implications of
placing a substance on the Candidate List is partially an open
question. Inclusion on the Candidate List triggers some
unambiguous legal requirements for companies (e.g., notification
requirements throughout the supply chain).234 Placement of a
chemical on the Candidate List may also elicit some market deselection of the chemical due to the stigma of being listed, as well
as the potential for further regulation. Many believed that
REACH envisioned that all substances placed on the Candidate
List would—with perhaps only a few exceptions—eventually be
placed on the Authorization List, but that perception may not
prove to be a reality.
A drawback of placing many potential SVHCs on the
Candidate List is that the list was intended to send a market
signal for de-selection listed substances, even before they are
placed on the Authorization List.235 To avoid unnecessary deselection, some suggested that a screening assessment should
precede placement of a substance on the Candidate List.236 An
additional motivating factor for pre-Candidate List screening is
that REACH does not provide for a de-listing process for
Candidate List substances that are not added to the
Authorization List.237 In other words, once a substance is placed
on the Candidate List, the substance cannot be removed until
231. See PRIORITISATION FOR AUTHORISATION, supra note 230.
232. Herbatschek et al., supra note 175, at 152–54.
233. Id. at 152. See generally REACH, arts. 7, 31, 33.
234. See Summary of Obligations Resulting from Inclusion in the Candidate
List of Substances of Very High Concern for Authorisation, ECHA,
http://echa.europa.eu/candidate-list-obligations (last visited Nov. 7, 2014).
235. Herbatschek et al., supra note 175, at 133–34.
236. See id. at 135.
237. Id. at 136.
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after it is placed on the Authorization List, and a scientific case
for removal from the Authorization List has been made.238
ECHA and the Commission have taken the position that a
substance on the Candidate List can be de-listed (using the same
criteria for de-listing that applies to substances on the
Authorization List), but the legal viability of this position is
arguable.239
Given the unclear repercussions and potential drawbacks of
placing all SVHCs on the Candidate List, the Commission
introduced the concept of risk management options (RMO)
analysis prior to candidate-listing decisions. Figure 4 below
depicts the authorization listing process, including where in the
process RMO analysis occurs.

238. Id. at 139 (see “procedure for de-listing” from the Authorization List).
239. Id. at 136.
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Figure 4. Process for Inclusion of Substances on the
REACH Authorization List
Technical Dossier in Accordance with Annex XV
- Submitted by Member State or ECHA (at the
request of the Commission)
- Supports identification of substance as SVHC

-

Evaluation of Dossiers for Risk Management
Screening Assessment
Risk Management Options
o Authorization
o Restriction

o Other Legislation
o No Action
Member State Committee
Split Decision

Unanimous Decision to List

European Commission
Candidate List

ECHA Recommendation

-

ECHA recommends to European Commission
which SVHCs to place on Authorization List

European Commission

Authorization List: Annex XIV
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To fulfill the goal of considering all SVHCs for inclusion on
the Candidate List by 2020, the Commission released the
Roadmap on Substances of Very High Concern in February
2013.240 In December 2013, ECHA released the SVHC Roadmap
to 2020 Implementation Plan detailing a proposal for prioritizing
SVHCs for screening assessment, conducting screening
assessments, and considering various risk management
options.241
The Roadmap identifies the Commission’s criteria for
identifying “relevant SVHCs” for prioritization to undergo RMO
analysis.242 Relevant SVHCs are those that meet the SVHC
criteria listed in Article 57 (PBT, vPvB, CMR, or equivalent
concern), that are registered for the non-intermediate uses, for
which the prima facie case of unacceptable risk (triggering
restriction) cannot be currently made, that are not exempt from
authorization, and that are not subject to regulation under other
EU legislation.243
ECHA’s Implementation Plan outlines a screening process by
which substances will be selected for RMO analysis. The
registration database will constitute the primary source of
information, and chemicals registered for non-intermediate uses
will be prioritized for RMO analysis.244 Authorities will initially
identify potential SVHCs by applying an automated program to
search the registration database for chemicals that potentially
satisfy the Article 57 criteria.245 Authorities will then apply an
automated screening program to the potential SVHCs that are
registered for non-intermediate uses to screen for selection
criteria, including high volume, highest potential for fulfilling the
Article 57 criteria, structural similarity to chemicals on the
Candidate List, and additional informational needs.246 The

240. See SVHC ROADMAP, supra note 68, at 4.
241. See ECHA, SVHC ROADMAP TO 2020 IMPLEMENTATION PLAN 6 (2013)
[hereinafter SVHC IMPLEMENTATION PLAN], available at http://echa.europa.eu/
documents/10162/19126370/svhc_roadmap_implementation_plan_en.pdf.
242. SVHC ROADMAP, supra note 68, at 8–10.
243. Id.
244. SVHC IMPLEMENTATION PLAN, supra note 241, at 12.
245. Id. at 12–13.
246. Id. at 11–12.
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outcome of the screening will yield a pool of “substances of
potential concern.”247
Screened chemicals will be sorted into various hazard groups
(e.g., potential PBTs, CMRs, etc.).248 Expert and coordinating
groups within ECHA will assess the chemicals in each group to
determine if they satisfy the criteria to be considered SVHCs
and/or assist Member States and ECHA.249 For example, the
PBT Expert Group is responsible for determining whether
potential PBTs meet the Annex XIII criteria for classification as a
PBT, vPvB, or substance of equivalent concern to a PBT/vPvB.250
If an expert group determines that a chemical meets the
SVHC criteria, the chemical will be added to the pool of chemicals
subject to RMO analysis.251 If the group determines that there is
not enough information or that existing information is of too poor
of quality to make a determination on the criteria, then the
chemical may be subjected to additional information gathering
(e.g., substance evaluation) to gain data sufficient to make a
determination.252 The Implementation Plan notes that chemicals
requiring additional information will be subject to further
prioritization. As additional information is added to the
registration database, screening will undergo regular
reiterations.253
The next tier of analysis entails an evaluation of risk
management options to determine if risk management is
necessary and, if it is, to determine the most appropriate
approach to risk management.254 This process is shown below in
Figure 5. The details of RMO analysis are ambiguous, but the
available documents seem to envision a consideration of whether
or not authorization is an appropriate or optimal regulatory
strategy, given consideration of hazard and exposure data as well

247.
248.
249.
250.
251.
252.
253.
254.

Id. at 12.
Id. at 13.
Id.
SVHC IMPLEMENTATION PLAN, supra note 241, at 29–30.
See id. at 23, 26, 29.
Id. at 29–30.
Id. at 13.
See SVHC ROADMAP, supra note 68, at 8–10.
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as consideration of the restriction process and other regulations
that might already apply.255
Figure 5. SVHC Identification Roadmap256

Prioritization

Screening Assessment

If not enough information
- direct contact with registrant(s),
- dossier evaluation, and/or
- substance evaluation

If concern, RMO Analysis

No action

Candidate
List

Restriction

Other
legislation
(e.g., CLP
Regulation)

Authorization List

255. See generally EU Commission to Propose Five Substance Restrictions
Under RoHS2, CHEM. WATCH (Feb. 7, 2014), http://chemicalwatch.com/18294/eucommission-to-propose-five-substance-restrictions-under-rohs2 (illustrating EU
Authorities exhibiting a preference for restrictions over authorization for some
chemicals).
256. Adapted from SVHC IMPLEMENTATION PLAN, supra note 241, at 9 (fig.1).
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It appears that each substance that is placed on the
Candidate List will undergo at least an assessment to determine
if it should be placed on the Authorization List.257 ECHA is
responsible for drafting a proposed recommendation for
additional listings at least once every two years.258 After public
consultation and dialogue with the Member State Committee,
ECHA forwards a recommendation to the European Commission,
which makes final decisions about the Authorization List.259
The Implementation Plan provides some clarity as to the
screening assessments and RMO analyses that substances will
undergo prior to risk management. Moreover, updated guidance
from ECHA provides some indication of factors that will be
considered when evaluating whether to place potential SVHC on
the Candidate List.260 Nonetheless, the European Authorities
have a large degree of discretion on how priorities will be set and
stakeholders do not have a clear understanding of which
substances will undergo screening assessments/RMO analyses
first.261
4. Restriction
The restriction authority under REACH is essentially a
carry-forward risk management approach that European
Authorities possessed prior to the enactment of REACH. It is
seen as the “safety net” under REACH to address risks that are
not adequately addressed through registration, evaluation, and
authorization.262
The European Commission is authorized to issue restrictions
on the production, placement on the market, and use of selected
chemicals to address “unacceptable risks” to human health and

257. See PRIORITISATION FOR AUTHORISATION, supra note 230, at 3–4.
258. See Role of the Member State Committee in the Authorisation Process,
supra note 221.
259. See id.
260. See ECHA, GUIDANCE, supra note 220, at 6–7.
261. See Herbatschek et al., supra note 175, at 152–54.
262. ECHA, GUIDANCE, supra note 220, at 10.
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the environment.263 The restrictions may entail a wide variety of
measures, but are generally applied on a use-by-use basis. When
issuing a restriction, the analytic burden of proof rests with the
Commission.
The restriction authority is particularly suitable for dealing
with risks that arise from the aggregate production and use of a
chemical or a group of chemicals by multiple manufacturers and
users. The restriction authority has several advantages for the
Commission compared to the authorization process. Only
substances that are shown to be SVHCs can be listed in the
authorization process whereas restrictions can be applied to any
chemical and use that poses unacceptable risks to human health
and the environment. Moreover, authorization operates on a
chemical-by-chemical basis whereas the Commission may be able
to address groups of chemicals or target narrow uses through the
restriction authority.
The Commission has already decided to regulate some
chemicals under its restriction authority rather than under
authorization.264 Additionally, the RMO seems to envision that
substances on the Candidate List could be subjected to
restrictions rather than authorization. Yet, the Commission has
not put forward any formal procedure for determining which
chemicals and uses should be a priority for regulation under the
restriction approach.265 The following sub-section draws lessons
from the Canadian and EU approaches to prioritization and
assessment.
C. Lessons
1. Some Form of Formal Prioritization for Risk
Assessment and Management is Essential
Though both CEPA and REACH represent the state of the
art in chemicals governance, they take very different approaches.
263. REACH, art. 68(1). See European Comm’n, Restrictions, ENTERPRISE &
INDUSTRY,
http://ec.europa.eu/enterprise/sectors/chemicals/reach/restrictions/
index_en.htm (last updated Aug. 29, 2014).
264. See Bergkamp & Penman, supra note 11, at 8; Herbatschek et al., supra
note 175, at 146.
265. Herbatschek et al., supra note 175, at 152–54.
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CEPA is designed to facilitate governmental decision-making on
whether substances are CEPA-toxic. The emphasis of REACH, at
its present stage of implementation, is on encouraging adequate
control of risk through registration and on identifying SVHCs for
management. We must emphasize that those processes are not
directly analogous to one another, and a substance that is CEPAtoxic will not necessarily be a SVHC under REACH and vice
versa. What’s more, the complexity of these laws is a product of
the political contexts within which they are being implemented—
REACH in particular with its separate programs and distribution
of authority between the Commission, ECHA, and Member
States.
Nonetheless, the experiences of both Canada and the EU
make abundantly clear the desirability and necessity of
prioritization in assessment and management.266 Thousands of
existing chemicals lack data on basic properties, uses,
environmental
releases,
and
exposures.
Through
its
categorization process, Canada identified 4,300 priority chemicals
for more in-depth assessment while tens of thousands of
substances must be registered with ECHA.267 The European
Commission projects a need to make SVHC decisions on as many
as 440 substances by 2020.268
The approaches to priority setting under CEPA and REACH
differ, but both systems recognize a need to focus public and
private sector resources on a limited number of chemicals. The
priorities set in Canada seem to be manageable, but the
tractability of the EU approach is better demonstrated for
registration than it is for authorization. Indeed, the resources and
workload for the EU Authorities were a major consideration in
the development of the EU Roadmap on Substances of Very High
Concern.269
Once large numbers of registration dossiers were submitted
under REACH, EU Authorities realized that they needed
266. See generally Ditz, supra note 75 (describing that one of the persistent
flaws in U.S. regulatory programs is lack of priority setting); CASS SUNSTEIN,
THE COST-BENEFIT STATE: THE FUTURE OF REGULATORY PROTECTION 6 (2002).
267. See infra Part III.A.1.
268. SVHC ROADMAP, supra note 68, at 12.
269. See id. at 12–13.
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mechanisms to set some priorities to review registration dossiers.
Targeted compliance checks on registration dossiers have a sound
priority-setting rationale, since ECHA can focus on those portions
of dossiers where the potential value of a compliance check is
The priority-setting procedures for authorization,
high.270
substance evaluation, and restriction under REACH are not yet
fully worked out.271 NGOs have raised concerns that ECHA and
the Commission are too slow at formally listing substances as
SVHCs.272 The recent SVHC Roadmap and RMO analysis
proposed by the EU may help set priorities for authorization in
the future.
Interestingly, both Canada and Europe are setting priorities
based on hazard and exposure, but they are doing so in different
ways. The CMP incorporated information on hazard and exposure
in the categorization and CMP prioritization processes. Under
REACH, hazard and exposure both play a role in the tiered
registration process and in the design of registration dossiers.
Hazard characteristics certainly drive decisions about which
substances are placed on the Candidate List in the REACH
authorization process, but exposure potential is also exerting a
subtle role, as described in the SVHC Roadmap and
Implementation Plan.273 Priorities for substance evaluation and
restrictions under REACH may also be based on exposure as well
as hazards, but the details have not yet been worked out.
Based on the experiences in Canada and Europe, it is
apparent how critical priority setting is for the practical
management of existing chemicals. Any TSCA reform effort
would be wise to encourage or require, at a minimum, some
rudimentary form of priority setting, presumably a scheme that
considers both elements of hazard and exposure. Furthermore,
both Canadian and European experiences suggest that the U.S.
might do well to either include as much clarity on prioritization
criteria and processes as possible in the legislation itself and/or
270. See Herbatschek et al., supra note 175, at 130.
271. Id. at 152.
272. See The EU Regulation of Chemicals, INT’L CHEM. SECRETARIAT,
http://www.chemsec.org/what-we-do/influencing-public-policy/eu-chemicalsregulation/reach (last visited Nov. 7, 2014).
273. See generally SVHC IMPLEMENTATION PLAN, supra note 241; SVHC
ROADMAP, supra note 68.
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delegate EPA wide authority to determine its own prioritization
scheme for assessment and management. Since EPA already has
a workable scoring system to assist in priority setting, detailed
legislative language may not be necessary.274 Some legislative
clarity would reduce the potential for practical implementation
problems and uncertainty that Europe is facing. The Canadian
experience, though, is not a perfect guide for the U.S., as it is
unlikely that EPA could enact a strategy analogous to the CMP
through rulemaking without years of litigation. A prioritization
scheme for assessment and management should be formalized in
legislation, be stated plainly and unambiguously, and should
provide EPA with a broad degree of technical and policy
discretion.
2. Prioritization with Limited Data is Feasible
The most interesting lesson from the Canada-Europe
comparison is that it is feasible, based on CEPA’s experience, to
undertake a large-scale, credible prioritization process with
extremely limited data,275 thereby avoiding the time and expense
associated with the numerous required information submissions
under REACH. Instead of waiting for (or requiring) hard data on
each chemical in commerce, the Canadian authorities have been
executing their professional judgment in the use of existing data
and screening/modeling exercises, in effect allowing information
for some chemicals to serve as a basis for predicting information
for other chemicals.
Government officials and stakeholders mostly report that
Canada’s prioritization effort through the CMP has been effective
in identifying chemicals of concern from a risk perspective and in
stimulating more in-depth assessments of the risks associated
with the specific uses of those chemicals.276 However, the
274. See OFFICE OF POLLUTION PREVENTION & TOXICS, EPA, TSCA WORK PLAN
CHEMICALS: METHODS DOCUMENT 6 (2012), available at http://www.epa.gov/oppt/
existingchemicals/pubs/wpmethods.pdf [hereinafter OPPT].
275. See generally Ditz, supra note 75; ENVTL. DEF., supra note 120.
276. See generally ENVTL. DEF., supra note 120; GRANVILLE, supra note 116;
Letter from Peter Goodhand, Chief Exec. Officer, Can. Cancer Soc’y, Richard
Paton, President & Chief Exec. Officer, Chemistry Indus. Ass’n of Can., Peter
Robinson, Chief Exec. Officer, David Suzuki Found., & Rick Smith, Exec. Dir.,
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political environment in Canada may not be as receptive to NGO
analysis and critique of chemicals management as it is in the U.S.
Thus, the lack of heavy criticism in Canada of a judgment-laden
process may be somewhat misleading. Nonetheless, the
stakeholders seem to consider CEPA 1999 and the CMP notable
improvements over prior approaches.277 Key ingredients of the
CEPA success in prioritization are the widespread use of
screening and modeling techniques, consideration of both health
and environmental impacts, the use of rudimentary exposure
information as well as hazard characteristics, and strict
legislative deadlines in the categorization process.
Based on the CEPA model, a simplified tiered approach to
risk assessment of a single chemical might proceed as follows.
The first tier is a preliminary assessment that can be performed
even if very few data are available, by applying worst-case
scenarios for exposure and conservative assumptions about
toxicity. If risk is absent using these inputs, there is no need for
more detailed information. If risk is present, regulatory
authorities may require industry to refine the exposure and
toxicity estimates in a second tier, based on hard data or more
realistic, validated models. If risk is not present in the second
tier, no more information is required. If risk is present, industry
is required to implement risk management measures that reduce
exposures until safety is accomplished. Under this approach, risk
assessment is iterative: simple risk assessments are updated as
better data become available.278
Whereas CEPA begins with a prioritization of risk
assessment based on limited data, REACH first fills the
information gap and then employs a prioritization mechanism for

Envtl. Def., to James Flaherty, Minister of Fin., Peter Kent, Minister of Env’t,
Leona Aglukkaq, Minister of Health, & Stockwell Day, President, Treasury, Bd.
& Minister of Asia-Pacific Gateway (Jan. 21, 2011) (on file with author)
(supporting funding for CMP Phase 2).
277. See ENVTL. DEF., supra note 120.
278. See PRESIDENTIAL/CONGRESSIONAL COMM’N ON RISK MGMT & RISK
ASSESSMENT, FRAMEWORK FOR ENVIRONMENTAL HEALTH RISK MANAGEMENT 26
(1997),
available at http://www.riskworld.com/nreports/1997/risk-rpt/pdf/
epajan.pdf; see generally NRC 2013, supra note 98, at 7, 138, 224.
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risk management that makes use of risk assessments.279 The
CEPA and REACH approaches have advantages and
disadvantages from a priority-setting perspective.
An advantage of the CEPA approach is that priorities are set
rapidly because they can be based on the limited available data
and screening/modeling.280 Because CEPA is based on the
precautionary principle, a lack of data does not constitute a
barrier to risk assessment, and the risk assessment process is
conducted with conservative assumptions. Industry can respond
to conclusions drawn from risk assessments that use estimation
techniques by generating additional data. Moreover, the
information-collection burdens on industry are limited because
they face data-submission requirements only for the small share
of existing chemicals that are identified as a priority for risk
assessment.
A disadvantage of the CEPA approach in its reliance on
screening/modeling techniques is that it does little to address
data gaps. REACH, on the other hand, compiles a huge volume of
information through the registration dossiers, but the database is
so large that much of it may never be fully examined.281
Moreover, during the initial phase of registration, only a small
number of chemicals were regulated under REACH (via
restrictions or authorization), in part because industry was in the
process of preparing dossiers for registration.282 Now that
numerous registrations have been submitted (and many more
will be submitted in 2018), ECHA faces a priority-setting
dilemma in addressing imperfections in the dossiers. For sure,
REACH was designed to achieve a level of quality in the dossiers:
all companies manufacturing or importing the same chemical are
expected to pool their expertise, registrants know they may face
quality checks by ECHA, NGOs and the public can review the
dossiers on ECHA’s website, ECHA is performing compliance
checks, and European Authorities can apply penalties for
279. Ditz, supra note 75, at 10317 (indicating that the purpose of registration
is to generate data rather than prioritize chemicals for assessment and
management); Renn & Elliott, supra note 62, at 242.
280. See generally Ditz, supra note 75.
281. Abelkop et al., supra note 79, at 11056.
282. See Herbatschek et al., supra note 175, at 90–94.
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violations under REACH.283 Nonetheless, there are already
indications that there are significant quality problems with
registration dossiers.284
Another potential disadvantage of the CEPA approach is that
some errors will inevitably occur in the priority-setting process
because of the heavy reliance on limited data and
screening/modeling exercises. Both false-positive and falsenegative errors are expected to occur.285
A false-positive error occurs when a chemical is treated as a
priority or is determined to be CEPA-toxic when it should not
be.286 False-positive errors are of some concern because both
government and industry will waste resources evaluating a
chemical that does not pose a health or ecological risk. The rapid
screening component of the program was introduced to, in part,
address this concern. Based on the latest exposure information,
substances can enter a streamlined risk assessment process, so
that both industry and government resources can be focused on
substances of higher potential concern. Beyond the prioritization
process, industry can also provide data to aid in further refining
risk assessments. Additionally, the affected companies may
experience some unjustified market de-selection of their products
due to the adverse publicity that the government creates for their
products. However, the adverse consequences of false-positive
errors may be limited and temporary, especially if the process
constitutes prioritization of a substance for assessment without
placing it on a formal list. The review processes in Canada, which
can be buttressed by additional data from industry, may expose
any false-positive errors and allow safe chemicals—or at least
safe chemical uses—to be removed from the government’s
priorities.
283. See generally id. at 94–95. For a description of how penalties are applied,
see MILIEU ENVTL. LAW & POLICY, REPORT ON PENALTIES APPLICABLE FOR
INFRINGEMENT OF THE PROVISIONS OF THE REACH REGULATION IN THE MEMBER
STATES 7 (2010), available at http://ec.europa.eu/enterprise/sectors/chemicals
/files/reach/docs/studies/penalties-report_en.pdf.
284. See, e.g., Stieger et al., supra note 184.
285. For the classic paper that conceptualized the error problem in chemical
priority-setting procedures, see Talbot Page, A Generic View of Toxic Chemicals
and Similar Risks, 7 ECOLOGY L. Q. 207, 219–39 (1978).
286. See id. at 220.

67

3_ABELKOP&GRAHAM FINAL

2015

8/24/2015 12:05 PM

REGULATION OF CHEMICAL RISKS

175

A false-negative error occurs when a chemical is classified as
low priority when it should be classified as high priority, or
determined to not pose a risk when it should be classified as
CEPA-toxic.287 False-negative errors are more serious because
they are errors that are less likely to be corrected at a later stage,
as industry has little incentive to produce data that are not
required.288 Notably, public interest organizations have raised
concerns over false-negative errors about the way that HC and
EC conduct SLRAs under the CMP, including insufficient
consideration of certain toxicity endpoints and low dose effects
(especially endocrine disrupting effects), deficiencies in data,
failure to consider differences in exposure to higher risk groups
(e.g., women), failure to consider cumulative effects of exposures
to multiple chemicals, and inadequate application of
precautionary approaches to assessment.289 On the other hand,
HC and EC note that they have made considerable efforts to
incorporate the precautionary principle into their assessment
processes and to consider endocrine disrupting effects, differential
risk to certain groups (including women and children), and
cumulative effects of exposure to multiple chemicals when data
are available.290 These critiques do not seem to be inherent to

287. Id.
288. See Ditz, supra note 75, at 10316-17. On why false-negative errors are
particularly intolerable for public health, see Mara E. Long, Predicting
Carcinogenicity in Humans: The Need to Supplement Animal-Based Toxicology,
14 AATEX 553, 553–57 (2007).
289. Dayna Nadine Scott & Sarah Lewis, Regulating Toxics: Sex and Gender
in Canada’s Chemicals Management Plan, in OUR CHEMICAL SELVES: GENDER,
TOXICS, AND ENVIRONMENTAL HEALTH (Dayna Nadine Scott ed.) (forthcoming
Dec. 2014); Scott, supra note 149, at 59. See CSM & CELA, supra note 164, 6, 9.
290. On the consideration of endocrine disrupting effects, see Federal Research
on Hormone Disrupting Substances as Required Under the Canadian
Environmental Protection Act, 1999, OFF. OF THE AUDITOR GEN. OF CAN. (Dec. 14,
2012), http://www.oag-bvg.gc.ca/internet/English/pet_340_e_37607.html. On
combined exposures and cumulative effects, refer to the screening assessments
for PBDEs and phthalates, see generally Gov’t of Can., Phthalate Substance
Grouping, CHEMICAL SUBSTANCES, http://www.chemicalsubstanceschimiques.gc
.ca/group/phthalate/index-eng.php (last modified Aug. 15, 2014); Gov’t of Can.,
Polybrominated
Diphenyl
Ethers
(PBDEs),
CHEMICAL
SUBSTANCES,
http://www.chemicalsubstanceschimiques.gc.ca/fact-fait/glance-bref/pbdeeng.php (last modified Feb. 14, 2013). On the precautionary principle, see
Health Canada’s Adherence to the Precautionary Principle, OFF. OF THE AUDITOR
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the way that CEPA is designed, but rather in the way that
screening assessments are conducted. Should EPA conduct
screening risk assessments under a reformed TSCA, it would do
well to perform evaluations with these points in mind with the
expectation that reasonable minds will differ on the adequacy of
particular methodological approaches to risk assessment.
Reliance on limited hazard data and screening/modeling will
suffer from some false-negative errors, but the rate of error is
likely to be relatively small if the screening and modeling
exercises are conservative (i.e., health protective) in their design,
which means that the exercises would be generally biased in
favor of pushing borderline cases into the priority category.291
There are ways to combine multiple screening exercises in order
to minimize the false-negative error rate.292 Moreover, for
existing chemicals that have been used for decades without any
demonstration of adverse effects, there is a practical upper
boundary on the possible magnitude of impacts from any falsenegative error and continued use. There is also a strong body of
statistical evidence supporting the use of read-across techniques,
in vitro tests, and acute toxicity as surrogates for, or predictors of,
chronic toxicity.293 There is a similar body of statistical evidence
supporting PBT determinations based on limited data, chemical
GEN. OF CAN. (Mar. 1, 2010), http://www.oag-bvg.gc.ca/internet/English/
pet_289_e_33553.html.
291. For a useful case study illustrating the conservatism in Quantitative
Structure Activity Relationships (QSARs), see Patricia Ruiz et al., Prediction of
Acute Mammalian Toxicity Using QSAR Methods: A Case Study of Sulfur
Mustard and Its Breakdown Products, 17 MOLECULES 8982, 8993 (2012). But for
a skeptical view of the utility of QSAR approaches, see SCHETTLER ET AL., supra
note 32, at 242–43. An additional concern is that industry-generated risk
assessments might be less conservative than government-generated
assessments.
292. Long, supra note 288, at 557. It is important to have flexibility to allow
new information to enter the process as science and information evolve and to
identify new priorities not identified by particular prioritization criteria. For
example, CEPA has various, tiered information feeders for assessment.
Overview of the Existing Substances Program, ENV’T CAN., supra note 112.
293. For a readable discussion of alternatives to full-scale animal testing that
can predict human risk, see Toxicity Testing Overview, NON-ANIMAL METHODS
FOR TOXICITY TESTING, http://alttox.org/mapp/toxicity-testing-overview/ (last
updated Aug. 8, 2014). For a more in-depth discussion, see NAT’L RESEARCH
COUNCIL, TOXICITY TESTING IN THE 21ST CENTURY: A VISION AND A STRATEGY 1
(2007).
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structure, and modeling.294
To the extent possible, risk
assessment should also emphasize assessing groups of similar
chemicals together, as in the CMP’s SGI and petroleum sector
approaches. Group approaches have a better chance of accounting
for cumulative exposures and also build efficiency into the
assessment process. Even if SLRA methods improve, the CEPA
approach is vulnerable to a higher rate of false-negative error
than a system that would operate with full information.
The REACH approach is not, however, a full-information
approach because: (1) it is using rudimentary (rather than full)
data sets, and (2) REACH is implemented in ways that permit
registrants, under certain conditions, to use some of the same
screening/modeling exercises that were employed in Canada (to
reduce the number of animal tests).295 Thus, it seems possible
that the REACH approach could have a lower rate of false
negatives than the CEPA approach, but it is difficult to know in
practice whether such an advantage exists or how large the
advantage may be.
It is also useful to compare the Canadian and EU approaches
from the perspective of public confidence.296 CEPA may have an
advantage over REACH in the near term, since Canada has
moved much faster than Europe to focus on priority chemicals. In
the long run, the REACH approach could garner more public

294. See ABELKOP, ROYER & GRAHAM, supra note 28 (estimation methods for
measuring persistence, bioaccumulation, and toxicity are described in chapter
2). See also HENRIK TYLE ET AL., DANISH EPA, IDENTIFICATION OF POTENTIAL
PBTS AND VPVBS BY USE OF QSARS 2 (2002), available at
http://eng.mst.dk/media/mst/69087/QSAR%20PBT%20final%20clean.pdf.
295. See ECHA, GROUPING OF SUBSTANCES AND READ-ACROSS APPROACH - PART
I: INTRODUCTORY NOTE 5 (2013), available at http://echa.europa.eu/documents/
10162/13628/read_across_introductory_note_en.pdf. See generally Nicholas Ball
et al., The Challenge of Using Read-Across within the EU REACH Regulatory
Framework; How Much Uncertainty Is Too Much? Dipropylene Glycol Methyl
Ether Acetate, an Exemplary Case Study, 68 REG. TOXICOLOGY & PHARMACOLOGY
212 (2014); Grace Patlewicz et al., Use of ‘‘Read-Across’’ for Chemical Safety
Assessment Under REACH, 65 REG. TOXICOLOGY & PHARMACOLOGY 226 (2013);
Marta A. Sobanska, Analysis of the Ecotoxicity Data Submitted Within the
Framework of the REACH Regulation, 470 SCI. OF TOTAL ENV’T 1225 (2014).
296. On the case for public confidence as a valid criterion to consider in
regulatory reform, see generally DAVID VOGEL, THE POLITICS OF PRECAUTION:
REGULATING HEALTH, SAFETY, AND ENVIRONMENTAL RISKS IN EUROPE AND THE
UNITED STATES 63, 252 (2012).
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trust if the practical difficulties in implementation of assessment
and management diminish and if the registration data yield risk
assessments that produce meaningful gains in health and
environmental protection. Given its purported reliance on hard
data, REACH may not require the same degree of public trust in
the screening/modeling techniques and associated expert
judgments that are inherent to the CEPA approach.
On the other hand, REACH may fail to generate public
confidence if it does not meet public expectations for timely
conclusions, or if it becomes apparent that most of the large
volume of information in registration dossiers is never reviewed
by public officials through a rigorous process. If some of the
registration data prove to be unreliable, which is likely,297 and if
those errors are not detected and corrected through ECHA’s
review processes, then REACH may be perceived as a regulation
with significant error, particularly a potential for false-negative
errors (since registrants are unlikely to submit dossiers with
known false-positive errors). The pace of implementation may
also become a public-confidence problem, since multiple rounds of
registration dossiers and evaluations of potential SVHCs may
overwhelm the technical capabilities and resources of European
Authorities. Thus, on the whole, it is not apparent which system,
CEPA or REACH, will earn more public confidence in the long
run.
With respect to TSCA reform, it is encouraging that EPA has
already developed a scoring system for chemical priority setting
that has been published and subjected to public comment.298 It is
also beginning to be used in priority-setting applications.299 The
297. Ball et al., supra note 295; Natasha Gilbert, Data Gaps Threaten
Chemical Safety Law, 475 NATURE 150, 150-51 (2011). See Costanza Rovida et
al., How are Reproductive Toxicity and Developmental Toxicity Addressed in
REACH Dossiers?, 28 ALTEX 273 (2011); Christina Rudén & Sven Ove
Hansson, Registration, Evaluation, and Authorization of Chemicals (REACH) is
but the First Step—How Far Will It Take Us? Six Further Steps to Improve the
European Chemicals Legislation, 118 ENVTL. HEALTH PERSP. 6, 10 (2010);
Stieger et al., supra note 184; Martin Scheringer, PBT Assessment, Workshop
on PBT Science and Policy, December 4, 2013, Brussels, Belgium, at 7.
298. OPPT, supra note 274 (describing EPA’s prioritization approach to
chemical risk assessment); ABELKOP, ROYER & GRAHAM, supra note 28 (chapter
5).
299. OPPT, supra note 274, at 2.
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EPA system has subtle differences from the Canadian and
European approaches that need to be examined carefully before it
is mandated in a legislative context. For example, EPA’s system
places relatively greater weight on toxicity than persistence and
bioaccumulation compared to the EU’s and Canada’s use of the
PBT concept. Like Canada and Europe, EPA sees a role in
priority setting for information on both hazard and exposure.300
Thus, there is some reason for optimism that the U.S. can devise
a credible priority-setting system for application to existing
chemicals.
We conclude with a cautionary remark: the Canadian
regulatory culture is more cooperative and less adversarial than
that in the U.S. TSCA reformers who seek to replicate the
Canadian priority setting process in the U.S. may need to
reconsider some of the legalistic aspects of the current TSCA
regime (e.g., hybrid rulemaking and the substantial evidence test
of judicial review).301 If TSCA reform cannot achieve a somewhat
more cooperative regulatory culture between EPA, industry, and
environmental groups, then a fragile priority setting process
based on limited data, modeling, and professional judgment may
not survive the brutal forces of administrative litigation in the
U.S.
3. Ample Opportunity to Review/Appeal Initial
Listing Decisions is Important
A heavy reliance on screening data necessitates the
incorporation of institutions for adaptive management and
flexibility into chemicals governance.302 That is, once a decision
is made based on evidence that is inherently imperfect and
incomplete, stakeholders should be given opportunities to provide
additional information as it becomes available, especially through
advancements in the science of risk assessment. A difficulty is
balancing the need to move forward with the desire of certain
stakeholders to circle back. For example, how much data is
300. Id.; ABELKOP, ROYER & GRAHAM, supra note 28 (chapter 5).
301. 15 U.S.C. §§ 2605(c), 2618(c)(1)(B)(i) (2012).
302. On the importance of incorporating institutions for adaptive management
into regulatory programs, see Robin Kundis Craig & J.B. Ruhl, Designing
Administrative Law for Adaptive Management, 67 VAND. L. REV. 1, 15 (2014).
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sufficient to warrant an appeal? To the extent possible, a
regulatory system should encourage stakeholder input into the
assessment process at an early stage so as to avoid unnecessary
appeals. However, the generation of hard data and precautionbased regulation do not necessarily move at the same speed.
Appeals or reviews of previous decisions may be necessary. Such
processes should be incorporated into the assessment processes,
prior to management decisions, as well as into priority-setting
decisions.
Once a chemical is officially listed by the government as a
priority chemical for risk assessment and regulation, the
chemical may become stigmatized in the marketplace.303 Lists of
chemicals for management (e.g., the REACH Candidate List) are
likely to have more of a stigmatizing effect than priority lists of
substances for assessment.304 Chemical users in the chrome
plating and industrial tooling sectors, for example, have already
been impacted by de-selection pressures under REACH.305 In the
United States, stigma may cause market de-selection of the
chemical,306 may prompt state and local regulation of the

303. Herbatschek et al., supra note 175, at 134.
304. See id.
305. See CTR. FOR STRATEGY & EVALUATION SERVS., INTERIM EVALUATION:
IMPACT OF THE REACH REGULATION ON THE INNOVATIVENESS OF THE EU CHEMICAL
INDUSTRY (2012), available at http://ec.europa.eu/enterprise/sectors/chemicals/
files/reach/review2012/innovation-final-report_en.pdf; KERSTIN HEITMAN &
ANTONIA REIHLEN, TECHNO-ECONOMIC SUPPORT ON REACH: CASE STUDY ON
“ANNOUNCEMENT EFFECT” IN THE MARKET RELATED TO THE CANDIDATE LIST OF
SUBSTANCES
SUBJECT
TO
AUTHORIZATION
(2007),
available
at
http://ec.europa.eu/environment/chemicals/reach/pdf/background/report_announ
cement_effect.pdf; Guido Grunwald & Phillipp Hennig, Impacts of the REACH
Candidate List of Substances Subject to Authorisation: The Reputation
Mechanism and Empirical Results on Behavioral Adaptations of German Supply
Chain Actors, 11 J. BUS. CHEMISTRY 53 (2014); REACH, ROWAN TECH. GROUP,
http://www.rowantechnology.com/US-and-European-rules/european-regulations/
reach/ (last visited Nov. 8, 2014) (arguing the listings under REACH can lead to
product de-selection; such pressures are already impacting sectors such as
chrome plating and industrial tooling; there are replacement chemicals for the
substances listed under REACH but companies fear that the replacement
chemicals may also be listed as SVHC; the chemicals, such as chromic acid and
cobalt salts, serve as coatings and are used for corrosion control on aircraft).
306. Retailers such as Wal-Mart are inclined to use official lists of chemicals of
concern when pressuring their suppliers for greener products. See Melody M.
Bomgardner, Wal-Mart Details Chemicals Policy, CHEMICAL & ENGINEERING
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substance,307 and may elicit product liability claims related to the
chemical’s alleged hazards.308
Previous literature on
technological stigma suggests that once a technology is
stigmatized, it is difficult for the stigma to be removed based on
additional evidence or a revised governmental determination.309
Thus, it is important that the initial listing determinations by
agencies are subject to appeals that can detect and reverse
erroneous false-positive listings.
The design of REACH was somewhat sensitive to this
concern. Before a substance is placed on the Candidate List, there
is a comment period under Article 59(4) that allows any
stakeholder to make a case in favor or in opposition to the
listing.310 This is a consultation process rather than an appeal
mechanism. A candidate listing can also be appealed to the
European Court of Justice.311
REACH does not contain a mechanism whereby stakeholders
can obtain an independent, transparent scientific review of a
listing decision. The regulatory personnel who propose a chemical
for listing under REACH are the same personnel who evaluate
any comments that are received from stakeholders during
consultation. Appeals to the European Court of Justice are
legalistic in nature, and the European Authorities are accorded
significant discretion by the Court.312
NEWS, Mar. 10, 2014, at 19–21, http://cen.acs.org/articles/92/i7/Walmart-TargetTake-Aim-Hazardous.html.
307. On the growing activism among state regulators, see Cheryl Hogue, State
Lawmakers Introducing Bill to Restrict Chemicals, CHEMICAL & ENGINEERING
NEWS, Feb. 18, 2013, at 37, available at http://www.environmentalandturf.com/
pdf/CEN-Online_State%20Lawmakers%20Introducing%20Bill%20To%20Restri
ct%20Chemicals_February,%202013.pdf.
308. See, e.g., Roger Meiners & Bruce Yandle, Common Law and the Conceit of
Modern Environmental Policy, 7 GEO. MASON L. REV. 923, 961–62 (1999); Gary
T. Schwartz, Reality in the Economic Analysis of Tort Law: Does Tort Law
Really Deter?, 42 UCLA L. REV. 377, 418–19 (1994).
309. Robin Gregory et al., Technological Stigma, 83 AM. SCIENTIST 220, 220–23
(1995). See generally RISK, MEDIA, AND STIGMA: UNDERSTANDING PUBLIC
CHALLENGES TO MODERN SCIENCE AND TECHNOLOGY (James Flynn et al., eds.,
2001).
310. REACH, art. 59(4).
311. Id. art. 94.
312. See id. art. 94; Consolidated Version of the Treaty on the Functioning of
the European Union, art. 263, Oct. 26, 2012, 2012 O.J. (C 326) 162, available at
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CEPA, on the other hand, has a scientific appeal procedure:
CEPA authorizes the Minister of the Environment to establish a
Board of Review made up of expert scientists to revisit decisions
on whether substances are CEPA-toxic or not, for example, when
new information becomes available.313 The most notable example
to date is Siloxane D5, which EC and HC determined to be CEPAtoxic, thereby authorizing risk management.314 In 2009, industry
stakeholders requested the establishment of a Board of Review to
revisit the determination on Siloxane D5.315 The Minister agreed
to establish a board to review the determination, and industry
submitted additional data that was not previously available to
the government.316 Reviewing the new data, the board suggested
that the government reverse its determination that Siloxane D5
is CEPA-toxic, and the government accepted the recommendation
and reversed its determination. Although this particular case
involved industry submission of new data, an appeal procedure is
also available in Canada when the interpretation of existing data
is the sole point of controversy. The appeal procedure in Canada
may garner more widespread political support if it is also
available for use by the NGO community to reverse a
questionable decision that a chemical is not toxic under CEPA.
The absence of an appeal procedure (other than judicial
review) for decisions to identify substances as SVHCs and to
place them on the Candidate List and Authorization List is a
salient issue. Even without a substance evaluation, Member
States can propose a substance for restriction or nominate a
substance for inclusion on the Candidate List. Member States,
through REACH’s substance evaluation process, also have the
https://www.ecb.europa.eu/ecb/legal/pdf/c_32620121026en.pdf. REACH art. 91
lists certain decisions that are subject to appeal, but the scope of the art. 91 is
quite limited. REACH, art. 91.
313. See generally SILOXANE D5 BOARD OF REVIEW, REPORT OF THE BOARD OF
REVIEW FOR DECAMETHYLCYCLOPENTASILOXANE (SILOXANE D5) (2011), available
at http://www.ec.gc.ca/lcpe-cepa/515887B7-AF58-45B7-ADA9-B4ADF8F204DB/
CdR-BoR-D5_eng.pdf.
314. SILOXANE D5 BOARD OF REVIEW, REPORT OF THE BOARD OF REVIEW FOR
DECAMETHYLCYCLOPENTASILOXANE (SILOXANE D5) 16 (2011), available at
http://www.ec.gc.ca/lcpe-cepa/515887B7-AF58-45B7-ADA9-B4ADF8F204DB/
CdR-BoR-D5_eng.pdf.
315. Id.
316. Id. at 17.
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authority to influence SVHC listing decisions, and such decisions
do not have to rely on—or be consistent with—the scientific data
and determinations made by industry scientists in the
registration dossier.317
On the other hand, the information in the registration
dossiers may be used by industry to persuade ECHA, the
Commission, and other Member States that a provocative Annex
XV dossier prepared by one Member State should not be accepted.
Although the time and resources invested in registration dossiers
are substantial, the presence of the registration dossier under
REACH may provide a valuable tool for industry that is not
available in the CEPA process (which does not require industry to
submit registration dossiers at the outset). The advantage that
industry gains through registration may be heightened if the
quality of the dossier (i.e., the reliability and completeness of the
information on hazard, uses, exposure pathways, and risk
management measures) is strong.
Finally, the formal incorporation of external expert peer
review of draft risk assessments should be considered.318 Peer
review of risk assessments need not take a substantial amount of
time—a few weeks to a few months—and could greatly reduce the
risk of false positive and false negative outcomes. Peer review
may be especially warranted when there is either a high chance
of a decision-making error or when the impact of an error would
be particularly troublesome in terms of human and ecological
health on the one hand and economic impacts on the other.
For TSCA reformers, a challenge might be to design a
scientific appeal procedure that would not unduly delay or chill
the priority-setting process but would offer industry and NGOs a
viable mechanism to override—or compel reconsideration of—
decisions that lack adequate scientific support.319 To a great
317. Herbatschek et al., supra note 175, at 131 (Substance evaluation may
proceed based on information in the registration or dossier or “any other
appropriate source.”).
318. NRC 1983, supra note 24, at 144.
319. In the United States, TSCA reformers have decades of experience with
independent review bodies such as the EPA Science Advisory Board, the
National Research Council of the National Academy of Sciences, and the Health
Effects Institute. For a description of the origins and early work of these groups
in chemical risk assessment, see generally HARNESSING SCIENCE FOR
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extent, the notice and comment requirements for informal
rulemaking (and threat of judicial review) may accomplish this
task without the need for an additional appeal procedure.
Stakeholders may generate and submit additional data in
response to a rulemaking notice from EPA. EPA would then have
to consider the data prior to its final decision, lest the agency risk
its decision being overruled under judicial review as arbitrary
and capricious. In the alternative, if a review mechanism is built
into the risk assessment and management processes, judicial
review may not be necessary at all or Congress may prescribe a
particularly deferential standard of review.
Additionally, the distinction between prioritization decisions
as opposed to assessment and management decisions is crucial.
Prioritization decisions should not be considered final agency
actions that are subject to judicial review unless stakeholders can
demonstrate the priority-setting determination per se triggers
significant real-world impacts. Thus, here again, reformers must
keep in mind that EPA’s regulatory culture is much more
influenced by litigation risk than either the Canadian or
European regulatory cultures.
4. Discretionary Risk Management Accelerates
Priority Setting
Once a priority-setting process has determined that a
chemical is of concern and requires further scrutiny, the system
can be designed to have either automatic (mandatory) or
discretionary risk management outcomes. One can certainly
argue on policy grounds that risk management discretion is
appropriate because a variety of measures are available, and a
measure that is appropriate (i.e., effective and cost-effective) for
one use may not be for another. Here, we make a second
argument for risk-management discretion based on the fact that
priority setting appears to progress rapidly when it is known that
regulators have some discretion in risk management at the
conclusion of a priority-setting process.

ENVIRONMENTAL REGULATION (John D. Graham ed., 1991); SHEILA JASANOFF,
THE FIFTH BRANCH: SCIENCE ADVISERS AS POLICYMAKERS 181 (1998).
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Canada’s prioritization scheme is designed to separate the
risk assessment and management processes. Recall that under
CEPA, the government conducts SLRAs to inform a
determination as to whether or not a substance is CEPA-toxic.320
The determination that a substance is CEPA-toxic provides EC
and HC with the legal basis for adding the substance to the Toxic
Substances List, and the addition of the substance to the TSL in
turn provides EC and HC with the legal authority and obligation
to recommend and enact risk management. The determination
that a substance is CEPA-toxic, though, does not automatically
lead to any particular management measure.
The legislative choice to separate assessment and
management decisions in Canada has allowed the Canadian
chemical categorization and CMP to work as quickly as they
have. A similar outcome may be desired by TSCA reformers.
Indeed, the speed with which EC and HC are completing the
assessments under the CMP is a large part of what makes the
Canadian approach attractive as a potential model for TSCA
reform. Attaching mandatory management measures, especially
highly stringent ones, to the outcomes of risk assessments might
have been problematic because it would have elevated the weight
of prioritization and assessment decisions, resulting in more
contention and lobbying about the information and analysis
supporting those decisions.321
Since the CMP process is
separated from risk management decision-making, it may not
have withstood the intense stakeholder scrutiny that would have
resulted from mandatory risk-management measures, such as
phase-outs and substitution.
On the other hand, the initial reluctance of the European
Commission to list a large number of SVHCs may have been due
to a fear that a literal, legalistic reading of REACH calls for
automatic phase-out of all chemicals designated as a SVHC.322
320. CEPA § 74.
321. In the U.S. regulatory system, highly stringent regulatory mandates have
induced reluctance among regulators to open rulemakings. See generally John
D. Graham, Saving Lives Through Administrative Law and Economics, 157 U.
PA. L. REV. 395, 441 (2008).
322. A similar behavioral pattern was observed in the U.S. under the Clean
Air Act. When the U.S. Congress mandates a highly stringent risk-management
approach for a listed chemical, regulators are unlikely to list chemicals under
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The EU’s approach in the SVHC Roadmap provides an indication
that the EU will build more flexibility into both the listing and
risk management phases. Also, the pace of SVHC listings under
REACH accelerated only after the RMO approach in the SVHC
Roadmap was formulated and proposed.323 However, the pace of
SVHC listings might have accelerated only temporarily to meet
short-term political commitments rather than as a response to
additional clarity provided by the SVHC Roadmap.
An alternative approach that was rejected would have
ensured that all potential SVHCs were added to the Candidate
List, and all chemicals on the Candidate List were added to the
Authorization List,324 even though the risk management
ramifications would have been dramatic. The SVHC Roadmap
and Implementation Plan seem to envision consideration of risk
management options prior to considering substances for inclusion
on the Candidate List.325 The lack of legislative clarity on this
question creates confusion as to the precise roles of prioritization
and assessments under REACH.326 Indeed, litigation may be
required to fully resolve this question.327 In general, the extreme
complexity of REACH may place unnecessary burdens on both
government and stakeholders.328
Overall, the experiences of Canada and the EU suggest that
for prioritization and assessment to move quickly, the choice of
risk management measures should be preserved as a separate
the provision. Such behavior was observed under section 112 of the Clean Air
Act, which regulates toxic air pollution. John D. Graham, The Failure of Agency
Forcing: The Regulation of Airborne Carcinogens Under Section 112 of the Clean
Air Act, 34 DUKE L.J. 100 (1985). See generally JOHN MENDELOFF, THE DILEMMA
OF
TOXIC SUBSTANCE REGULATION: HOW OVERREGULATION CAUSES
UNDERREGULATION 134–37 (1988).
323. On ECHA’s most recent additions to the Authorization List, see
Herbatschek et al., supra note 175, at 135; ECHA Proposes Five Substances for
Authorisation, CHEMICAL WATCH (Feb. 10, 2014), http://chemicalwatch.com/
18322/echa-proposes-five-substances-for-authorisation.
324. See REACH, Preamble (77), art. 58.
325. See SVHC IMPLEMENTATION PLAN, supra note 241, at 13–14.
326. Herbatschek et al., supra note 175, at 152–55.
327. See generally EUROPEAN ENVTL. BUREAU & CLIENT EARTH, IDENTIFYING
THE BOTTLENECKS IN REACH IMPLEMENTATION: THE ROLE OF ECHA IN REACH’S
FAILING IMPLEMENTATION 42–43 (2012), available at http://www.eeb.org/EEB/
?LinkServID=53B19853-5056-B741-DB6B33B4D1318340.
328. See Abelkop et al., supra note 79, at 11045.
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question. For TSCA reformers, preserving a range of options for
risk management of different uses (as a part of legislative design)
may help accelerate the priority setting and risk assessment
processes.
Decoupling risk management from risk assessment
necessitates deadlines for both processes. Both CEPA and
REACH incorporate strict deadlines into their assessment and
management processes. Experience with CEPA in particular
demonstrates the importance of strict deadlines for categorization
and for screening assessment. Risk management instruments
must also be introduced according to specified time periods as
prescribed in CEPA sections 91 and 92: following a decision to
recommend a substance for inclusion on the TSL, the ministries
have two years to propose a risk management instrument and
another eighteen months to finalize it.329 Thus, TSCA reform
legislation may benefit from the inclusion of mandatory deadlines
for prioritization and assessment of priority chemicals and
associated management decisions. The harder challenge for TSCA
reformers is to design deadlines that are practically enforceable,
since the agency and stakeholders bypass many deadlines in U.S.
regulatory systems when there is no penalty on anyone for
missing the deadlines.
Additionally, we noted above that prioritization decisions
should not be considered final agency actions that are subject to
judicial review, at least if there are no demonstrated real-world
impacts of the priority-setting determination. If assessment and
management decisions are separated, the drafters of TSCA
reform legislation should give careful thought to legislating
burdens of proof for assessment and management decisions that
do not impair EPA’s ability to reach scientifically sound decisions
within an expeditious timeframe. Given that assessment and
management decisions have different implications, burdens of
proof for assessment and management decisions should not be the
same.
Lastly, the separation of assessment and management
decisions should not give license to extra stages of litigation that
drain public and private resources and impede expeditious and
329. CEPA §§ 91(1), 92(1).
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scientifically sound risk assessment and management decisions.
TSCA reformers may consider focusing judicial review at either
the assessment or the management stage, but not both unless it
can be demonstrated that the priority-setting determination has
real-world impacts such as market de-selection, tort litigation, or
state and local regulatory actions. That is, if assessment decisions
analogous to CEPA-toxicity findings are subject to judicial review,
then EPA should have permissive authority to apply risk
management tools following notice and comment. In the
alternative, TSCA reformers may want to provide EPA with
permissive authority to determine that risk management of a
particular substance or use is warranted, but focus judicial
review efforts on EPA’s risk management decisions.
5. Adequate Public Resources are Necessary
Both Canada and the EU have dedicated substantial public
funding to their prioritization and assessment processes. In fiscal
year 2014, ECHA’s budget was approximately €119 million (~
$160 million U.S).330 The EU Member States also expend public
resources on REACH to oversee ECHA and Commission
activities, conduct substance evaluations, and administer other
functions. The Netherlands alone spends approximately four to
five million Euros per year, apart from REACH enforcement
activities. If the activities of all twenty-eight Member States are
counted, the public investment in REACH in the Member States
may be ten to fifteen times the level of the investment in the
Netherlands.331 The Canadian government has allocated about
$500 million Canadian (~ $450 million U.S.) for each of the first
two five-year phases of the CMP,332 and accounts from
government and stakeholders in Canada report that this level of

330. ECHA, PRELIMINARY CONCLUSIONS, 32ND MANAGEMENT BOARD MEETING 2
(2013), available at http://echa.europa.eu/documents/10162/13608/preliminary
_conclusions_mb32_en.pdf; ECHA, WORK PROGRAMME 2014, at 68 (2014),
available at http://echa.europa.eu/documents/10162/13608/final_mb_39_2013_
wp_2014_en.pdf.
331. These numbers reflect personal estimates from peer reviewers.
332. Backgrounder: Canada’s Chemicals Management Plan, HEALTH CAN. (Oct.
2011), http://hc-sc.gc.ca/ahc-asc/media/nr-cp/_2011/2011-128bk-eng.php.
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funding has been necessary for EC and HC to meet legislative
goals.
Public resources committed to REACH are larger than those
committed to the CMP. Perhaps that is to be expected since the
European economy is many times larger than that of Canada.
Chemicals sales in 2012 were €539 billion in the EU and $45
billion (Canadian) in Canada.333 ECHA experienced early budget
shortfalls, though they were largely due to infrastructural and
implementation difficulties that have now been mostly
addressed.334 Regardless of how they are compared, both Canada
and the EU provide substantial public funds to chemicals
assessment and regulatory decision-making.
TSCA reformers need to find creative ways to generate
additional revenue for EPA to implement TSCA reform. Taking a
cue from ECHA, which collects registration fees, EPA could
partially fund risk assessment with fee-generated revenue.
Reliance on general federal revenue is probably the least
attractive approach, since there are so many competing claims for
those dollars. Fees on companies that manufacture, process,
and/or use high-priority chemicals would be a sensible “user-fee”
approach.335 Although the amount of public sector resources that
are required will vary by system design, any credible system
aimed at addressing the large volume of existing chemicals will
require significant public sector resources.

333. Chemicals, EUR. COMMISSION, http://ec.europa.eu/enterprise/sectors/
chemicals/index_en.htm (last visited Nov. 8, 2014); Manufacturing Sales, by
Subsector, STATISTICS CAN., http://www.statcan.gc.ca/tables-tableaux/sumsom/l01/cst01/manuf11-eng.htm (last modified Oct. 16, 2014).
334. See, e.g., Industry Bodies Surprised by ECHA Funding Concerns,
CHEMICAL WATCH (July 25, 2008), http://chemicalwatch.com/931/industry-bodiessurprised-by-echa-funding-concerns.
335. See Charles M. Auer, Periodic Reporting of Hazard Data, Exposure
Information on Existing Chemicals, BNA DAILY ENV’T REP., Apr. 14, 2010, at B7, available at http://www.actagroup.com/uploads/docs/00059082.pdf; Lynn L.
Bergeson, Do It Now, or It May Never Be Done, ENVTL. F. (Washington, D.C.),
May/June 2014, at 446.
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BURDEN OF DATA GENERATION AND
SAFETY DETERMINATION

Any plausible reform of TSCA needs to address two
fundamental questions: Where should the burdens of generating
data and of making safety determinations be placed?336 At a high
level of abstraction, TSCA, CEPA, and REACH all call on
government and stakeholders to identify chemicals of concern,
prioritize them for assessment and management decisions,
conduct risk assessments, and make risk management decisions.
Thus, in this part we compare the Canadian and European
burdens as we draw insights about how TSCA reform legislation
might structure the legal obligations and related formal
relationships between government and industry. Given the way
that TSCA has been interpreted in previous litigation, some legal
commentators believe that one or more of the burdens of proof
under TSCA need to be reconsidered through reform.337
Legislation can place the burden of data production for
assessment wholly on the government, wholly on industry, or
some hybrid combination. In theory, legislation could require the
government to generate much of the toxicity data or predictions
on its own. The government could also utilize public funds to
estimate releases and exposures for specific uses by undertaking
inspection and monitoring programs throughout the supply chain
of chemical production from use to disposal. In today’s world of
severe constraints on public sector resources and expertise,
neither TSCA, CEPA, nor REACH have put the data burden
primarily on government. In one way or another, all three
regimes envision industry as the data generator.
Placement of the burden of proof of safety is also a
fundamental feature of chemicals regulation that can affect the
design and function of the entire regulatory program:
336. In the legal community, these burdens are known as “the burden of going
forward” and the “risk of non-persuasion.” Fleming James, Jr., Burdens of Proof,
47 VA. L. REV. 51 (1961). The burden of going forward places the obligation on a
certain party to produce evidence. Id. Here, we refer to this burden as the
burden of data generation. Id. The risk of non-persuasion indicates which party
loses if the evidence does not meet the relevant standard of proof. Id. We refer to
this as the burden of making safety determinations. Id.
337. Applegate, Synthesizing, supra note 74, at 736–37.
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The allocation of burden of proof is more than just a means to a
regulatory end; it is also a normative position. Burden of proof
expresses a fundamental public policy by placing responsibility
for determining a chemical’s safety either with the manufacturer
or with the government, making it either an essentially private
or essentially public decision, respectively. The normative burden
of proof also gives direction to regulators in their substantive
evaluation of a chemical, telling them how selective to be, how
doubts are to be resolved, and how judgment is to be exercised. 338

Indeed, who holds the burden of making safety
determinations is a central issue that must be resolved in TSCA
reform: Do companies in the industry have any legal obligation to
make an affirmative technical case that their uses of existing
chemicals satisfy the prevailing safety standard in legislation?
Under the laws of the fifty states that govern products liability,
companies already have some safety obligations, but here we
refer to an additional legal obligation that would arise from a
safety standard in TSCA reform legislation.
With regard to proving the safety of existing chemicals,
REACH is often seen as accomplishing a reversal of the burden of
proof from government to industry whereas the Canadian
approach leaves much of the burden of making safety
determinations in the hands of government. As clear as the legal
theory may be, the realities of both CEPA and REACH are more
complex than the previous sentence suggests. If our research has
revealed anything, it is a confirmation of what risk managers
have known for decades—that successful chemicals risk
management requires an enormous amount of cooperation
between government and stakeholders in industry and public
interest organizations. Thus, while CEPA and REACH do have
quite different allocations of legal responsibility, implementation
of both legislative designs has been a cooperative effort. At a
practical level, both CEPA and REACH share burdens among
government and stakeholders, shifting them back and forth,
depending on the nature and stage of the regulatory process.
Since there are interesting interconnections between the
burden of data generation and the burden of proving safety under
338. Id. at 745.
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a legislated safety standard, we discuss the two burdens together.
If manufacturers or downstream users must affirmatively show
that the ways in which they use chemicals meet a legislated
safety standard, then they have an added incentive to generate
additional information beyond that provided by marketplace
competition and duties of care under tort law.339 If the burdens
of producing data and proving unacceptable risk rest with the
government, then manufacturers and downstream users may be
inclined to refrain from making scientific investments in data
generation until they are compelled to do so. Given this
conceptual background, we turn to a look at how Canada and the
EU have resolved these difficult issues.
A. CEPA 1999 and the CMP
CEPA primarily places the burden of data production on
industry but maintains the burden of proof of risk (that a
substance or use is unsafe) on the government.340 The burdens
are structured to facilitate cost-effective decision-making and
flexibility in the application of risk management. Since data
generation and analysis are expensive, CEPA is designed to
produce only the amount of data and analysis that are necessary
to reach a management decision. In this respect, the CEPA
approach reduces the risk of information overload on government
at the same time that it places the burden of making safety
determinations on government. Moreover, the spirit of the CMP
is that of a cooperative endeavor between stakeholders and
government in identifying and managing risks. Although this
may seem idealistic, CEPA and the CMP have operated
effectively through iterative processes of interaction and feedback
between government and stakeholders.
CEPA section 71 authorizes EC to require the submission of
data from any person who “may reasonably be expected to have
access” to it for the purpose of determining “whether a substance
is . . . or is capable of becoming [CEPA-]toxic, or for the purpose of

339. Id.
340. See ERICA CRAWFORD & TIM WILLIAMS, PARLIAMENTARY INFORMATION &
RES. SERV., LIBRARY OF PARLIAMENT, INTERNATIONAL MANAGEMENT OF CHEMICALS
9 (2006).
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assessing whether to control, or the manner in which to control, a
substance.”341 Recall that a substance is CEPA-toxic “if it is
entering or may enter the environment in a quantity or
concentration or under conditions that” may result in harm to
human health or the environment.342 A finding that a substance
is CEPA-toxic constitutes the government’s burden of
demonstrating that a risk exists. The statute, therefore, directly
links the burdens of data production and proof of (un)safety.
Under CEPA sections 71 and 72, authorities can require the
submission of existing and new data through surveys (mandatory
data submissions) of companies.343 There is no substantial
burden of proof or procedural hurdle that EC must surpass to
issue a data submission survey under section 71 other than that
the purpose must be to inform risk assessment or management
decision-making. EC publishes a notice of the data submission
requirement in the Canada Gazette, similar to the U.S. Federal
Register.344
The notice describes the parameters of the survey, including
what substances the survey applies to, who must respond (e.g.,
those who imported or used a quantity of the substance in a
calendar year greater than 100 kilograms at a concentration of
0.001 % by weight in a product or mixture intended for
residential use), the total quantity imported or used, the Function
Code and the Consumer and Commercial Code (as used in the
U.S. by EPA), a description of the generic name of the substance,
a description of the mixture or product containing the substance,
studies on hazard characteristics (e.g., as persistence,
bioaccumulation, and toxicity), confidentiality requests, and the
date by which the information must be submitted to the

341. CEPA § 71.
342. Id. § 64.
343. Id. §§ 71, 72. CEPA section 72 conditions authority to require generation
of new information under CEPA section 71(c) on authorities having a reason to
suspect that a substance could be CEPA-toxic, or if the substance has been
determined as a CEPA-toxic or is able to become one. Id. § 72. Therefore, the
government cannot require the generation of new information for a priori
information gathering.
344. See id. § 71(1)(a)-(b).
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government.345 For the Challenge, the notices applied to batches
of fifteen to thirty substances and addressed substances alone as
well as in products or mixtures.346 Other surveys can also be
mandated, for example, a “one-off” update on quantities
manufactured, imported, and exported for a large number of
substances, referred to as an “Inventory Update.”347
Some stakeholders have reported difficulty due to a lack of
clarity in requests (e.g., regarding the level of detail required) or
from the limitations they face accessing certain data (e.g., uses
throughout the supply chain).348 EC, however, has been diligent
in gathering feedback on data submission challenges and has
included stakeholders in the design of section 71 notices.349 EC
has encouraged companies to cooperate in submitting data on
their own and/or through industry organizations.350
Interestingly, information collected under REACH is finding
its way into Canada, though not directly through government-togovernment exchange. The Canadian government has in certain
instances entered into agreements with groups of REACH
registrants (called consortia) to collect data from REACH
registration dossiers from the registrants themselves rather than
from ECHA because the registrants own the data.351
Under the CMP, EC and HC use the information gathered in
section 71 surveys to conduct SLRAs to determine whether or not
substances are CEPA-toxic. In addition, some data are generated
345. Id. § 71(2). See, e.g., ENV’T CAN. GUIDANCE FOR RESPONDING TO THE NOTICE
RESPECT TO CERTAIN SELENIUM-CONTAINING SUBSTANCES (NOTICE) 5, 17–18,
22 (2013), available at https://www.ec.gc.ca/ese-ees/default.asp?lang=En
&n=ECA8FF32-1.
346. Elpi Karalis & Daren Kelland, Presentation at the Industry Coordinating
Group CEPA Update Conference in Mississauga, Ontario: Information
Gathering Under the Chemicals Management Plan (CMP) 3 (June 6, 2013) (on
file with authors).
347. Gov’t of Can., Domestic Substances List Inventory Update, CHEMICAL
SUBSTANCES,
http://www.chemicalsubstanceschimiques.gc.ca/plan/approachapproche /dsl-lis-eng.php (last modified June 12, 2013).
348. Karalis & Kelland, supra note 346, at 4–6.
349. Id. at 7, 12.
350. Karalis & Kelland, supra note 346, at 15.
351. Id. at 16; Daren Kelland & Elpi Karalis, Presentation at the Industry
Coordinating Group CEPA Update Conference in Mississauga, Ontario:
Information Gathering Under the Chemicals Management Plan (CMP) 6 (Oct. 9,
2014) (on file with authors).
WITH
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directly through contracts with the government or by the
government itself (e.g., biomonitoring studies, mining of existing
data, and development of predictive tools). Although industry has
expressed some difficulty in gathering and submitting data in
response to requests from the Canadian government, the data
submissions required under CEPA section 71 do not rise to the
level of detail or comprehensiveness of REACH registration
dossiers. The requests for data in Canada are far more limited
and targeted to exactly what Canadian regulators think they
need.
As noted above, the standard for authorizing risk
management is whether or not a substance is CEPA-toxic. The
placement of the burden of proof is squarely on the government.
EC and HC must find that a substance is CEPA-toxic in order to
apply risk management. The assessment process, which entails a
screening level risk assessment, is explicitly structured to answer
this question: whether a substance “is entering or may enter the
environment in a quantity or concentration or under conditions
that” may cause harm to human health or the environment.352
This is a risk-based standard, though it is certainly vague
compared to what a risk assessor would demand for practical
implementation. It does require the consideration of both hazard
and exposure. Regulators do not need to find that the use or
disposal of a substance actually presents a risk or likely presents
a risk, but rather that it may present a risk. Though there are
regulations that specify methods for determining persistence and
bioaccumulation,353 no guidance has been released that specifies
the ministries’ burden of proof in determining whether or not a
substance may enter the environment or may cause harm. In
other words, if use or disposal of a substance raises the plausible
possibility of a risk to human health or the environment, then
authorities are empowered to determine that the substance is
CEPA-toxic and initiate the risk management process.
Further, under certain evidentiary circumstances, CEPA
compels authorities to add a substance to the Toxic Substances
List. For example, if a SLRA indicates that a substance is CEPAtoxic, persistent, bioaccumulative, and its presence in the
352. CEPA § 64. See id. §§ 65(3), 77(4) (emphasis added).
353. Persistence and Bioaccumulation Regulations, supra note 111, at 1–2.

https://digitalcommons.pace.edu/pelr/vol32/iss1/3

88

3_ABELKOP&GRAHAM FINAL

196

PACE ENVIRONMENTAL LAW REVIEW

8/24/2015 12:05 PM

[Vol. 32

environment “results primarily from human activity,” it must be
recommended for addition to the TSL and is automatically
considered for “Virtual Elimination”354 —prohibition on the
release of a substance beyond a certain threshold under which the
substance cannot be accurately measured in emissions and
effluents.355 On the other hand, a determination that a substance
is CEPA-toxic, by itself does not automatically trigger the
application of any particular risk management instrument.
Further risk-management considerations are necessary to make
sure an appropriate response is made.
Recall that there are three potential outcomes if a SLRA
leads authorities to determine that a substance is CEPA-toxic.356
Authorities may opt to take no further action if, for example, they
determine that voluntary measures by industry, market deselection, or another action is appropriate to control the risks.357
They may add the substance to the Priority Substances List,
though this path has been all but abandoned as a risk assessment
provision.358 Finally, the ministries may recommend that a
substance be added to the TSL, which is a formal step toward risk
management measures.359
CEPA provides EC and HC with a wide variety of risk
management options to control exposure to CEPA-toxic
substances at any point in the chemical’s lifecycle. Once a
substance is recommended for addition to the TSL, the ministries
have two years to issue a “proposed regulation or instrument
respecting preventive or control actions in relation to a

354. CEPA, § 77(3); Toxic Substances List, ENV’T CAN., http://www.ec.gc.ca/
lcpe-cepa/default.asp?lang=En&n=0DA2924D-1 (last modified Nov. 6, 2013).
355. See generally The Canadian Environmental Protection Act, 1999 and
Virtual Elimination, ENV’T CAN., https://www.ec.gc.ca/lcpe-cepa/default.asp?
lang=En&n=BB1FDE0A-1 (Mar. 3, 2013).
356. CEPA § 77(2).
357. See id. § 77(2)(a).
358. See id. § 77(2)(b).
359. Id. § 77(2)(c). Substances that would have been determined to be CEPAtoxic, but the demonstrated absence of exposure in the Canadian context
prevented that conclusion, are controlled by the government’s policy of issuing a
SNAc, which effectively means the substance will need to be assessed as a new
substance should a manufacturer or importer wish to use it. SNAc Approach,
supra note 122.
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substance.”360 As of November 2013, there are 132 substances or
types of substances on the TSL.361
CEPA provides authority for EC and HC to adopt any of
about thirty different policy tools, including restrictions on the
quantity of manufacture, sale, import, or export; amount,
location, and conditions of releases; labeling, handling, and
storage; and the generation and submission of information.362
The agencies may also issue guidelines, standards, or codes of
practice or may facilitate voluntary risk management efforts.363
For example, authorities have issued regulations that pertain to
specific TSL substances (e.g., polybrominated diphenyl ethers and
PCBs),364 certain sources of TSL substances (e.g., pulp and paper
mill effluent containing chlorinated dioxins and furans),365
certain uses and products that contain TSL substances (e.g.,

360. CEPA § 91(1).
361. Toxic Substances List – Schedule 1, ENV’T CAN., http://www.ec.gc.ca/lcpecepa/default.asp?lang=En&n=0DA2924D-1&wsdoc=4ABEFFC8-5BEC-B57AF4BF-11069545E434 (last modified Aug. 4, 2014).
362. CEPA § 93.
363. Id. § 93 (risk management tools); id. § 95 (requirement to report
releases); id. § 98 (liability for remedial efforts after a release); id. § 100 (export
controls). See Meek & Armstrong, supra note 94, at 598; U.N., DEP’T OF ECON. &
SOC. AFFAIRS, supra note 137, at 8.
364. ENV’T CAN., PROPOSED RISK MANAGEMENT MEASURE FOR POLYBROMINATED
DIPHENYL ETHERS (PBDES) (2013), available at http://www.ec.gc.ca/eseees/92B7DD05-793A-4E4C-9742-3A25EB2529BE/PBDEs_Consultation_EN.pdf;
PCB Regulations (SOR/2008-27), ENV’T CAN., http://www.ec.gc.ca/lcpecepa/eng/regulations/detailReg.cfm?intReg=105 (last modified Aug. 26, 2014;
Polybrominated
Diphenyl
Ethers
(PBDEs),
ENV’T
CAN.,
http://www.ec.gc.ca/toxiques-toxics/Default.asp?lang=En&n=98E80CC61&xml=5046470B-2D3C-48B4-9E46-735B7820A444 (last modified Oct. 3, 2013);
Risk Management of DecaBDE: Commitment to Voluntary Phase-Out Exports to
Canada, ENV’T CAN., http://www.ec.gc.ca/toxiques-toxics/default.asp?lang
=en&n=F64D6E3B-1 (last modified July 23, 2013).
365. Polychlorinated dibenzodioxins, ENV’T CAN., http://www.ec.gc.ca/toxiquestoxics/Default.asp?lang=En&n=98E80CC6-1&xml=1794091E-5FC5-40F9-BB0BE823BFC418C6 (last modified July 23, 2013); Pulp and Paper Mill Effluent
Chlorinated Dioxins and Furans Regulations (SOR/92-267), ENV’T CAN.,
http://www.ec.gc.ca/lcpe-cepa/eng/regulations/detailReg.cfm?intReg=21
(last
modified Aug. 26, 2014).
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concentration limits for 2-butoxyethanol in products for indoor
use),366 and more general risk management tools.
One such tool is the Prohibition of Certain Toxic Substances
(PCTS) regulations.367 Authorities developed the PCTS
regulations because “it was suggested that it would be simpler
and more effective administratively to develop a generic bannedsubstances regulation to which substances would be scheduled
The PCTS
rather than having separate regulations.”368
regulations include several sub-lists, also called schedules.369 At
present, the twelve substances listed on Schedule 1 are prohibited
from manufacture, import, sale, and use.370
PCTS Schedule 2 functions somewhat like REACH
authorization: listed substances are prohibited from manufacture,
import, and sale, unless exemptions are provided under limited
authority.371 However, Canada’s exemption mechanism may be
more flexible. The Minister of the Environment must issue a
permit if “there is no technically or economically feasible
alternative,” “the applicant has taken the necessary measures to
minimize or eliminate any harmful effect of the toxic substance
on the environment and human health,” and the applicant has
prepared a plan to phase out the use of the substance within
three years after the permit is issued.372 Schedule 2 lists five
substances with permanent permitted uses, one substance with a
temporary permitted use, two with permitted concentration
limits, and two with reporting thresholds. Thus, although the
CEPA-toxicity standard does not necessarily mandate the
consideration of socio-economic data, consideration of substitutes,
or differentiation in uses, such factors are built into the risk
366. 2-Butoxyethanol
Regulations
(SOR/2006-347),
ENV’T
CAN.,
http://www.ec.gc.ca/lcpe-cepa/eng/regulations/detailReg.cfm?intReg=97
(last
modified Aug. 26, 2014).
367. Prohibition of Certain Toxic Substances Regulations, SOR/2012-285
(Can.),
available
at
http://laws-lois.justice.gc.ca/PDF/SOR-2012-285.pdf
[hereinafter PCTS Regulations].
368. Polybrominated Biphenyls, ENV’T CAN., http://www.ec.gc.ca/toxiquestoxics/Default.asp?lang=En&n=98E80CC6-1&xml=7194BA9D-887F-4426-A2BEE7E20560B67B (last modified Aug. 8, 2013).
369. PCTS Regulations, supra note 367, at 3.
370. Id. at Schedule 1, Part 1.
371. Id. at Schedule 2, Parts 1–3.
372. Id. § 10.
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management decision-making process that follows a finding that
a substance is CEPA-toxic and its addition to the TSL.
Under an alternative tool, the agency may require industry
to develop Pollution Prevention (P2) Plans, programs to minimize
the release of substances listed on the TSL.373 Through P2 plans,
EC develops a risk management objective for a particular
substance and compels businesses to develop their own
management strategies for preventing releases of the
substance.374 EC has used P2 plans as precursors to or in lieu of
other risk management strategies, especially those where
information asymmetries make it difficult for the agency to
determine what the most effective or efficient management option
might be.375
Another risk management instrument that is gaining
momentum is the use of a Significant New Activity (SNAc)
requirement, which is very similar in concept to the TSCA
Significant New Use Rules, for substances whose current use(s) is
either extremely limited and well-controlled, or if quantities in
current Canadian commerce are zero or very low.376 The SNAc is
applied to enforce notification of new or increased use (with an
associated requirement to provide risk-related information as per
a New Substance Notification), which allows the regulator to
conduct an updated risk assessment.377
Some criticize the Canadian approach for not fully reversing
the burden of proof of safety on to industry.378 The legislation
does not require industry to make a safety determination, but
CEPA does authorize EC and HC to compel industry to provide
373. See Pollution Prevent (P2) Plans, ENV’T CAN., http://www.ec.gc.ca/lcpecepa/default.asp?lang=En&n=BC71EA4E-1 (last modified Sept. 24, 2013).
374. ENV’T CAN., POLLUTION PREVENTION PLANNING PROVISIONS OF PART 4 OF
THE CANADIAN ENVIRONMENTAL PROTECTION ACT, 1999, FREQUENTLY ASKED
QUESTIONS
1-3
(2008),
available
at
http://publications.gc.ca/
collections/collection_2009/ec/En4-91-2-2008E.pdf [hereinafter ENV’T CAN.,
POLLUTION PREVENTION].
375. See generally id. at 3.
376. See generally SNAc Approach, supra note 122.
377. Policy on the Use of Significant New Activity Provisions of the Canadian
Environmental Protection Act, 1999, ENV’T CAN., https://www.ec.gc.ca/eseees/default.asp?lang=En&n=5CA18D66-1 (last modified Dec. 24, 2013).
378. See, e.g., Adam Briand, Reverse Onus: An Effective and Efficient Risk
Management Strategy for Chemical Regulation, 53 CAN. PUB. ADMIN. 489 (2010).
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data in specific cases379 and, in fact, this is an integral first step
to the assessments done under the CMP. Moreover, the SLRAs
utilize a tiered approach starting with upper-bound exposure
estimates and refine those estimates, as necessary and where
possible, depending on the level of information available.380 P2
plans also reverse the burden of proof of safety onto industry by
establishing a risk management objective that industry is
responsible for meeting.381
The spirit of the CMP is that it is a cooperative endeavor
between government, industry, and NGO stakeholders. To be
sure, praise of CEPA and the CMP is certainly not universal, as
many specific decisions have raised controversy. Nonetheless,
many stakeholders, including both industry and NGOs, seem to
be pleased with the degree of activity under CEPA and the CMP,
especially as compared to the level of activity prior to the
enactment of CEPA 1999.382 As of 2013, none of the stakeholders
are seeking to overhaul the system to the degree they are
currently in the United States.383
B. REACH
REACH places the data-generation and risk-assessment
burdens primarily on industry. The obligations vary depending on
the quantity of the substance to be imported or manufactured, the
potential for the substance to cause harm to persons or the
natural environment (toxicity), and whether the substance is an
existing substance or a new substance. Recall that greater
amounts of information are required for chemicals that are
manufactured or imported in higher volume. Once the 10-tonne
threshold is reached for a registrant, a Chemical Safety Report
(CSR) for the substance must be added to the registration

379. CEPA § 71(1).
380. This is a technical process that is motivated by value-of-information
thinking. See generally NAT’LRESEARCH COUNCIL, UNDERSTANDING RISK:
INFORMING DECISIONS IN A DEMOCRATIC SOCIETY 110–11 (1995).
381. See ENV’T CAN., POLLUTION PREVENTION, supra note 374, at 2–3.
382. See ENVTL. DEF., supra note 120, at 15; Goodhand et al., supra note 276.
383. Cheryl Hogue, Support Grows for Chemical Law Reform, CHEMICAL &
ENGINEERING NEWS, June 10, 2013, at 22–23.
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dossier.384 The CSR must include a chemical safety assessment,
including information on hazards to human health and the
environment, physiochemical hazards, and an assessment on
whether the substance qualifies as PBT or vPvB.385 If the safety
assessment reveals that the substance is hazardous or qualifies
as a PBT or vPvB, then additional information is required,
including exposure scenarios and risk characterization.386
Information on substances makes its way through the supply
chain via documents called Safety Data Sheets.387
One of the common misconceptions about REACH is that it
compels numerous new toxicity tests on thousands of chemicals
that have been marketed for years without any toxicity
information.388 REACH does require basic information regarding
hazards,389 but REACH is designed to minimize the number of
new animal toxicity tests. ECHA and the Member States have
issued detailed guidance on the numerous avenues that
registrants can pursue to avoid the time and expense of animal
toxicity testing.390 They can report previously conducted tests (if
they are applicable and sufficient), they can make inferences
based on structurally similar chemicals, they can allow a test of
one chemical to serve for an entire category of chemicals, and
they can perform modeling exercises to predict acute and chronic
ecotoxicity.391 The registrants bear the full responsibility for
justifying these “adaptations,” and the process of obtaining ECHA
approval for adaptations is burdensome for industry, since it

384. REACH, arts. 10(b), 14(1).
385. Id. art. 14(3).
386. Id. art. 14(4).
387. See id. arts. 31-32.
388. See, e.g., WARGO, supra note 28, at 287 (The “REACH testing program” is
“an important step” because it “will require toxicity testing by manufacturers of
more than 30,000 compounds.”).
389. REACH, Annex VII–X.
390. See generally ECHA, GUIDANCE ON INFORMATION REQUIREMENTS AND
CHEMICAL SAFETY ASSESSMENT (2012), available at http://echa.europa.eu/
documents/10162/13632/information_requirements_r7b_en.pdf (discussing as an
example, aquatic toxicity to sediment organisms). See also UK REACH
COMPETENT AUTH., MINIMIZATION OF ANIMAL TESTING (2012), available at
http://www.hse.gov.uk/reach/resources/18animaltesting.pdf.
391. See generally Herbatschek et al., supra note 175, at 127, 150 (for
example, Quantitative Structure-Activity Relationships).
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involves preparation of detailed justification documents and a
laborious process of answering questions from ECHA.392 In some
cases, registrants decide it is less onerous to perform tests—even
if they are expensive—than to seek ECHA acceptance of
adaptations.393
One indication of the limited quantity of animal testing that
is induced by REACH is the proportion of requests for approval of
animal tests in relation to the number of registration dossiers
submitted to ECHA. By May 2013, ECHA had received 33,656
registration dossiers on 8,469 substances.394 The number of
dossiers including a proposal for animal testing was modest:
about 800 tests were proposed (by 2012), 62 percent for a single
toxicity endpoint (reproductive effects, either developmental or
two-generation studies).395 Additionally, some of these tests are
not expected to be conducted because ECHA approval of some
tests will render other proposed tests unnecessary, since
registrants will be able to use “read across” techniques to allow a
test of one substance in a category to satisfy the data requirement
for other chemicals in that category.396
One of the innovative features of REACH is the requirement
that multiple manufacturers of the same chemical join together
and submit a single dossier (“one substance, one registration”).397
Companies form Substance Information Exchange Forums
(SIEFs) and contractual organizations called consortia to
facilitate information sharing, which means that test data in the
possession of one company can be used to meet the obligations of

392. ECHA, HOW TO AVOID UNNECESSARY TESTING ON ANIMALS 12 (2010),
available
at
http://echa.europa.eu/documents/10162/13655/pg_avoid_animal_testing_en.pdf.
393. Gerwin Schaafsma et al., REACH, Non-Testing Approaches and the
Urgent Need for a Change of Mind Set, 53 REG. TOXICOLOGY & PHARMACOLOGY
70, 78 (2009).
394. Bjorn Hansen & Mike Penman, Is REACH Achieving Its Objectives?, in
THE EUROPEAN UNION REACH REGULATION: LAW AND PRACTICE 376–77 (Lucas
Bergkamp ed., 2013).
395. Id. at 387.
396. Id.
397. Registration,
ECHA,
http://echa.europa.eu/en/regulations/reach/
registration (last visited Nov. 5, 2014).
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all companies in the group.398 A lead registrant may bear the
brunt of the work but may also collect some fees from other
companies in the group to defray some of the costs of being a lead
registrant.399 One company in a SIEF must sell its data to
others, a pattern that has led to some interesting negotiations
since there is no obvious way to set a price for data from an older
toxicity study. Elsewhere, we have written about some of the
complex financial and legal issues that arose during the initial
formation and operation of SIEFs and consortia under REACH.400
The transaction costs were substantial (and arguably greater
than they needed to be), but there is no question that the
collaboration between manufacturers (and users) of chemicals has
reduced the amount of new toxicity tests and other data
gathering that might otherwise have been necessary.401 Equally,
the requirement has forced a significant workload on industry.
Starting with the 2010 registration deadline and now with
the recent passage of the 2013 registration deadline, REACH has
stimulated the assembly of a massive electronic database of
chemical properties, uses, exposure pathways, and risk
management measures. The huge inventory is housed at
ECHA.402 Thus, some of the data gaps on chemicals in commerce
have been filled, and more data gaps on lower-volume chemicals
will be filled by the next registration deadline in 2018.
There is some evidence that the actual act of gathering and
submitting the data has produced some positive benefits.403
Registration has not only facilitated communication among risk
398. See Adam D.K. Abelkop et al., How can REACH be Improved?, in THE
EUROPEAN UNION REACH REGULATION: LAW AND PRACTICE 390, 393–94 (Lucas
Bergkamp ed., 2013).
399. See Mike Penman & Martin Richards, REACH Consortia, in THE
EUROPEAN UNION REACH REGULATION: LAW AND PRACTICE 185, 191 (Lucas
Bergkamp ed., 2013).
400. Abelkop et al., supra note 79, at 11051-53.
401. Mike Penman & Martin Richards, REACH Consortia, in THE EUROPEAN
UNION REACH REGULATION: LAW AND PRACTICE 186 (Lucas Bergkamp ed., 2013).
“If each stakeholder had to submit their own intrinsic hazard data, . . . a large
amount of unnecessary animal testing [could occur].” Id. Hungary and the UK
succeeded with an amendment to REACH calling for “one substance, one
registration.” Id.
402. See Registered Substances, supra note 189.
403. Abelkop et al., supra note 79, at 11056.
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managers and other professionals within different branches of
large companies, but it has also facilitated communication
between different companies throughout the supply chain of
chemical products. Stakeholders have indicated that this
communication has allowed them to achieve some efficiencies in
operations, data gathering, and decision-making on chemical uses
and product design.404 In addition, a large portion of registration
information is now publicly available on the Internet, through
ECHA’s website, for examination by governments around the
world, public interest organizations, consumers, processors,
retailers, and companies throughout the chemical industry.405
A challenge for the EU is to ensure that the information is
put to good use in risk management. European Authorities
indicate that registration dossiers require registrants to make
affirmative safety determinations that risks of chemicals are
“adequately controlled.”406 Thus, REACH is said to reverse the
burden of proof of safety onto industry.
In our view, the ideal of reversing the burden of proof is
commendable. It should be the responsibility of companies to
ensure the safety of the products that they place on the market.
In practice, however, the implementation of the reversed burden
of proof has presented challenges. EU Authorities indicate that a
finding of “adequate control” is a central part of some registration
dossiers, but stakeholders seem to be less certain of this
obligation, perceiving registration as more of a data collection
process than a risk management process. Part of the difficulty
might be traced to some ambiguity as to the meaning of
“adequate control,”407 but the bigger issue may be a perception
that EU Authorities must ultimately take action under the
authorization or restriction processes to ensure adequate control
404. See id. at 11046–47.
405. Registered Substances, supra note 189.
406. Abelkop et al., supra note 398, at 390–93.
407. See id. at 390; David Santillo & Paul Johnston, Effect Thresholds and
‘Adequate Control’ of Risks: The Fatal Flaws in the EU Council’s Position on
Authorisation Within REACH, 13 ENVTL. SCI. & POLLUTION RESEARCH INT’L 425,
429 (2006). But see REACH, Annex I § 6.4 (describing how adequate control is
defined and ECHA’s guidance on how it is defined in practice); ECHA, GUIDANCE
IN A NUTSHELL: CHEMICAL SAFETY ASSESSMENT, 18–19 (2009), available at
http://echa.europa.eu/documents/10162/13632/nutshell_guidance_csa_en.pdf.
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of exposures (e.g., ECHA cannot pull a registration because it
believes risk management measures are inadequate).408
Moreover, the safety determinations made by registrants
within registration dossiers might not always be the same
determinations that a regulator would make. As an example, the
ECHA PBT Expert Group concluded that Siloxane-D5 is a vPvB
and should therefore be classified as a SVHC and slated for
authorization.409 However, the registrants have concluded in
their dossier that it is not a vPvB.410 Substances that are vPvB
(along with PBTs and CMR substances) are considered “nonthreshold” substances under the statute.411 That is, they are
substances for which, under REACH, it is assumed that there is
no safe level of exposure, and hence the risks cannot be
adequately controlled. For substances that REACH presumes do
not have a safe level of exposure, it is a mystery how a
registration dossier could demonstrate adequate control of
exposure (unless exposures are eliminated). Yet, the registrants
have determined that risks are, in fact, adequately controlled.
This apparent inconsistency might not have any practical impact;
it is entirely plausible that risks are adequately controlled (after
all, the Canadian Board of Review determined that Siloxane-D5,
as it is used in Canada, is not CEPA-toxic). However, this case
raises broader questions about the clarity of regulatory mandates
under REACH and the potential for contradictory outcomes under
different parts of the regulation (i.e., registration versus
authorization).412

408. See MILIEU ENVTL. LAW & POLICY, supra note 283, at 7.
409. ECHA, IDENTIFICATION OF PBT AND VPVB SUBSTANCE: RESULTS OF
EVALUATION OF PBT / VPVB PROPERTIES 120 (2014), available at
http://echa.europa.eu/documents/10162/13628/decamethyl_pbtsheet_en.pdf.
410. ECHA,
PBT
Assessment:
Overall
Result,
DECAMETHYLCYCLOPENTASILOXANE,
http://apps.echa.europa.eu/registered/data/
dossiers/DISS-9d82d68d-a71c-2317-e044-00144f67d249/AGGR-987c9eda-73dc413e-9d74-c56194ad1383_DISS-9d82d68d-a71c-2317-e044-00144f67d249.html#
AGGR-987c9eda-73dc-413e-9d74-c56194ad1383 (last visited Nov. 8, 2014).
411. See REACH, art. 60(2)–(3).
412. Elsewhere we have argued that the REACH’s safety standard under
authorization is not consistent with the standard under registration because
registration process does not permit the registrant to consider benefits (under
the “adequate control” standard) whereas the authorization process permits
consideration of benefits during socio-economic analysis of specific uses. See
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Additionally, the concept of “safety” is a social construct and
different sectors of society have different views about what is
“safe.” Although the concept of placing the burden of proof on
industry may be superficially attractive to some, the risk outcome
is based largely on companies’ determinations of what constitutes
“safety.” Chemical manufacturers have the most direct control
over internal safety in handling chemicals and less control over
the safety in how chemicals are used downstream. More
importantly, industry can make a safety determination, but
cannot decide on societal acceptance of its position on risk.
Acceptable levels of risk may turn on whether emphasis in a risk
assessment is placed on hazard or exposure data; this has
historically been a point of contention between industrial
interests and consumer health and environmental advocates.
What’s more, the Siloxane-D5 case raises questions about the
trustworthiness of safety determinations in registration dossiers:
if Annex XV dossiers rely primarily on data from registration
dossiers to identify SVHCs, then companies have a strong
incentive to find that their substances do not have vPvB, PBT,
CMR, or endocrine disrupting properties. The same can be said of
the data submitted under CEPA (and indeed any regulatory
program). The difference is that the volume of data that the
government must inspect under CEPA is much more manageable,
and government is not relying on industry to self-regulate.
REACH does not rely wholly on industry to regulate itself
through registration; ECHA conducts audits of the registration
dossiers, often requesting or compelling clarifications or
additional data/analysis.413
The EU may also supplement the safety measures in
registration dossiers by managing risks through the
authorization and restriction mechanisms under REACH.414
Recall that once a SVHC is placed on the Authorization List, it
must be phased out unless the Commission approves
authorization requests for specific uses.415 As an alternative, the
Abelkop et al., supra note 398, at 390–93; Abelkop et al., supra note 79, at
11062–64.
413. See Herbatschek et al., supra note 175, at 130.
414. Id. at 133–152.
415. See id. at 136.
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Commission can establish more targeted restrictions on the
manufacture, placement on the market, or use of a substance that
it determines to pose an unacceptable risk to human health or the
environment.416
Therefore, the notion that REACH fully reverses the burden
of proof of safety is a misleading oversimplification. Under
authorization and restriction, the burden shifts to the
government to identify SVHCs, place chemicals on the Candidate
List and then the Authorization List, or apply restrictions. After a
chemical is placed on the Authorization List, the burden shifts to
Each
industry to apply for use-specific authorizations.417
authorization request must certify either that adequate control of
risks for threshold substances has been accomplished or that
benefits exceed risks in the case of non-threshold substances
(socio-economic analysis).418 If a company chooses the socioeconomic route of justification, it must also demonstrate that no
suitable alternatives to the SVHC are available for the specific
use.419
In December 2013, Rolls-Royce was the first company to gain
an opinion from ECHA that the Commission should approve an
authorized use of a substance (DEHP) on the Authorization List
by making the case that risks are adequately controlled in a
specific aerospace application: the seven-year authorization is for
the use of DEHP—short for Bis(2-ethylhexyl) phthalate, a
reproductive toxin—in the manufacture of aero engine fan
blades.420 In 2013, ECHA received a total of eight authorization
requests covering two phthalates in seventeen different uses.421
In 2014, ECHA received nineteen authorization requests.422

416. See id. at 145.
417. See id. at 139.
418. Id. at 140.
419. Herbatschek et al., supra note 175, at 140.
420. Press Release, ECHA, Authorisation to Use a Substance of Very High
Concern - First Opinions Adopted (Jan. 3, 2014), available at http://echa.europa.
eu/view-article/-/journal_content/title/authorisation-to-use-a-substance-of-veryhigh-concern-first-opinions-adopted.
421. Id.
422. Statistics on Received Applications, ECHA, http://echa.europa.eu/
web/guest/addressing-chemicals-of-concern/authorisation/applications-forauthorisation/received-applications (last modified Mar. 20, 2015).
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Prior to the first authorization decision, the common perception
among industry stakeholders was that the authorization process
would be strict, onerous, and unpredictable with regard to
outcome.423 Such perceptions are likely to evolve as practical
experience with the authorization process is accumulated. There
is no precedent yet for an authorization based on socio-economic
analysis.
Overall, the REACH regulation imposes burdens of proof on
both industry and government. Those burdens are sometimes
independent of each other, but in some cases (e.g., authorization)
the sharing of burdens is an iterative process. Both stakeholders
and government have experienced “growing pains” in the first
years of REACH implementation, but the statute has so far
proven to be workable, despite its complexity. In the years ahead,
the inspection of a greater volume of registration dossiers, along
with more experience with the authorization process, will yield
additional insight into the workability of REACH’s approach to
chemicals management.
C. Lessons
1. Industry Should Be Required to Produce and
Supply Safety Data
In addition to accepting some level of responsibility for
placing a chemical in the marketplace, manufacturers and
processors are likely the least-cost providers of safety
information.424 Many jurisdictions, including the EU, U.S., and
Canada, have pre-manufacturing or pre-marketing notification
requirements for new substances. The European and Canadian
laws include specific data requirements to accompany the
registration package. Hence new substances introduced into
commerce may have a more extensive database than many
existing (legacy) chemicals. Given this precedent, it is not
unreasonable to expect industry to generate and provide similar
423. Herbatschek et al., supra note 175, at 134, 139–45.
424. See GUIDO CALABRESI, THE COST OF ACCIDENTS 135–97 (1970); Jonathan
B. Wiener, The Real Pattern of Precaution, in THE REALITY OF PRECAUTION:
COMPARING RISK REGULATION IN THE UNITED STATES AND EUROPE 519, 529
(Jonathan B. Wiener et al. eds., 2011).
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databases for existing chemicals; and the industry’s response to
recent challenges such as the various High Production Volume
initiatives425 tend to confirm that it understands these
expectations, although there is still a long way to go before the
entire spectrum of legacy chemicals has been dealt with. On the
other hand, the careful use of limited data and modeling—
coupled with safe experience to date—argues against broadly
applicable data requirements.
Both CEPA and REACH place the burden of data production
primarily on industry.426 TSCA section 2 also states, “the
development of such data should be the responsibility of those
who manufacture and those who process such chemical
Government as well as
substances and mixtures.”427
stakeholders in industry and public interest organizations
engaged in the TSCA reform debate all contend that the
placement of the burden of data production should be on industry.
One of the reasons for the broad consensus is
straightforward: the chemicals marketplace is characterized by
an information asymmetry in favor of industry. Manufacturers,
processors, and users are in the best position to obtain data on
intrinsic properties, uses, releases, exposure scenarios and
pathways, and risk management measures.428 They can do so at
a lower cost than government can because they already have
established commercial relationships with each other and
because government is in a poor position to appreciate the wide
variety of uses throughout industry, the many possible exposure
scenarios, the numerous opportunities for chemical releases into

425. See
High
Production
Volume
(HPV)
Challenge,
EPA,
http://www.epa.gov/hpv/index.htm (last updated Apr. 22, 2013).
426. However, EC and HC have also spent significant resources and time
mining existing data and developing predictive tools. See generally The HealthRelated Components of Categorization of the Domestic Substances List (DSL):
Approach, Results, and Next Steps, HEALTH CAN., http://www.hc-sc.gc.ca/ewhsemt/contaminants/existsub/categor/approach-approche-eng.php (last modified
Jan. 31, 2008).
427. 15 U.S.C. § 2601(b)(1) (2012).
428. See Applegate, RESCUING, supra note 87, 263–65.
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the environment, and the wide range of risk management
measures that are already employed by companies.429
The approval processes for agricultural chemicals and
pharmaceuticals also place the burden of data generation on the
private sector, as do the various permit processes under the Clean
Air Act and Clean Water Act and those applicable to many other
industrial facilities such as oil and gas development, mining
operations, and waste disposal (e.g., incinerators and landfills).
Thus, there is plenty of regulatory precedent for placing the
burden of data generation on industry.
Some scholars have raised issues about the trustworthiness
of data generated by industry.430 After all, companies may
perceive that they have little to gain and much to lose by
providing regulators with information about the potential risks of
using their chemicals. Since only a small percentage of
registration dossiers are checked fully by ECHA, registrants may
perceive that they can “cut corners” in the registration process.431
The use of SIEFs under REACH may create an informal
policing of information quality in registration dossiers. If a SIEF’s
lead registrant proposes to submit low-quality or misleading
information to ECHA, the other registrants in the SIEF who
placed their trust in the lead registrant may lose confidence in
the lead registrant and seek corrective action.432 None of the
registrants want to be exposed to the risk of potential delays, a
refusal of registration based on inadequate information, or the
potential reputation damages caused from submitting misleading
429. For a discussion of the issues regarding whether data should be
generated by industry or government, see Applegate, RESCUING, supra note 87,
at 263–75.
430. Id. at 273–75; JOE THORNTON, PANDORA’S POISON: CHLORINE, HEALTH, AND
A NEW ENVIRONMENTAL STRATEGY 98–99 (2000) (arguing that corporate funding
of toxicological research has biased thinking in favor of the concept of
thresholds); Daniel Uyesato et al., REACH’s Impact in the Rest of the World, in
THE EUROPEAN UNION REACH REGULATION FOR CHEMICALS: LAW AND PRACTICE
335, 361 (Lucas Bergkamp ed., 2013) (discussing the government of Japan’s
preference to not rely on industry-generated data).
431. See generally Compliance Checks, ECHA, http://echa.europa.eu/
regulations/reach/evaluation/compliance-checks (last visited Nov. 6, 2014).
432. See generally Lucas Bergkamp & Mike Penman, Conclusions, in THE
EUROPEAN UNION REACH REGULATION FOR CHEMICALS: LAW AND PRACTICE 410,
427 (Lucas Bergkamp ed., 2013).
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safety information to the government. More generally, it is not
difficult to imagine negative consequences that could result for a
company that is shown to have submitted incomplete, misleading,
or fraudulent data to a regulatory body. Under U.S. tort laws,
such behavior could increase the risk of punitive damage awards
against a company, assuming that a worker or consumer was
ultimately harmed by chemical exposure and a jury is made
aware of the company’s misbehavior.433
Procedures for review of regulatory data—sometimes called
“regulatory science” due to the applied nature of the information
and the possible role of policy drivers or assumptions in the datageneration or data-analysis parameters—should therefore be
built into any regulatory system for chemicals.434 Both CEPA
and REACH have issued guidance concerning the quality of
submitted data (e.g., the use of Good Laboratory Practices (GLP)
is required by law and emphasized in guidance), have issued test
guidelines based on internationally agreed test methods
(determined by OECD), and have incorporated detailed
procedures to review industry-generated data.435 On the other
hand, neither CEPA nor REACH precludes the consideration and
use of non-GLP studies.
Since government scientists and their contractors often have
a crucial role to play in the review of industry-generated data and
analyses, it is vital that the scientific staff of regulatory agencies
receive adequate funding and training to perform their qualitycontrol and data review/interpretation roles. Insofar as data
433. Under U.S. tort law, a company might face large punitive damages if it
intentionally misled the government, and this resulted in harm to consumers or
the environment. Gertz v. Robert Welch, Inc., 418 U.S. 323, 350 (1974) (defining
punitive damages); ALEXANDER VOLOKH, REASON FOUND., POLICY STUDY NO. 213:
PUNITIVE DAMAGES AND ENVIRONMENTAL LAW: RETHINKING THE ISSUES 10 (1996),
available at http://reason.org/files/76a01f43ff7eec045e97b61c0f23caf5.pdf; Rae
Zimmerman, Governmental Management of Chemical Risk: Regulatory Processes
for Environmental Health 103–05 (1990) (citing examples of chemical damage
claims against Monsanto for $16 million in 1983 and $108 million 1986, the
latter including $100 million in punitive damages).
434. Sheila Jasanoff, Watching the Watchers: Lessons from the Science of
Science Advice, GUARDIAN, Apr. 8, 2013, http.www.theguardian.com/science
/political-science/2013/apr/08/lessons-science-advice.
435. See, e.g., REACH, art. 13(4) (requiring that ecotoxicological and
toxicological tests be carried out under GLP or other international standards);
Karalis & Kelland, supra note 346.

https://digitalcommons.pace.edu/pelr/vol32/iss1/3

104

3_ABELKOP&GRAHAM FINAL

212

PACE ENVIRONMENTAL LAW REVIEW

8/24/2015 12:05 PM

[Vol. 32

about chemicals are made publicly available (as is increasingly
the case in the EU and Canada), public interest groups and
interested academics and consultants can also serve as informal
critics of quality and relevance. The more that industry data are
made available for public scrutiny and are subjected to rigorous
review by qualified scientists, the more likely it is that the public
will trust the resulting regulatory outcomes.
2. Industry Should Be Required to Analyze Submitted
Data and Make Safety Determinations for
Envisioned Uses Under the Applicable Standard of
Safety
Under U.S. and Canadian law, chemical manufacturers and
users are already subject to affirmative duties of care that are
expressed in tort laws.436 TSCA, however, places the burden of
making the safety determination on the government, as does
CEPA.437
European law relies more heavily on administrative
regulation (than tort law) to impose duties of care on industry,
and thus it should not be surprising that REACH placed the
burden of making a safety determination on industry (e.g., in the
registration process and when use-specific authorizations to
market a SVHC are requested).438 REACH also places the safetydetermination burden on government under the authorization
and restriction procedures. Thus, it is more accurate to describe
REACH as a hybrid statute, where some of the safetydetermination responsibility is placed on industry and some on
government.
As TSCA reformers consider this question, it should be
apparent that either arrangement can be workable, as both the
Canadian and European safety-determination systems have been
operational for almost a decade. The harder question to answer is
436. See Renn & Elliott, supra note 62, at 228 (stating the potential civil
liability in the United States from chemical risks is at least as important as the
regulatory system).
437. Denison, Ten Essential, supra note 75, at 10020.
438. See Lucas Bergkamp, Does REACH Present a Business Opportunity?, in
THE EUROPEAN UNION REACH REGULATION FOR CHEMICALS: LAW AND PRACTICE
396, 408 (Lucas Bergkamp ed., 2013).
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which safety-determination approach—or what form of hybrid
model—is preferable in the U.S. under a reformed TSCA, given
the nature of our legal system, the track record of our regulatory
authorities in risk assessment and management, the likely
constraints on public funding of U.S. regulators, and our political,
commercial, and scientific cultures.
Although either burden location in TSCA reform could work,
we are inclined to favor a reversal of the burden in the United
States as has been implemented in the REACH registration
system—companies should be compelled to make a safety
determination for specific uses under a statutory standard;
determinations should then be reviewed by government
regulators. Elsewhere we have argued that the safety standard in
REACH is not clear and consistent,439 but we do believe that a
clear and consistent safety standard should be politically
determined. Once the safety standard is established, it should be
the responsibility of industry to make the initial showing that
they have complied with the standard, and the government
should be the final arbiter as to whether industry has complied
with the standard. We offer four practical reasons for this policy
preference, in addition to our philosophical preference that those
who market products have an ethical responsibility to vouch for
their safety on the basis of evidence.
First, if the federal government, through EPA risk
assessments and management decisions, shoulders the burden of
accomplishing chemical safety evaluation, we fear that the riskassessment work will be performed slowly, and in some cases, it
will simply not get done. The result may be insufficient protection
of the public and a resulting lack of public trust in the reformed
regulatory system. Despite the positive experience in Canada
under the CMP as discussed above, our fear is rooted in the welldocumented (glacial) pace by which EPA completes hazard
assessments under the Integrated Risk Information System and
the limited number of risk assessments completed under
TSCA.440 Moreover, EPA has experience in developing a wide
439. Abelkop et al., supra note 398, at 390.
440. On EPA’s slow pace of issuing risk assessment guidelines and performing
hazard assessments for specific chemicals, see E. Donald Elliott & Gail
Charnley, Private Product-Risk Assessment and the Role of Government, 23
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variety of risk assessment guidelines that could be applied to
industry risk assessments.441 We have reason to be confident in
EPA’s ability to review risk assessments and safety
determinations made by industry.
The new role we propose for EPA as reviewer of industry risk
assessments approximates the role of U.S. regulators in many
other health, safety, and environmental programs ranging from
pharmaceuticals and medical devices to nuclear reactor safety.
Indeed, EPA already plays this reviewer role in a variety of its
own programs. For example, when agricultural chemical
companies make a case for “reduced risk” pesticides under the
Federal Insecticide, Fungicide, and Rodenticide Act (and thus
become eligible for accelerated registration decisions), EPA is put
in the role of reviewing the risk assessments prepared by
industry.442 Likewise, although EPA does not routinely review
industry risk assessments under TSCA’s new chemical program,
the agency does have relevant experience reviewing TSCA section
5(h)(4) exemption requests, where it must grant or deny a
requested exemption to the requirement that a company prepare
a pre-manufacturing notice (PMN) package for a new chemical.
EPA in effect must evaluate the company’s claim that there will
not be an unreasonable risk with the new chemical without a
PMN. To better ensure that safety is provided, EPA may insist
that amendments be made to the exemption request, and then
those amendments are treated as kind of a binding PMN on the
company. More generally, the company’s general obligation to
prepare a PMN (an organized package of technical and
commercial information) under TSCA has proven to be a very
valuable starting point for EPA review rather than being
compelled to create a dossier from scratch (as they are currently
expected to do for existing chemicals).
Another illustration of EPA acting as a reviewer of industry
information occurred in the Organization for Economic
JOHN LINER REV. 73, 77 (2009). See generally NRC 2009, supra note 38, at 45–47,
56–57.
441. See Guidance & Tools, EPA, http://www.epa.gov/risk_assessment
/guidance.htm (last updated Apr. 28, 2014).
442. See
Conventional
Reduced
Risk
Pesticide
Program,
EPA,
http://www.epa.gov/opprd001/workplan/reducedrisk.html (last updated Mar. 4,
2014).
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Cooperation and Development’s Screening Information Data Set
(SIDS) program.443 Companies prepared an initial package of
information—the SIDS Initial Assessment Report—that could be
used by EPA in the OECD’s international dialogue. EPA reviewed
the package and, where appropriate, requested revisions, prior to
the package being submitted by EPA to the OECD’s international
review.444
We recognize that EPA has recently pledged445 (and indeed
has made some) significant progress in the preparation of risk
assessments under the current TSCA regime,446 though the scope
of the activity is modest compared to what has happened in
Europe since 2006.447 At its recent accelerated pace, it would
take EPA ten years to complete risk assessments for the 83
chemicals in the current TSCA Work Plan.448 If EPA faces
hundreds of priority chemicals under a reformed TSCA, as should
be expected given the experiences in Canada and the EU, it is
difficult to have confidence in its ability to get the job done.
Second, U.S. policymakers should strongly consider formally
incorporating external peer review of risk assessments into TSCA
reform. With industry-produced assessments, external peer
review overseen by EPA (i.e., EPA would choose the reviewers)
could facilitate public confidence in the quality of the
assessments.

443. See OECD SIDS Voluntary Testing Program for International High
Production Volume Chemicals, EPA, http://www.epa.gov/oppt/chemtest/
pubs/oecdsids.html (last updated Apr. 27, 2011).
444. See generally Robert Diderich, The OECD Chemicals Programme, in RISK
ASSESSMENT OF CHEMICALS: AN INTRODUCTION 623, 633 (C.J. van Leeuwen &
T.G. Vermeire eds., 2007).
445. Cheryl Hogue, Assessing Chemicals: New EPA Effort Targets Dozens of
Substances Already on the Market for In-Depth Scrutiny, CHEMICAL &
ENGINEERING NEWS, Apr. 30, 2012, at 28–30.
446. See
Assessments
for
TSCA
Work
Plan
Chemicals,
EPA,
http://www.epa.gov/oppt/existingchemicals/pubs/riskassess.html (last updated
Oct. 23, 2014).
447. U.S. GOV’T ACCOUNTABILITY OFFICE, GAO-13-249, TOXIC SUBSTANCES: EPA
HAS INCREASED EFFORTS TO ASSESS AND CONTROL CHEMICALS BUT COULD
STRENGTHEN ITS APPROACH 16 (2013).
448. U.S. GOV’T ACCOUNTABILITY OFFICE, GAO-13-696T, CHEMICAL
REGULATION: OBSERVATIONS ON THE TOXIC SUBSTANCES CONTROL ACT AND EPA
IMPLEMENTATION 13 (2013).
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Third, placing a regulatory obligation on industry to make a
finding of safety prior to placing—or continuing to place—a
chemical on the marketplace might not be as onerous as some in
industry fear, especially since many companies in the industry
already have hands-on experience preparing dossiers and making
such determinations under REACH. Rather than expect EPA risk
assessors to reinvent the wheel based on a similar body of data, it
may make sense for companies doing business in the United
States to provide what they have done in Europe for submission
to EPA, with appropriate adaptations as determined by EPA.
Even if TSCA reform would not grant REACH registration
dossiers or responses to CEPA section 71 surveys complete
reciprocity, the data burdens on U.S. companies would not be as
great as those under REACH and CEPA. Over the last decade,
regulatory efforts in Europe, Canada, and elsewhere have
facilitated an enormous increase in information on chemical
hazards and exposures as well as advancements in risk
assessment techniques. To most effectively take advantage of this
changing landscape, a reformed TSCA should apply dynamic,
adaptive assessment and management decision-making
processes.
Nonetheless, it may not be wise for U.S. policy makers to
apply a formal registration system to as many chemicals as in
Europe. There are small and medium-sized businesses in the U.S.
that do not do business in Europe, and they would have a steep
learning curve under a proposal to transfer a REACH-like
registration system to the U.S. TSCA reform should attempt to
minimize rent seeking by multinational firms that have
experience under REACH. Even under our modest registration
recommendation (focused on high priority chemicals), federal
programs for compliance assistance may be necessary for small
and medium-sized American companies and their customers.
A registration program under a reformed TSCA does not
necessarily need to contain the same data elements that are
specified under REACH, but the presumption should be in favor
of international harmonization. Careful justification needs to be
provided for each departure from the REACH requirements
(addition or exclusion). A key question will be what information
will be required about production volume, uses, and exposure
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scenarios, given that EPA already has a Chemical Data Reporting
rule that is compelling companies to submit some of this
information.449 Registration would be valuable in confirming the
quality of the existing information and in generating more
detailed information from companies (manufacturers, processors,
and users) to support exposure and risk assessment on a use-byuse basis. More detailed information on implementation of risk
management measures would also be highly desirable compared
to the rudimentary information required under REACH. The
TSCA registration could call for such information as part of a
REACH-like Chemical Safety Report.
There will be a natural tendency for U.S. companies to fear
SIEF-like processes that compel collaboration among multiple
companies that are usually in the business of competition.
However, as we have documented elsewhere, many of the
problems with formation of SIEFs in Europe can now be
prevented in the U.S., since we know what caused problems in
Europe and many of those issues were preventable. If Congress
tries to engineer a registration process without any SIEF-like
entities, the risk of unintended consequences and bureaucratic
snafus is greater than if U.S. legislation builds on the experience
(“warts and all”) of REACH.
Fourth, a registration system under a reformed TSCA could
apply exclusively to high priority chemicals—identified through a
Canadian-style prioritization process—rather than nearly all
chemicals, as is the case in Europe. Under such a system, the
sheer number of registration dossiers we have in mind is vastly
smaller than the volume that ECHA must process under REACH.
If, as we expect, a U.S. registration system for high-priority
chemicals proves to be workable for government and the
stakeholders, Congress (or EPA) could then decide at a later date
whether it is worthwhile to extend the registration system to
lower-priority chemicals. Since the last REACH registration
deadline is not until 2018 (when many small and medium-sized
European companies will be required to register), it certainly
makes sense—on the merits, and as a matter of prudent political
449. See TSCA Inventory Update Reporting Modifications; Chemical Data
Reporting, 76 Fed. Reg. 50, 816 (Aug. 16, 2011) (codified in 40 C.F.R. pts. 704,
710, and 711).
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judgment—to wait until after 2018 to decide whether, given the
experience of small companies in Europe, low-volume chemicals
should be included in a U.S. registration system.
IV.

CONCLUSION

We conclude by describing a practical approach to TSCA
reform that can draw from what we regard as the best of both the
Canadian and European experiences. First, Canada has
demonstrated that a manageable number of high-priority
chemicals can be identified based on limited data and
screening/modeling exercises. TSCA reform could pursue
promptly in that fashion, without forcing the assembly of
thousands of electronic dossiers by industry that have been
required under REACH. Indeed, we have already noted that EPA
has a well-developed scoring system that could be used to identify
a manageable number of existing chemicals for high-priority risk
assessment and management.
Second, for the high priority chemicals, TSCA reform could
pursue a targeted registration system that places the burden of
data generation and safety determination (for specific uses) on
industry. This registration system could draw on the key
innovations from the European experience: no data, no market;
and one substance, one registration. A reformed TSCA should
include a clear, consistent, and workable safety standard. The
role of EPA would be to review the industry’s safety
determinations under that standard on a case-by-case basis,
exercising ultimate authority to reject the registration or to insist
on more information or stronger risk management measures.
Industry would have strong incentives to meet registration
deadlines, as they have under REACH, because companies would
not be permitted to market high-priority chemicals without the
registration. Registrants could pay registration fees as well as
continual user fees to fund the assessment and management
processes.
Third, the burden of making safety determinations could
then flip back to EPA. The agency could utilize registration data
to determine whether a clear, risk-based safety standard is met,
requiring industry to provide additional data if necessary. If EPA
finds that the standard is not met, EPA should be given
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discretion to apply a wide variety of risk management
instruments through informal rulemaking. Risk assessment as to
whether the standard is met should be separate from a
determination of which risk management instrument to apply.
EPA’s burdens of proof for finding that the safety standard is not
met and for determining which risk management tool(s) to apply
should be permissive.
One of the advantages of a focus on high priority chemicals is
that it can be aligned with the growing market forces for safety
that are already at work in the United States. Chemical
manufacturers are facing market de-selection of the chemicals
that present the greatest concern, with encouragement to
compete on the basis of green and sustainable chemistry for safer
substances.450 Already, retailers like Target and Wal-Mart are
requesting greater information on chemicals from products
manufacturers and restricting sales of products with worrisome
chemical inputs.451
The TSCA reform approach that we have suggested will
accelerate green market forces for chemical uses that cannot be
defended through registration while reassuring retailers that
some uses of hazardous chemicals do not, due to little or no
exposure, pose significant risk and can safely be continued. TSCA
reform should support these efforts to increase the amount of
information available to retailers and consumers, regardless of
where the burden of proof is placed.
Because the TSCA reform process is ongoing, we believe that
it is most productive to highlight general lessons that policy
450. The burden of producing registration dossiers under REACH has not
necessarily spurred innovation in green chemistry. In fact, the early years of
REACH implementation have witnessed a shift of highly skilled scientists in the
industry from research and development to regulatory compliance. The result
may be more data generation and warehousing than innovations in green
chemistry. CTR. FOR STRATEGY & EVALUATION SERVS., INTERIM EVALUATION:
IMPACT OF REACH REGULATION ON THE INNOVATIVENESS OF THE EU CHEMICAL
INDUSTRY, REPORT TO EUROPEAN COMMISSION, ENTERPRISE AND INDUSTRY, at iii
(2012), available at http://ec.europa.eu/enterprise/sectors/chemicals/files/reach/
review2012/innovation-final-report_en.pdf.
451. See Melody M. Bomgardner, Walmart and Target Take Aim at Hazardous
Ingredients,
CHEMICAL
&
ENGINEERING
NEWS,
Feb.
17,
2014,
http://cen.acs.org/articles/92/i7/Walmart-Target-Take-Aim-Hazardous.html;
Bomgardner, supra note 306.

https://digitalcommons.pace.edu/pelr/vol32/iss1/3

112

3_ABELKOP&GRAHAM FINAL

220

PACE ENVIRONMENTAL LAW REVIEW

8/24/2015 12:05 PM

[Vol. 32

makers should take away from the Canadian and European
experiences rather than comment on a particular draft bill. It is
noteworthy, however, that the most recent draft bills that have
been presented in committees in the Senate (Chemical Safety
Improvement Act) and the House of Representatives (Chemicals
In Commerce Act) do in fact include several of the elements that
we suggest. Both include prioritization mechanisms as an initial
step to identify high priority chemicals, and both separate risk
However,
assessment from risk management decisions.452
neither includes a registration mechanism. We recognize that the
concept of registration may not seem desirable given the complex
and burdensome European experience, but we suggest the hybrid
approach nonetheless in the spirit of generating some productive
dialogue on a new idea in the TSCA reform debate.
Although we have tackled some of the critical issues in the
TSCA reform debate by drawing lessons from Canada and
Europe, we conclude by acknowledging some key issues that this
Article has not addressed. We have not covered how extensive the
ecological and human health data requirements for high-priority
chemicals should be; what the safety standard under TSCA
reform should be; how non-threshold chemicals should be
regulated; whether and how state and local regulation of
chemicals should by preempted under TSCA reform; whether and
how the United States should participate in international
chemicals treaties; and how confidential business information
and public disclosure of data should be handled in TSCA reform.
Though we have commented on judicial review, the particular
role that it should play under a reformed TSCA statute is a
significant open question as well. We encourage scholars and
practitioners interested in TSCA reform, and chemicals
regulation in general, to critique our suggested directions and
tackle some of the hard issues that we have not addressed.

452. S. 1009, 113th Cong. § 6(c)(1), (2), (9) (2013); STAFF OF H.R. ENERGY &
COMMERCE COMM., 113TH CONG., DISCUSSION DRAFT ON CHEMICALS IN COMMERCE
ACT § 6(b), (c) (Comm. Print 2014), available at http://docs.house.gov/meetings
/IF/IF18/20140429/102160/BILLS-113pih-TheChemicalsinCommerceAct.pdf.
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Elliott†
Cathy
Fehrenbacher*
Christina
Franz*
Vincenza
Galatone*

https://digitalcommons.pace.edu/pelr/vol32/iss1/3

Apr. 2013
May 2013

Occidental Chemical Corporation
Department of Ecology, Washington
State
ExxonMobil
Organization for Economic
Cooperation and Development
BASF
Environment Canada
Environment Agency, United
Kingdom
Covington & Burling, LLP; Yale
Law School
Environmental Protection Agency,
USA
American Chemistry Council

Jan. 2012
Mar. 2013

Nov. 2012

Environment Canada

Apr. 2013

May 2014
Apr. 2013
June 2013
May 2014
May 2013
May 2014
Mar. 2013
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Mike
Gallagher*
Anna Gergely‡
John Giesy*
Serena
Giordano‡
Geoff
Granville*†
Mark
Greenwood*
Joshua Grice*
Joseph H.
Guth*
Dale Hattis‡
Veerle
Heyvaert†
Ron Hites*
Phil Howard*
David Kent*
Amardeep
Khosla*
Masaru Kitano*
Joop de
Knecht*
Akos Kokai*
Eeva Leinala*‡
Fe de Leon*
Peter Lepper*
Gordon
Lloyd*‡
Laurence
Libelo*
Jeff Lincer*‡
Petteri Mäkelä‡
Don Mackay*
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Department of Ecology, Washington
State
Steptoe & Johnson, LLP
University of Saskatchewan
European Chemicals Agency

Mar. 2013

GCGranville Consulting Corp.

Feb. 2014

Greenwood Environmental Council

Dec. 2012

Department of Ecology, Washington
State
University of California, Berkeley

Mar. 2013

Clark University
London School of Economics

May 2014
May 2014

Indiana University
Syracuse Research Corporation
Keller & Heckman
Industry Coordinating Group for
Canadian Environmental Protection
Act
Meiji University
Organization for Economic
Cooperation and Development
University of California, Berkeley
Health Canada
Canadian Environmental Law
Association
European Chemicals Agency
Chemistry Industry Association of
Canada
Environmental Protection Agency,
USA
Researchers Implementing
Conservation Action
European Chemicals Agency
Trent University

Apr. 2013
Jan. 2012
Mar. 2013
Feb. 2013

May 2014
May 2013
May 2014

Feb. 2013

Apr. 2013
Apr. 2013
Mar. 2013
Mar. 2013, May 2014
Feb. 2014
Mar. 2013
Mar. 2013, May 2014
Mar. 2013
Sept. 2013, May 2014
May 2014
Feb. 2013
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Petteri Mäkelä*
Gary Marchant
Kevin
Masterson*
Bette Meek*
Kai Melzer‡
John Moffett*
David Morin*
D. Warner
North†
Johanna
Peltola-Thies*
Ortwin Renn†
Todd Royer‡
Christina Rudén
Jake
Sanderson*‡
Linda Santry*
Martin
Scheringer‡
Dayna Scott†
Jennifer Seed*
David Shortt*
Dick Sijm*‡
Georg Streck*
Anna-Liisa
Sundquist*
Jose Tarazona*
Eisaku Toda*
Henrik Tyle*
Kees van
Leeuwen†
Marta Venier‡
Rob Visser*
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REGULATION OF CHEMICAL RISKS
European Chemicals Agency
Arizona State University
Department of Environmental
Quality, Oregon
University of Ottawa
European Chemicals Agency
Environment Canada
Environment Canada
NorthWorks, Inc.

Mar. 2013
May 2014
Mar. 2013

European Chemicals Agency

Mar. 2013

University of Stuttgart
Indiana University
Stockholm University
Environment Canada

May 2014
Apr. 2014
May 2014
Apr. 2013

NOVA Chemical Corp.
ETH Zürich

Apr. 2013
May 2014

Osgoode Hall Law School, York
University
Environmental Protection Agency,
USA
Dow Chemical Canada ULC
RIVM
DG-Enterprise, European
Commission
European Chemicals Agency

May 2014
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Apr. 2013
May 2014
Apr. 2013
Apr. 2013
May 2014

Mar. 2013
Apr. 2013
May 2013, May 2014
Apr. 2013
Mar. 2013

European Chemicals Agency
Ministry of the Environment, Japan
Environmental Protection Agency,
Denmark
Utrecht University

Mar. 2013
May 2013
May 2013

Indiana University
Organization for Economic
Cooperation and Development (ret.)

May 2014
Jan. 2013

May 2014
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Mike Walls*
David
Widawksy*
Jonathan
Wiener‡
Dolf van Wijk*
Graham
Willmott*

American Chemistry Council
Environmental Protection Agency,
USA
Duke University
Cefic
DG-Enterprise, European
Commission

[Vol. 32
Nov. 2012
Mar. 2013
Sept. 2014
Apr. 2013
Apr. 2013

Note: The interview subjects do not necessarily agree with the methods,
findings, or recommendations in this report.
* Interview Subject
† Compensated Peer Reviewer
‡ Commenter
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